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SUMMARY 
Recent studies have identified in vivo binding profiles of key mesodermal 
regulators across the Drosophila melanogaster genome.  Many of the occupied sites 
lie in the vicinity of loci encoding yet other transcription factors.  The analyzed cis-
regulatory modules drive expression in a variety of complex spatio-temporal patterns 
that cannot be explained by the binding of the core regulators alone.  Thus there 
clearly are additional, unknown transcription factors in the regulatory network that 
governs the process of embryonic mesoderm specification and muscle differentiation. 
In order to identify novel myogenic regulators in a systematic way, and 
thereby enrich the underlying network, I initiated a molecular screen to uncover new 
players.  Candidate putative transcription factors were prioritized based on their 
expression in mesoderm and on available ChIP-on-chip and expression profiling data. 
Their role in myogenesis was subsequently assayed using Drosophila deficiency lines 
whose phenotypes were analyzed with a muscle-specific marker.  Altogether, 67 
different deficiency and loss-of-function lines were used individually or in 
combination to delete 46 transcription factors with mesodermal expression.   In 21 of 
the 46 cases, the mutant embryos displayed specific defects in the development of one 
or more muscle types.   
One pair of partially overlapping deficiencies placed in trans showed a failure 
in myoblast fusion, a process that gives rise to muscle syncytia from mononucleated 
myoblasts.  The corresponding deleted candidate gene was MED24, a subunit of the 
Mediator complex, which is a general co-activator of transcription.  Muscle-specific 
knockdown of MED24 or MED14, another subunit of the complex whose deletion by 
deficiency lines phenocopies that of MED24, leads to lethality.  To establish whether 
MED24 and MED14 are indeed involved in muscle development, I generated smaller 
deletion lines using FRT-mediated recombination.  While deletion of MED14 does 
not affect myogenesis, embryos deficient for MED24 display supernumerary 
mononucleated myoblasts.  Both small deletion lines were then combined together to 
detect possible redundancy that could obscure the requirement of MED14 and 
MED24 in muscle development.  
Another candidate transcription factor within the myogenic network based on 
ChIP-on-chip experiments is the transcriptional repressor Tramtrack69 (Ttk69).  
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Ttk69 is expressed in the primordium of visceral and, more transiently, somatic 
muscle.  In ttk69 mutant embryos, homozygous for a loss-of-function allele, myoblast 
fusion is delayed, the myoblasts aggregate in clusters, and fail to migrate towards the 
ectodermal attachment sites.  Two distinct myoblast populations, a founder cell and 
multiple fusion competent myoblasts, contribute to each muscle fibre.  As revealed by 
immunohistochemistry and in situ hybridization, in ttk69 mutants there are 
significantly more founder cells formed while the number of fusion competent 
myoblasts is decreased.  Consistently, ectopic expression of Ttk69 in the founder 
cells, but not fusion competent myoblasts, gives rise to severe myoblast fusion 
defects.  These phenotypic analyses suggest a model where Ttk69 is required for 
specification of fusion competent myoblasts and in its absence, their conversion to a 
founder cell-like fate may occur.   
According to the proposed model, Ttk69 would repress founder cell genes 
within the fusion competent myoblasts.  To determine whether this holds true on a 
global scale, I performed a high-resolution ChIP-on-chip experiment in 6-8 hour wild 
type embryos.  Indeed, Ttk69 binding was significantly enriched in the vicinity of 
founder cell-specific genes as compared to fusion competent myoblast-specific genes.  
ChIP-on-chip data generated for Lame duck, a transcriptional activator essential for 
fusion competent myoblast determination, showed the opposite tendency.  It therefore 
appears that proper specification of fusion competent myoblast identity requires both 
positive input from Lame duck and inhibition of founder cell-specific genes by Ttk69.  
These findings advance our limited knowledge about the role of transcriptional 
repression within the myogenic regulatory network. 
Finally, I re-evaluated the role of Snail, a well-established transcriptional 
repressor involved in early mesoderm specification and gastrulation.  Multiple 
observations suggested that Snail may also play a positive role in regulating 
mesodermal genes.  To investigate this possibility, I performed luciferase assays with 
previously characterized mesodermal enhancers and showed that Snail can elevate 
their activation levels.  In one case, this ability of Snail was suppressed upon 
mutagenesis of putative Snail binding motifs, both in cell culture and in vivo.  
Moreover, expression of the enhancers and their associated genes is significantly 
reduced in snail mutant embryos.  Snail thus seems to play a dual role in repressing 
non-mesodermal genes, but also in contributing to the activation of some early 
mesodermal genes.  
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ZUSAMMENFASSUNG 
Jüngste Studien haben die in-vivo Bindungsprofile der bedeutendsten 
mesodermalen Transkriptionsfaktoren genomweit in Drosophila melanogaster 
identifiziert. Viele dieser Bindungsstellen befinden sich in direkter Nähe weiterer 
Transkriptionsfaktoren. Die analysierten cis-regulativen Module (CRMs) werden in 
verschiedenen räumlichen und zeitlichen Mustern exprimiert. Diese komplexen 
Muster können mit der Aktivität der wenigen Schlüsselfaktoren nicht erklärt werden. 
Es muss daher weitere, bislang unbekannte Transkriptionsfaktoren geben, die  
Genregulation bei der embryonalen Mesodermspezifizierung und 
Muskeldifferenzierung beeinflussen.  
Um systematisch neue Transkriptionsfaktoren zu identifizieren, und somit das 
genetische Netzwerk der Muskelentwicklung zu erweitern, startete ich einen 
molekulare Analyse. Potenzielle Transkriptionsfaktoren wurden anhand mehrerer 
Kriterien, wie z.B. ihrer mesodermalen Exprimation und ihrer möglichen Regulation 
durch besagte Schlüßelfaktoren, bevorzugt. Deren Wichtigkeit für die Myogenese 
wurde anhand von Defizienz- und ’Loss-of-function’ Mutanten studiert. Insgesamt 
wurden 67 solcher Mutanten benutzt um 46 Transkriptionsfaktoren zu untersuchen. In 
21 von 46 Fällen konnte ich bestimmte abnorme Phänotypen in der 
Embryonalmuskulatur beobachten. 
In einem besonders interessanten Fall kann man mit sich teilweise 
überschneidenden Defizienzmutanten einen klaren Myoblastfusionsdefekt 
beobachten.  Interessanterweise ist das hier fehlende Gen Med24, welches ein 
Bestandteil des Mediator Komplexes ist. Da der Mediator Komplex ein genereller Co-
Activator der Genexprimation ist, bestand hier die Möglichkeit, dass es sich in Med24 
um eine gewebe-spezifische Komponente des Mediator Komplexes handelt. Auch 
Med14 könnte eine muskelspezifische Rolle im Mediator Komplex spielen. Ein 
muskelspezifischer ’knock-down’ von Med24 als auch Med14 ist früh in der 
Embryonalentwicklung letal. Um die Rolle beider Faktoren in der Muskelentwicklung 
näher zu untersuchen habe ich durch FRT-Rekombination wesentlich kleinere, 
zielgerichtete Segmente entfernt. Während Verlust von Med14 nicht zu 
Myogenesedefekten führt, zeigen Med24-defiziente Embryonen eine hohe Anzahl von 
mononuklearen Myoblasten auf.     
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Ein weiterer Transkriptionsfaktorkandidat der Drosophila Muskelentwicklung 
ist der Repressor Tramtrack69 (Ttk69).  Ttk69 wird in den Anlagen der Viszeral- und, 
weniger stark und weniger dauerhaft, auch in der Skelettmuskulatur exprimiert.  
 In ttk69 Mutanten, ist die Fusion der Myoblasten verzögert – Myoblasten 
aggregieren und migrieren scheinbar nicht zu ihren respektiven ektodermalen 
Ansatzstellen (attachment sites).  Zwei bestimmte Zelltypen, Gründer Zellen (founder 
cells, FCs) und Fusions-kompetente Myoblasten (fusion competent myoblasts, 
FCMs), tragen zu jeder Muskelfibrille bei.  Sowohl Immunohistochemie, als auch in-
situ Hybridisierung zeigen, dass ttk69 Mutanten wesentlich mehr FCs aufweisen, 
während die Zahl der FCMs geringer ist. Embryonen die gezwungen werden Ttk69 in 
FCs, nicht aber in FCMs zu exprimieren, sterben meist ab. Dies könnte darauf 
hindeuten, dass Ttk69 für die Spezifizierung von FCMs nötig ist, und das diese Zellen 
in der Abwesenheit von Ttk69 dazu neigen sich als FCs heranzubilden 
 Es ist daher möglich, dass Ttk69 dazu dient die Exprimation von FC-Genen 
in den FCMs zu unterdrücken. Um diese Möglichkeit näher zu untersuchen, habe ich 
eine ChIP-on-chip Studie an 6-8 Std. Wildtyp-Embryonen durchgeführt.  In der Tat, 
Ttk69 konnte insbesondere in der Nähe von FC-spezifischen Genen gefunden werden. 
Interessanterweise zeigen ChIP-on-chip Studien mit Lame Duck, einem Aktivator 
wichtig für FCM Identität, den gegengesetzten Phänotyp auf – Lame Duck ist vor 
allem in der Nähe von FCM Genen zu finden. Es scheint daher, dass zur 
Spezifizierung der FCMs sowohl Genaktivierung durch Lame Duck, als auch negative 
Regulation von FC Genen durch Ttk69 nötig ist. Diese Resultate erweitern unser sehr 
limitiertes Verständnis der Rolle der Genrepression innerhalb des Drosophila 
Muskelnetzwerks. 
Schließlich habe ich auch die Rolle des Repressorproteins Snail näher 
untersucht. Snail ist vor allem für die Etablierung der naïven Mesodermanlage und für 
den Ansatz der Gastrulation wichtig. Einige Observationen legen es nahe, daß Snail 
einige Gene auch positiv regulieren könnte. Um dies näher zu erschließen habe ich 
Luciferase Studien durchgeführt. Tatsächlich ist es der Fall, das einige CRMs durch 
Zusatz von Snail in ihrer Aktivität steigen. Insbesondere in einem Fall konnte ich 
zeigen, das die gesteigerte CRM Aktivität auch tatsächlich von den Snail 
Bindungsstellen abhängt, sowohl in Zellkultur, als auch in vivo. Zusätzlich ist auch 
noch die in vivo Aktivität einiger CRMs in Snail Mutanten gemindert. Daher scheint 
Snail tatsächlich eine Doppelrolle zu spielen, indem es viele nicht-mesodermale Gene 
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in der Mesodermanlage unterdrückt, andere mesoderm-spezifische Gene aber 
aktiviert. 
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ABBREVIATIONS 
ºC degrees Celsius  kDa kilodaltons 
AEL after egg laying l litre 
bp basepairs M molar 
BDGP Berkeley Drosophila Genome  
Project 
MAPK mitogen activated protein 
kinase 
bHLH basic helix-loop-helix ml mililitres 
BTB bric-a-brac, tramtrack, broad-
complex 
mRNA messenger RNA 
cDNA complementary DNA ng nanograms 
ChIP chromatin 
immunoprecipitation 
nM nanomolar 
CNS central nervous system NuRD  Nucleosome Remodeling and 
Deacetylase  
CTD carboxy-terminal domain PCR polymerase chain reaction 
CRM(s) cis-regulatory module(s) PNS peripheral nervous system 
DAPI 4',6-diamidino-2-phenylindole Pol II RNA Polymerase II 
DNA deoxyribonucleic acid PWM position weight matrix 
DSHB Developmental Studies 
Hybridoma Bank 
 
RAS rat sarcoma 2 viral oncogene 
dsRNA double-stranded RNA RNA ribonucleic acid 
EMS ethyl methanesulfonate RNAi RNA interference 
EST expressed sequence tag S2 Schneider 2 
FC(s) founder cell(s) SELEX Systematic Evolution of 
Ligands by Exponential 
Enrichment 
FCM(s) fusion competent myoblast(s) SOP sensory organ precursor 
FDR false discovery rate TAF(s) TBP-associated factor(s) 
FGF fibroblast growth factor TBP TATA-box-binding protein 
FLP flippase TF(s) transcription factor(s) 
FRT flippase recognition target TSS(s) transcriptional start site(s) 
GFP green fluorescent protein UAS upstream activating sequence 
GTF(s) general transcription factor(s) UTR untranslated region 
Ig immunoglobulin µl microliters 
kb kilobase pairs µM micromolar 
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GENE SYMBOLS 
ac achaete Hsp70 Heat shock protein 70 
abd-A abdominal A htl heartless 
ase 
bap 
asense jumu jumeau 
Atg18 Autophagy-specific gene 18 Kr Krüppel 
ato atonal l(1)sc lethal of scute 
bap bagpipe lbe ladybird early 
Bcl-6 B-cell lymphoma 6 lmd lame duck 
bin biniou lwr lesswright 
bnl branchless lz lozenge 
btl breathless Mdr49 Multi drug resistance 49 
Cdk8 Cyclin-dependent kinase 8 MED1-
31 
Mediator complex subunit 1-
31 
ci cubitus interruptus Mef2 Myocyte enhancer factor 2 
CtBP C-terminal Binding Protein MESR4 Misexpression suppressor of 
ras 4 
CycC Cyclin C MHC Myosin heavy chain 
CycE Cyclin E mmy mummy 
dap dacapo msi musashi 
dl dorsal noc no ocelli 
Dll Distal-less odd odd skipped 
dmrt11E doublesex-Mab related 11E phyl phyllopod 
Doc1-3 Dorsocross1-3 pnr pannier 
dpn deadpan pyd polychaetoid 
dpp decapentaplegic rap retina aberrant in pattern 
dTCF Drosophila  T-cell factor repo reversed polarity 
duf dumbfounded rho rhomboid 
en engrailed rib ribbon 
esg escargot row relative of woc 
E(spl) Enhancer of split Complex rst roughest 
eya eyes absent run runt 
eve even skipped sc scute 
fog folded gastrulation scrt scratch 
ftz fushi tarazu sina seven in absentia 
gt giant sinaH sina homologue 
h hairy sim single-minded 
hb hunchback slp sloppy paired 
hbs hibris sna snail 
hh hedgehog sns sticks and stones 
HmgZ HMG protein Z sog short gastrulation 
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srp serpent TRF3 TBP-related factor 3 
stg string ttk69 tramtrack69 
sug sugarbabe ttk88 tramtrack88 
Su(H) Suppressor of Hairless twi twist 
svp seven up Ubx Ultrabithorax 
TAF3 TATA binding protein 3 vnd ventral nervous system 
defective 
ths thisbe wg wingless 
tin tinman wntD wnt inhibitor of Dorsal 
tll tailless zen zerknüllt 
trbl tribbles zfh1 Zn finger homeodomain 1 
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1 INTRODUCTION 
1.1 Differential gene expression: the basis for development 
 Neurons, hepatocytes, myoblasts, melanocytes, fibroblasts, oligodendrocytes.  
These are only a fraction of the broad cell categories that are found in our bodies.  It is 
estimated that we are made of hundreds of different cell types, each having a very 
unique morphology and a highly specialized role.  The function of a neuronal cell 
cannot be replaced by a myoblast, and vice versa.  Yet all the cells originate from one 
single cell, and they are identical at the level of their deoxyribonucleic acid (DNA) 
sequence.  How such a tremendous diversity of cell types possessing the same genetic 
information are generated from an individual cell remains a fundamental question of 
developmental biology.  
The key to cell diversification is the way in which DNA information is 
interpreted and used.  The protein repertoire of neurons is very different from 
myoblasts, even though the genome encoding the proteins is the same.  It is the 
differential expression of genes that leads to the protein, and thereby cellular, 
diversity.  As the expression of neuronal rather than muscle proteins within a muscle 
cell would have detrimental effects for a developing organism, gene expression is 
subject to tight control at multiple tiers.  These range from the accessibility of the 
DNA sequence to the transcriptional apparatus, through stability and splicing of the 
synthesized ribonucleic acid (RNA), to the translation, folding, and activity of the 
protein.  All the processes leading from the DNA sequence to a protein and their 
control are tightly coordinated in space and time (reviewed in [1]).  The first step of 
gene expression regulation is the initiation of transcription, when genes are 
transcribed into primary transcripts in a highly controlled and complex manner [2].    
 
1.1.1 The initiation of transcription is key to differential gene 
expression 
Transcription is fundamental to all biological processes, cell types, and species.  
Its initiation requires the binding of the general transcriptional apparatus to the basal 
promoter sequences that lie in the immediate upstream vicinity of the transcriptional 
start site (TSS).  In eukaryotes, there are three RNA polymerase enzymes, each 
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transcribing a particular type of RNA, but it is RNA polymerase II (Pol II) that is 
responsible for transcription of protein-coding genes and regulatory, non-coding 
RNAs (reviewed in [3]).  Eukaryotic Pol II is recruited to the promoter region via the 
assembly of general transcription factors (GTFs).  
The regulation of transcriptional initiation is essential for differential gene 
expression and thereby development.  It is achieved through the binding of sequence-
specific transcription factors (TFs) to their binding sites, which are typically clustered 
in regulatory elements (reviewed in [4]).  As these elements can be located at any 
distance from the regulated gene and can influence transcriptional output positively or 
negatively, they are often referred to as cis-regulatory modules, or CRMs.  Typically, 
the CRMs in the Drosophila genome are about 500 base pairs (bp) in size and contain 
binding sites for multiple TFs.  The activity of a given CRM is therefore a readout of 
the combination of inductive as well as restrictive inputs supplied by several TFs. 
When CRMs are analysed individually in transgenic reporter assays, they can 
recapitulate all or a part of the gene’s expression, but only when they are examined 
collectively is the full expression of the gene recovered.  The expression of a gene is 
therefore driven by multiple modular CRMs which integrate inputs from several 
regulators (reviewed in [5]) (Figure 1.1-1). 
 
Figure 1.1-1: Tissue-specific gene expression is driven by the activity of cis-regulatory 
modules 
A locus of a hypothetical gene whose expression is driven by three cis-regulatory modules 
(CRMs A, B, C) at different times and locations in the Drosophila embryo.  Each CRM 
consists of clusters of binding sites (shown only for the CRM B) recognized by distinct 
transcription factors, TFs.  The basal promoter is positioned at the start of the transcriptional 
unit.  Note that CRMs can be located upstream, downstream, or in the intronic regions of the 
regulated gene.  Embryo images are from [6]. 
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1.1.2 Transcriptional repression in developmental decision making 
Undoubtedly, transcriptional repression is at least as important as transcriptional 
activation in controlling gene expression during development.  Repression is 
particularly important when broad morphogen gradients are translated into sharp 
domains of gene activity (reviewed in [7]) or when a particular cell identity is  
specified and maintained over time (reviewed in [8]). 
There are multiple indirect mechanisms to suppress transcription which do not 
require the repressor to directly bind to DNA.  For instance, via the inhibition of 
nuclear import of an activator, inaccessibility of the regulatory sequences due to 
chromatin composition, or titration of the activator by direct protein-protein 
interaction. An important category are transcriptional co-repressors which by 
themselves cannot bind DNA, but are recruited by sequence-specific TFs through 
direct or indirect protein-protein interaction.  Co-repression is often mediated by 
localized histone deacetyletion which results in gene silencing [9]. 
Sequence-specific, DNA binding transcriptional repressors can block 
transcription by a number of mechanisms.  The simplest manner is competition for 
overlapping binding sites between an activator and a repressor.  Originally it was 
assumed that this mechanism was broadly used in setting up the anterior-posterior 
axis in Drosophila embryos [10].  However, mutagenesis and rearrangement of the 
implicated binding sites suggested that another mechanism, named quenching, might 
be used instead [11].  In this situation, both the activator and repressor bind to nearby 
sites, however the repressor prevents interaction between the activator and the basal 
transcription machinery, thereby quenching its transcriptional activity.  An example of 
a TF that represses transcription via quenching is Snail, a repressor of non-
mesodermal gene expression in early embryogenesis.  When Snail’s binding motifs 
are placed within a 100 bp distance from the activator sites, they can efficiently 
mediate short-range repression [12].  More recently, Snail was found to directly 
interact with two general co-repressor proteins, the C-terminal Binding Protein 
(CtBP) [13] and Ebi [9], that are essential for repression of its target genes.   
Another mode of transcriptional repression is a direct interaction of the 
repressor with the basal transcriptional apparatus.  While the two mechanisms 
described above enable repression of selective CRM activity, the outcome of direct 
repression is a complete abolishment of transcription, named silencing [14].  
1.1 Differential gene expression: the basis for development  
 
 -23- 
Therefore, competition and quenching contribute to the modularity of CRMs and 
enable their inactivation independently of other CRMs, while silencing affects the 
total transcriptional activity of a gene. 
 
1.1.3 The Mediator complex and its role in the regulation of gene 
expression 
The Mediator complex was originally isolated in yeast Saccharomyces 
cerevisiae as a component of the basal transcription apparatus necessary for the 
transcriptional initiation by RNA Polymerase II (Pol II) [15].  It was then successively 
purified from higher organisms where it was found to have an evolutionarily 
conserved composition and function [16].  Likely reflecting the greater organismal 
complexity, the metazoan Mediator complex contains additional subunits that are 
organized into modules with distinct functions [17].  Individual subunits have been 
implicated in transcription of developmentally regulated genes (see Section 1.1.3.3) 
and mutant alleles are often lethal at early developmental stages [18, 19].  
Consequently, the Mediator complex operates as a further layer in gene expression 
control contributing to the developmental regulatory programs of multicellular 
organisms.   
 
1.1.3.1 Mediator subunits are organized into different domains 
There are currently 33 distinct genes classified by gene ontology terms [20] to 
encode members of the Drosophila Mediator complex.  Similarly to the yeast 
complex, they are organized in four modules [21-23].  Subunits of the tail module 
bind sequence-specific transcription factors [24], the largest head domain interacts 
directly with Pol II, and the middle subunits connect the two modules together and 
contribute to the Pol II interaction scaffold (Figure 1.1-2).  Importantly, the 
arrangement of the subunits into modules was also validated at the functional level as 
subunits within one module interact genetically in yeast [25]. 
The fourth and best studied Mediator domain is composed of Cyclin-dependent 
kinase 8 (Cdk8), Cyclin C (CycC), MED12, and MED13 (Figure 1.1-2).  Unlike the 
three core modules, the yeast Cdk8 submodule is separable and only loosely 
associated with the Mediator complex [26].   In yeast, this module plays a repressive 
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rather than activatory function [27] and it was suggested that it does so by inhibiting 
stable interaction between the Mediator complex and Pol II [28].  Phenotypic analyses 
showed that the Cdk8-CycC and MED12-MED13 pairs play different functions 
during Drosophila development as they control expression of different genes and their 
loss-of-function alleles cause distinct phenotypes [18, 29].  Cdk8 in addition 
stimulates TFIIH-mediated phosphorylation of Pol II carboxy-terminal domain (CTD) 
[30].  Apart from being essential for transcription itself, hyperphosphorylation of 
CTD also couples transcription with messenger RNA (mRNA) processing and 
chromatin remodelling (reviewed in [31]). 
  
 
Figure 1.1-2: Organization of the Drosophila Mediator complex  
The arrangement of the Mediator subunits was derived from pairwise interaction studies in 
yeast but seems to be conserved up to Drosophila [21, 32].  In black are Drosophila-specific 
subunits, whose physical position within the complex is unknown.  
 
 
1.1.3.2 Activation of transcription by the Mediator complex 
In contrast to yeast where the Mediator complex co-exists with Pol II as a 
holoenzyme, in higher organisms it is recruited to DNA independently [33].  
Chromatin immunoprecipitation (ChIP) experiments in yeast showed that orthologues 
of the Drosophila subunits MED12, MED14, MED17, and MED22 bind to upstream 
activating sequences (UAS) rather than promoter regions, and they do so even when 
the assembly of Pol II is genetically disabled or the promoter core sequences are 
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deleted [34].   The yeast subunits MED7 and MED13 were found to co-occupy not 
only regulatory elements, but also protein-coding regions [35].  The finding that the 
Mediator complex is recruited in a selective manner was confirmed at a global level 
when ChIP coupled with microarrays was used to determine in vivo binding profiles 
of yeast MED5, MED15, and MED17 subunits [36].  Surprisingly, the Mediator 
complex was found to occupy DNA only under stress conditions and its binding did 
not fully correlate with Pol II recruitment [36]. 
The Mediator complex directly interacts with some, but not all, general 
transcription factors (GTFs), which were suggested to provide promoter specificity. 
However, Mediator brings also sequence-specific TFs and Pol II together [30].  The 
Drosophila complex was purified using an anti-MED31 antibody, which revealed that 
it physically interacts with the sequence-specific transcriptional regulators Bicoid, 
Krüppel, Fushi tarazu, but not with Twist or Hunchback [30].  Consequently, the 
Mediator complex is often pictured as a bridge integrating signals from sequence-
specific regulators and the basal transcriptional machinery.   
The mechanisms by which Mediator stimulates transcription remain elusive.  
According to a reinitiation model [37], when Pol II leaves the promoter region and 
enters elongation, the Mediator complex and some GTFs remain localized at the 
promoter to which another molecule of Pol II could then be recruited.  However, the 
exact biochemical nature of the ability of Mediator to activate or repress transcription 
remains to be clarified. 
 
1.1.3.3 Specific regulatory functions of Mediator subunits in Drosophila 
development 
While yeast is an excellent system for elucidating the structure and mechanism 
of the Mediator complex, knowledge about its functional importance for cell viability 
and cell fate determination has been gathered in metazoan models, including 
Drosophila [18, 19, 38].  Differential usage of individual subunits in different 
developmental processes has become evident from multiple studies that are 
summarized in the Table 1.1-1. 
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Subunit(s) Tissue/cell type Role Ref. 
MED6 Follicle cells, imaginal discs Cell cycle regulation, cell viability [39] 
Patterning along anterior-posterior axis [40] 
Activation of Wingless targets [41] Wing disc 
Repression of Ubx [29] 
Eye disc Regulation of atonal and decapentaplegic (dpp); co-regulation of Atonal targets 
[38, 
42] 
Antennal disc Regulation of Distal-less and eyeless [42] 
Leg disc Malformation of sex combs and leg shortening in mutants; expression of bab2 [18] 
MED12 
MED13 
Crystal cells Differentiation by co-activation of Serpent and Lozenge targets [32] 
MED13 
MED17 
Imaginal discs Distal sex comb and labial identity specification [43] 
Cdk8-CycC Leg disc Malformation of sex combs in mutants [18] 
MED15 Imaginal discs Co-activation of Dpp targets, cell death in mutant clones [44] 
MED16 Cell line Activation of lipopolysaccharide genes [45] 
MED17 Cell line Activation of an antimicrobial peptide Drosomycin by Toll pathway [46] 
MED20 
MED30 Wing 
Reduced size, absence of veins, and cell 
death in mutant clones 
[44] 
 
MED23 Cell line Activation of heat shock-specific gene [45] 
MED24 Salivary gland Regulation of apoptosis [47] 
MED31 Blastoderm embryo Establishment of anterior-posterior axis [19] 
Table 1.1-1: Mediator subunits play specific roles in Drosophila development 
Overview of currently known roles played by the Mediator complex during Drosophila 
development with corresponding references. 
 
1.1.3.4 Links between the general transcriptional machinery and muscle 
development 
Individual Mediator subunits as well as GTFs have been implicated in several 
developmental processes, including myogenesis in Drosophila and vertebrates.   
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Although our understanding of the association between the general transcriptional 
apparatus and cell fate decisions is still very limited, the few known examples suggest 
it plays an important role that will certainly be subjected to further investigations. 
It is widely accepted that Pol II is recruited to the core promoter by TFIID, a 
protein complex composed of TATA-box-binding protein (TBP) and several TBP-
associated factors (TAFs).  Therefore the observation that the expression of TBP and 
most TAFs upon differentiation induction in murine muscle precursor cells is 
significantly reduced [48], was rather surprising.  Only two of the analysed subunits, 
TATA binding protein 3 (TAF3) and TBP-related factor 3 (TRF3) continue to be 
expressed and form a complex that is necessary for the myogenic regulator MyoD to 
activate transcription of its targets [48].  Similarly, expression of the Mediator 
subunits declines upon differentiation and the presence of Mediator is not required for 
transcription of muscle differentiation genes in vitro [49].  These exciting findings 
showing differential usage of the basal transcriptional machinery during cell 
differentiation provoke many questions which remain to be answered.  For example, it 
is currently not clear whether this is a muscle-specific phenomenon or a widely used 
mechanism common to all differentiating cells.  Requirement of other TAF proteins 
was previously described in Dorsal and Twist mediated activation of early 
mesodermal genes in Drosophila embryos [50].  How the levels and requirement of 
TAF proteins change with the progression of development has however not been 
addressed. 
A subunit of the Mediator head module, MED28, counteracts the smooth 
muscle differentiation program in two different murine cell types by negatively 
regulating the implicated genes [51].  Although in vivo evidence is still lacking, the 
results support the notion of tissue-specific roles for distinct Mediator subunits as well 
as the participation of the complex in negative aspects of gene regulation. 
Importantly, RNA interference (RNAi) against three subunits of the 
Drosophila Mediator complex, MED4, MED11, and MED24, were reported to lead to 
muscle-related defects during embryogenesis [52].  As the aim of the study was 
identification of novel neuronal regulators, the muscle phenotype was not presented or 
analyzed in more depth.  Nevertheless, together with the above-mentioned examples, 
this observation points to a role of specific Mediator subunits in Drosophila muscle 
development. 
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1.1.4 General principles of developmental cis-regulatory networks 
In higher organisms, a single sequence-specific TF can contribute to the 
expression of hundreds or even thousands of genes [53].  Specification of a given cell 
type requires many TFs, each having a specific set of target genes.  As a single CRM 
integrates inputs from multiple TFs, the control of gene expression is highly 
combinatorial.  Consequently, a developmental program is driven by intricate 
regulatory networks or circuits composed of many TFs impinging on a partially 
overlapping array of CRMs (reviewed in [54]). 
Regulatory circuits in addition to being very elaborate and dynamic are also 
highly interconnected.  For example, the networks governing the patterning of the 
Drosophila embryo along the anterior-posterior and dorsal-ventral axes are 
interconnected through the action of their key regulators [55, 56].  An emerging 
common theme of developmental networks is also their degree of feed-back and feed-
forward regulation, where TFs activate genes encoding yet additional TFs which then 
either feed forward or on each other to co-regulate common sets of target genes 
(reviewed in [57]). 
Developmental regulators are usually conserved across species, although their 
position within the regulatory network might have diverged.  For example, members 
of the Eya/Six family of TFs are essential for muscle development across metazoans. 
However, while they are positioned at the top of the regulatory hierarchy in 
vertebrates, in the invertebrate model systems Drosophila melanogaster and 
Caenorhabditis elegans they are placed further downstream of the myogenic 
regulators (Figure 1.1-3).   These changes in network architecture might reflect the 
natural differences in the physiology and complexity of the organisms.  In some 
systems, certain developmental subcircuits may be fixed across evolution not only at 
the level of the TFs and regulated processes, but also in the wiring between their 
components [58].  As the data required to perform direct interspecies comparisons of 
gene regulatory networks are still very limited, many questions regarding the 
conservation and divergence of network topology remain to be addressed.  
  
1.1 Differential gene expression: the basis for development  
 
 -29- 
 
Figure 1.1-3: Conservation and divergence of regulatory networks across evolution 
Comparison of the core regulatory network underlying myogenesis in vertebrates, D. 
melanogaster, and C. elegans.  TFs that are members of the same protein family are displayed 
in the same colour.  Full lines show direct transcriptional regulation and dashed lines 
represent genetic interactions currently lacking evidence for direct regulation. 
 
 
 
1.1.5 Drosophila muscle development as a model for dissecting the 
logic of regulatory networks 
The fruitfly Drosophila melanogaster has a long-lasting tradition in 
developmental genetics as an indispensable invertebrate model.  Thanks to a century 
of research, there is an enormous toolkit available to study Drosophila development, 
behaviour, diseases, or evolution at diverse levels.   Compared to vertebrate models, 
Drosophila has the great advantage of a fast generation time, relatively simple 
development, and a compact genome.  At the same time, many of its processes are 
analogous to those in vertebrates, both at the morphological and molecular level. 
One such process is the development of the larval musculature that occurs 
already during embryonic stages.  Similarly to vertebrates, there are three types of 
muscle tissues in Drosophila embryos: somatic (or body wall) muscle enabling 
locomotion, visceral muscle lining the digestive tract, and the heart (or dorsal vessel) 
pumping the haemolymph.  The myoblast cells that these tissues are composed of 
vary in their position, morphology, as well as function, yet they all come from a 
common pool of pluripotent mesodermal cells (Figure 1.1-4 A).  Decoding the cis-
regulatory mechanisms leading to the specification of the three muscle lineages is 
central to understanding muscle development and identifying general principles that 
are likely to be shared with other developmental regulatory networks.  
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Genetic, and more recently genomic, studies are beginning to reveal the 
molecular blueprints and the regulatory pathways leading to the specification of 
different muscle types.  There are five core transcription factors that orchestrate 
specification of mesodermal precursor cells and their progressive diversification and 
differentiation into the three muscle tissues (Figure 1.1-4 B).  The mesodermal master 
regulator is a basic helix-loop-helix (bHLH) factor Twist (Twi) that initiates a cascade 
of mesoderm-specific regulatory events.  Its immediate targets are Myocyte enhancer 
factor 2 (Mef2) [59], a major differentiation factor required for all three muscle types, 
and Tinman (Tin) [60], necessary for the specification of the heart, the visceral 
muscle, and a subset of the somatic muscles.  Tin promotes visceral muscle 
specification by activating Bagpipe (Bap), which then together with its target Biniou 
(Bin) establishes the visceral muscle identity program [61].  Mef2 is expressed until 
the very end of embryogenesis in all three muscle tissues where it induces 
differentiation by regulating expression of a variety of genes [62]. 
 
 
Figure 1.1-4: Muscle development in Drosophila melanogaster  
(A)  Overview of the three muscle types in the Drosophila embryo and an outline of the 
processes leading to their formation.  Embryo images are from [6]. 
(B)  The five key mesodermal TFs forming the core myogenic network.  The colour of the 
boxes indicates the tissues from (A) that have associated phenotypes for each TF. 
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1.2 Early stages of mesoderm development in Drosophila 
embryos 
1.2.1 A nuclear gradient of the transcription factor Dorsal 
subdivides the dorsal-ventral axis of the blastoderm embryo 
Division of the blastoderm embryo along the dorsal-ventral axis sets the 
boundaries between the presumptive mesoderm and ectoderm and serves as a 
paradigm to study how a single factor can trigger initiation of several unique 
developmental programs.  The TF Dorsal acts as a morphogen, where its nuclear 
concentration is distributed in a ventral to dorsal gradient.  The nuclear concentration 
gradient of Dorsal is interpreted at the cis level and leads to different transcriptional 
responses along the dorsal-ventral axis, resulting in patterning of the embryo into 
regions of cells with different identities. 
 
1.2.1.1 Establishment of a concentration gradient of nuclear Dorsal  
The foundation of the complex events leading to the nuclear Dorsal gradient 
formation is laid during oogenesis, when the maternally supplied Dorsal protein is 
prevented from entering the oocyte nucleus via an association with the protein Cactus 
[63, 64].  Upon fertilization, serine proteases localized in the space between the 
oocyte and its vitelline shell are, through a poorly understood mechanism, activated 
only in the ventral region where they produce activated Spätzle protein [65].  The 
activated Spätzle ligand binds to the ubiquitously distributed Toll membrane receptor 
and induces a cascade of signalling events, which lead to the phosphorylation and 
proteasome-dependent degradation of Cactus (reviewed in [66]).  At this stage, the 
embryo is still a syncytium and the cell membranes have not yet been formed, so the 
released Dorsal protein can readily enter the nuclei.  Since the Toll signalling pathway 
is activated by Spätzle ligand diffusing through the perivitelline space from the 
ventral-most region, the concentration of nuclear Dorsal protein is highest in the 
ventral-most cells and gradually decreases from the ventral to dorsal side of the 
embryo (Figure 1.2-1). 
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1.2.1.2 Different Dorsal concentrations elicit different transcriptional responses 
Although only two different Dorsal binding motifs have been identified [67, 
68], the differences in its effective concentration combined with other regulatory 
factors lead to several broad classes of regulatory responses (reviewed in [69]).  In the 
fourteen ventral-most cells, which contain the highest levels of nuclear Dorsal protein, 
Dorsal activates the expression of the mesodermal master regulator Twist via low 
affinity Dorsal binding sites [70].  Together with Twist, Dorsal then initiates the 
expression of a whole range of mesodermal genes, including snail [68].  In the lateral 
region of the embryo, intermediate levels of Dorsal specify the neurogenic ectoderm 
anlage.  Depending on the input from additional signalling pathways, Dorsal targets 
can be expressed throughout the entire neurogenic ectoderm (such as short 
gastrulation (sog) [71] or thisbe (ths) [72]) or only in subparts (such as rhomboid 
(rho) [67] or ventral nervous system defective (vnd) [73]).  Delineating the border 
between mesoderm and neurogenic ectoderm is a single row of mesectodermal cells 
marked by expression of single-minded (sim) [74].   
Although Dorsal is inherently a weak activator, in certain developmental 
contexts it can repress transcription [75].  By recruiting the general co-repressor factor 
Groucho [76], Dorsal negatively regulates transcription of decapentaplegic (dpp) [77] 
and zerknüllt (zen) [78] in the ventral and lateral regions of the embryo.  Therefore the 
absence or very low levels of Dorsal in the nuclei of the dorsal-most cells lead to the 
localized expression of dpp and zen, resulting in the specification of the dorsal 
ectoderm and extraembryonic tissues.  
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Figure 1.2-1: The establishment of the dorsal-ventral axis in the blastoderm embryo 
Cross section through a blastoderm (stage 5, staging according to [79]) embryo showing the 
mesoderm in blue, neurogenic ectoderm in purple, and dorsal ectoderm in yellow, which are 
specified by a gradient of intranuclear Dorsal protein (red).   Genes differentially expressed 
along the dorsal-ventral axis are shown next to the site of their expression. 
 
 
 
1.2.2 Twist and Snail: two major transcriptional regulators in the 
presumptive mesoderm 
Being a classic example of a true master regulator, the transcription factor Twist 
(Twi) is both essential for mesoderm specification [80] as well as being sufficient to 
convert non-mesodermal cells to a mesodermal fate [81].  The molecular mechanisms 
underlying this capacity have been recently uncovered by genome-wide studies [55, 
56], which established Twi as a direct regulator of a vast collection of genes involved 
in transcription, cell morphogenesis, migration, and proliferation.  One of the shared 
direct targets of Twi and Dorsal is snail (sna) [68], encoding a zinc finger 
transcriptional repressor that is critical for the specification of the presumptive 
mesoderm and its subsequent invagination during gastrulation [82].   
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Although the expression patterns of twi and sna are vastly overlapping, they are 
not fully coincident, which has important functional implications [83].  Twi is 
expressed in a graded fashion with the highest levels in the ventral-most mesodermal 
cells, but decreases in expression towards the more lateral regions [83].  The 
boundary of its expression is diffuse and extends up to the mesectoderm and the most 
ventral cells of the neurogenic ectoderm where Twi is required for the activation of 
respective genes (Figure 1.2-1).  Sna, on the other hand, shows a more uniform 
expression confined to the presumptive mesodermal cells [83].  Its boundaries are 
rather sharp and precisely define the border of the mesoderm as it represses 
mesectodermal and neuroectodermal gene expression within the mesodermal domain 
[83].  
In the mesoderm, Twist and Snail orchestrate expression of a repertoire of genes 
necessary for gastrulation, which is one of the first morphogenetic movements that a 
Drosophila embryo undergoes.  In the course of gastrulation, mesodermal cells are 
internalized in a two-step process.  During developmental stages 6 and 7 (staging 
according to [79]), the ventral-most cells undergo apical constriction where their 
apical surfaces become shorter.  This forces the basal side of the cells to ingress into 
the interior of the embryo, forming a furrow.  At stage 8, the new internal tube formed 
by the furrow dissociates and the cells spread laterally over the ectodermal cells [82].  
As a result, by stage 9 the mesodermal cells are arranged in a continuous sheet 
beneath the outer, ectodermal cells.  During stages 8 to 11, the mesodermal cells 
undergo three rounds of mitosis [79], hence their number increases rapidly. 
Up to late stage 10, the mesoderm is a homogenous population of pluripotent 
cells that are recognized by the expression of general, termed panmesodermal, 
markers twi and its targets Mef2 and tin.  Expression of sna undergoes a switch where 
at stage 8 it ceases to be expressed in the mesoderm and instead initiates in the 
neuroectoderm where it remains until the end of embryogenesis [84]. 
 
1.2.2.1 A dual role for Snail as both a positive and negative regulator of 
transcription 
Traditionally, Snail has been perceived as a dedicated repressor of transcription 
with a well-characterized set of direct target genes [56, 83].  Experimental results that 
suggested a positive regulatory input from Snail were therefore usually interpreted as 
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indirect effects of Snail repressing other, unknown repressor(s).  However, the recent 
findings from genome-wide chromatin immunoprecipitation techniques have inspired 
re-evaluation of the possibility that Snail could indeed elicit positive regulation of 
transcription.  These experiments showed that Snail occupies a number of enhancers 
that are active in mesodermal cells at the same stages as Snail binding was observed 
(Figure 4.3-1).  In light of these results, the evidence dispersed in literature within the 
past two decades is consistent with the premise that Snail could indeed function as a 
transcriptional activator. 
When some of the key mesodermal genes were described for the first time, their 
expression was analysed in the available mutant lines to identify their upstream 
regulators.  Consequently, it was noticed in individual studies, that mRNA transcripts 
of twi [85], Mef2 [86], tin [87], heartless (htl) [88], folded gastrulation (fog) [89], Zn 
finger homeodomain 1 (zfh1) and serpent (srp) [90], and at least three other 
mesodermal genes [91] are either substantially reduced or completely absent in sna-
deficient embryos.  Absence of mesodermal gene expression in sna mutants was often 
attributed to the reduction in twi mRNA [85] as Twi is the major activator of these 
genes [59, 60].  However, Twi protein persists in sna mutant embryos during and 
even after the stages when the expression of mesodermal genes is lost [82].  
Moreover, there is no known candidate repressor upstream of these genes that would 
be repressed by Snail, suggesting that Snail is directly needed for activation of 
mesodermal genes.  This proposal is strongly supported by an in vivo experiment 
where low levels of Snail protein introduced genetically into sna mutants partially 
restored tin expression in the presumptive mesoderm [92].  In contrast, the repression 
of rho and sim was not rescued by low levels of Snail [92], suggesting that repression 
and activation might need high and low levels of the TF, respectively. 
Another line of evidence for activatory input from Snail comes from reporter 
assays in Drosophila Schneider 2 (S2) cells.  The reporter was driven by a Snail 
binding sequence element identified in an electrophoretic mobility shift assay [93].  
When a Snail expression vector was co-transfected into the cells, the reporter activity 
levels were estimated to increase up to 32-fold [93]. 
In sna or twi mutant embryos, mesodermal cells fail to invaginate but can form 
irregular folds or a furrow, respectively [82].  When both sna and twi are absent, the 
mesodermal cells do not undergo any apparent cell shape changes and form a furrow 
only rarely [82].  Expression of Sna can induce partial invagination even in absence of 
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Twi while Twi is not able to rescue the gastrulation defect in sna mutant [92]. In 
addition, mesodermal cells expressing sim and rho can still invaginate [92], indicating 
that derepression of neuroectodermal genes is unlikely to be the only reason for 
gastrulation failure in sna mutants.  One of the proposed models explaining the 
gastrulation defects in sna mutant embryos therefore relies on Snail positively 
regulating genes that initiate the ventral furrow invagination [92]. 
Finally, a Snail-like TF can activate reporter expression in Caenorhabditis 
elegans animals through a Snail motif that is necessary for the reporter activity [94].  
In a human liver carcinoma cell line, Snail co-operates with two transcriptional 
activators and through direct DNA binding stimulates transcription of their target 
gene [95].  Therefore, the potential of Snail to perform a dual function might not be 
confined to Drosophila but may be a general feature of Snail-like TFs in multiple 
species. 
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1.3 Muscle development in Drosophila embryos 
1.3.1 Inductive signals from the ectoderm subdivide the mesoderm 
into four domains 
After gastrulation, the mesodermal cells are pluripotent and can give rise to any 
of the Drosophila muscle types [96].  The observation that the developmental fate of 
the transplanted mesodermal cells is related to their position in the embryo [96] 
suggested an involvement of other germ layers in mesoderm specification.  A 
molecular understanding of this process was initiated when the signals necessary for 
mesoderm patterning were identified.  Secreted ligands from the overlying ectoderm 
in combination with mesoderm intrinsic factors (for example Twist) subdivide the 
mesoderm into roughly four domains per each of the eleven thoracic and abdominal 
hemisegments.  
Along the dorsal-ventral axis, the dpp morphogen restricts the expression of Tin 
to the dorsal mesoderm [97] where it is required to specify the primordia of heart, 
visceral muscle, and dorsal somatic muscle [98]. The subdivision of the mesoderm 
along the anterior-posterior axis is under the control of the pair rule genes even 
skipped (eve) and sloppy paired (slp) along with the segment polarity genes hedgehog 
(hh) and wingless (wg), respectively [99].  Wg signalling via its effector Drosophila 
T-cell factor (dTCF) directly activates slp only in the Wg-compartment [100].  In the 
dorsal Tin-expressing domain of the Wg-compartment, the primordia of the cardiac 
and dorsal somatic mesoderm are established [101, 102] (Figure 1.3-1).  The ventral 
mesodermal cells that are not exposed to Dpp signalling will contribute to the 
remaining somatic musculature.  The dorsal part of the eve compartment, that does 
not receive Wg signalling, forms the visceral mesoderm primordium [101] while the 
ventral region gives rise to fat body (Figure 1.3-1).  The key regulator of fat body 
lineage is Serpent, a GATA-like TF whose deletion leads to an absence of fat body 
progenitors [103].  Differentiated fat body cells fill in the cavities between somatic 
and visceral musculature and are non-contractile cells that perform many of the 
metabolic functions of the mammalian liver [104, 105]. 
As a consequence of the subdivision of the mesoderm along the dorsal-ventral 
and anterior-posterior axes, there are three different types of muscle primordia in 
Drosophila embryos.  These give rise to somatic, visceral, and cardiac muscles.  Once 
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their fate is committed, the myoblasts of the somatic and visceral mesoderm initiate 
differentiation during which they change their morphology, migrate, divide, undergo 
fusion, interact with other cells, and finally produce functional, contractile myofibers. 
 
 
Figure 1.3-1: Subdivision of mesoderm by synergism between extrinsic and intrinsic 
signals 
The presumptive mesoderm is specified by ectodermally-derived dpp, hh, and wg signalling 
molecules in combination with mesodermally expressed eve and slp pair rule genes into four 
primordia.  Two of the eleven hemisegments are shown.  
 
 
1.3.2 Specification and morphogenesis of the visceral musculature 
The visceral musculature (VM) in the Drosophila embryo consists of four 
muscle types surrounding the gut: foregut VM, hindgut VM, trunk or midgut circular 
VM, and the longitudinal VM which forms a second muscle layer only around the 
midgut (reviewed in [106]). 
The establishment of the circular VM is the best characterized and its 
specification is initiated by the interplay of positive signals from Dpp and Tinman and 
negative regulation by Sloppy paired [101].  The outcome of their combined action is 
the activation of Bagpipe (Bap) only in the dorsal region of the eve compartment in 
each parasegment.  Bagpipe along with the effectors of Dpp signalling and Tin 
activate Biniou (Bin) [61].  Bin then feeds back and positively regulates Bap and 
deletion of either Bin or Bap results in a complete failure of circular VM formation 
[61, 107].  While Bin is a chief transcriptional regulator targeting a broad repertoire of 
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developmental genes, Bap has a more restricted regulatory potential and typically 
serves as a contributor to Bin-mediated regulation [108].   
Once specified, the circular VM progenitors migrate along the anterior-posterior 
axis to form a continuous row of cells that ingress inside the embryo.  These cells are 
however not a homogenous population as two distinct cell types, a founder cell and a 
fusion competent myoblast, undergo heterotypic fusion to form binucleated muscle 
syncytia [109].  These muscle cells then elongate vertically and cover the entire gut 
circumference.  Finally, the visceral muscle is further subdivided along the anterior-
posterior axis [110] and crosstalk between homeotic genes and signalling pathways 
specifies precise positions of the gastric caeca and the three constrictions around 
which the midgut will undergo morphogenetic looping at stages 15 and 16 [111]. 
 
1.3.3 Cardioblasts specification and the formation of a functional 
heart 
The Drosophila heart is a dorsally located linear tube, the main function of 
which is to pump the haemolymph throughout the larval body.  It is composed of two 
parts, the aorta and heart proper in the anterior and posterior portion of the embryo, 
respectively.  At a cellular level, two major cell groups contribute to the heart; the 
contractile cardiomyocytes or cardioblasts themselves and the supporting pericardial 
cells.  Both cell types arise from the dorsal embryonic mesoderm and are segregated 
through asymmetric cell division [112].  The integration of inputs from Dpp and Wg 
signalling and Tin, Dorsocross (Doc) and Pannier (Pnr) transcription factors leads to 
cardioblast specification within the cardiac mesoderm [113, 114].  In each 
parasegment, there are six cardiac cells that are further patterned, as four cells are tin-
positive, two of which express another TF, Ladybird early (Lbe) [115], while the two 
other cardioblasts are tin-negative but seven up (svp)-positive [116].  Eventually, the 
distinct cell fates translate into different physiological functions as, for example, the 
cells marked by svp in the three most posterior segments participate in the formation 
of ostia, the inflow tracts for the haemolymph [117]. 
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1.3.4 The specification of somatic muscle progenitors is orchestrated 
by crosstalk between multiple pathways 
The somatic muscle primordium contains persistently high levels of Twist 
protein, which requires Wg signalling and slp expression [118, 119].  In contrast, the 
visceral mesoderm and fat body are derived from the low-Twist expressing domain, 
as a result of Notch-mediated Twist repression ([120], see Section 1.3.4.1).  High 
levels of Twist are essential for somatic mesoderm specification as when they are 
genetically reduced, the somatic progenitors are specified as visceral mesoderm and 
fat body [81].  The population of somatic mesoderm cells is further patterned by the 
proneural gene lethal of scute (l(1)sc) into 19 myogenic competence fields per 
hemisegment [121].  Within each l(1)sc cluster, the l(1)sc expression is progressively 
restricted to a single cell by Notch-dependent lateral inhibition [122].  This cell is a 
muscle progenitor and in a process requiring Notch, asymmetric cell division, it forms 
two daughter cells [123].  In most cases, both daughter cells are different muscle 
founder cells (FCs) and each FC will eventually give rise to one of the thirty muscle 
fibres per hemisegment.  The remaining, l(1)sc-negative population of somatic 
myoblasts with activated Notch signalling, forms fusion competent myoblasts (FCMs) 
[124].  FCMs are thought to be a naïve population of myoblasts that become 
“entrained“ upon fusing with a FC to form a multinucleated muscle syncytium 
(reviewed in [125]).  
 
1.3.4.1 Notch signalling is required at multiple stages of somatic muscle 
development 
The Notch pathway is one of the key signalling pathways and is heavily used 
throughout the developmental life cycle of presumably all metazoans.  It is best 
known for its role in amplifying the differences between two similar, locally 
communicating cells, to give rise to two alternative developmental fates (reviewed in 
[126]).  In a simplified view, the Notch signalling operates via membrane-associated 
Notch receptor and its membrane-associated ligands.  If two adjacent cells, one 
expressing the Notch receptor and the other one its ligand, come in contact and 
binding of the ligand to Notch occurs, the intracellular Notch domain is released.  It 
then enters the nucleus where it constitutes a TF with Suppressor of Hairless (Su(H)) 
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protein.  Among its targets are genes encoding members of the Enhancer of split 
(E(spl)) complex of transcriptional repressors that typically block a particular cell 
fate. 
In the somatic muscle lineage, there are three steps during which Notch 
signalling plays a critical function (Figure 1.3-2): 
1. Setting up the myogenic competence field by restricting Twist expression: In 
embryos expressing a constitutively active form of the Notch receptor in the entire 
mesoderm at stage 10, the levels of Twist protein are reduced and the somatic 
mesoderm is not specified [81].  In Notch mutants, twist is expressed throughout the 
mesoderm and somatic muscle is formed at the expense of other muscle tissues. 
Differences in the levels of Twist along the anterior-posterior axis of the mesoderm 
are therefore essential for the correct subdivision of the muscle primordia and Notch 
signalling is hence another important pathway involved in this process.  
2. Progenitor selection by lateral inhibition:  Restriction of l(1)sc expression to a 
single muscle progenitor is likewise dependent on the Notch pathway as in embryos 
with ectopic Notch signalling throughout the mesoderm, no progenitors can be 
recognized by the expression of l(1)sc or later progenitor specific markers [121, 127].  
In wild type embryos, active Notch signalling leads to the restriction of l(1)sc 
expression to a single cell (“signal sending cell”) which will become the progenitor 
cell.  In the neighbouring cells receiving Notch input (“signal receiving cells”), the 
expression of l(1)sc is suppressed and  as a result, they acquire an FCM identity.   
3. Asymmetric cell division of the muscle progenitors: After specification of the 
progenitor cells, Notch signalling continues to be essential as it controls their 
asymmetric cell division [123].  The progenitors do not express an identical repertoire 
of proteins as they already initiate the program responsible for differentiation of the 
30 different muscle fibres (Figure 1.3-3).  When a progenitor divides, one of its 
daughter cells continues to be under active Notch signalling unlike the other one that 
expresses asymmetrically localized repressor of Notch, numb [123].  As a result, the 
cells differ in the collection of expressed genes that will eventually be reflected at 
morphological level.   
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Figure 1.3-2: Notch-dependent processes in somatic muscle development 
Schematic representation of key processes leading to somatic muscle specification.  At all 
three steps, Notch signalling plays an essential role.  For simplicity, only two progenitors per 
segment are shown. 
 
 
1.3.5 Myoblast fusion: when founder cells met fusion competent 
myoblasts 
In the suggested multistep process of myoblast fusion (reviewed in [125]), 
each of the 30 founder cells (FCs) in one hemisegment fuses with a defined number of 
neighbouring fusion competent myoblasts (FCMs) to form a multinucleated myotube. 
It is the molecular traits intrinsic to the FCs that dictate the unique features of each 
muscle fibre, such as its size, shape, or attachment.  These unique traits are conferred 
by transcription factors known as muscle identity genes, such as Krüppel, Slouch, or 
Ladybird [128-130], that are expressed in overlapping combinations in the individual 
FCs.  The currently known muscle identity factors and their combined expression 
patterns cannot account for the identity of all 30 muscle fibres, suggesting that more 
remain to be discovered.   
All FCMs, on the other hand, express lame duck (lmd), coding for a zinc 
finger transcription factor essential for their differentiation [131, 132].  In lmd mutant 
embryos, the undifferentiated FCMs undergo apoptosis and hence there are no 
multinucleated muscle fibres formed [131, 132].  The only known direct target of 
Lmd is the differentiation regulator Mef2 [131] and ectopic Lmd alone is sufficient to 
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drive Mef2 expression in the nervous system [133].  Lmd possibly also directly 
activates sticks and stones (sns), a transmembrane protein mediating recognition of, 
and adhesion to, FCs, as its mRNA levels are reduced in lmd mutants [131, 132].  
Interestingly, in lmd mutants twist expression remains inappropriately high in FCMs 
whereas in wild type embryos its expression in somatic mesoderm is normally 
reduced after stage 11 [132].  There is currently no evidence that Lmd acts to repress 
Twist directly, however, other members of the Gli family of TFs that Lmd belongs to 
can act as both transcriptional activators and repressors (reviewed in [134]).   
As a result of their distinct identities, the two types of myoblasts also differ in 
the machinery executing the fusion itself.  FCs express redundant Immunoglobulin 
(Ig)-domain transmembrane proteins dumbfounded (duf) and roughest (rst) [135] 
while the FCMs express, again redundantly functioning, sns and hibris (hbs) [136].  
In the first step of the myoblast fusion, the four transmembrane proteins mediate 
heterotypic recognition and subsequent adhesion between the two cell types.  Once 
the cells have tightly adhered to one another, electron dense plagues form at the points 
of cell contact and the plasma membrane breaks down.  In the first round of myoblast 
fusion only limited fusion occurs and myotubes contain on average only two to three 
nuclei [137].  In the second phase, initiated by the migration of unfused FCMs, 
multiple rounds of fusion events occur, leading to the largest muscle fibres, which are 
estimated to contain up to 25 nuclei [138]. 
 Not surprisingly, the dynamic events are accompanied by changes in the 
shape and thus in the underlying cytoskeleton of the involved cells.  In recent years, 
many components and regulators of the actin cytoskeleton involved in myoblast 
fusion have been elucidated in Drosophila [139-141].  Nevertheless, there are still 
many aspects to be clarified, such as how the number of fusion events is controlled or 
what the mechanisms of the pore formation and plasma membrane breakdown are.  
 
1.3.6 From myoblast fusion to muscle attachment 
Already during myoblast fusion, the growing myotubes are guided towards 
their attachment sites to which they will eventually establish firm connections.  The 
migration events can be separated into three consecutive steps [142].  During stage 
12, the founder cells that originated from a common muscle progenitor cell migrate 
away from each other and the first rounds of fusion commence [142].  At stage 13, the 
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myotubes extend cytoplasmic protrusions, or filopodia, that scan their surrounding for 
guidance cues [142].  During this time, myoblast fusion continues in the central part 
of the myotubes.  Finally, once the ectodermal tendon cells are reached, filopodia 
formation terminates and integrin-containing adhesion complexes are brought into the 
contact site of the two cells.  By the end of stage 16, all muscle fibres have completed 
the fusion process and are attached to the ectoderm. 
The epidermal tendon cells to which the somatic muscles attach are regularly 
arranged at the segmental borders (intersegmental) as well as within individual 
segments (intrasegmental) (reviewed in [143]).  Their specification is driven by the 
transcriptional factor Stripe that is able to induce expression of several tendon cell 
specific genes when expressed ectopically in the ectoderm [144].  At a molecular 
level, the mechanisms behind the directed myotube guidance and tendon cell 
recognition are poorly understood.  However, it seems that the signalling pathways 
involved in axonal pathfinding in the nervous system are utilized in myogenesis as 
well.  
By stage 17, when embryogenesis is completed and the transition to a larva is 
about to initiate, a stereotypic pattern of 30 somatic muscles is formed in each of the 
abdominal segments 2 to 7 (Figure 1.3-3).  Based on the dorsal-ventral axis, somatic 
muscles can be subdivided into three groups: dorsal, lateral, and ventral.  Each muscle 
fibre has a characteristic size, shape, and orientation with respect to the other muscle 
fibres.  This unique muscle morphology is reflected in the nomenclature system based 
on the muscle’s position and orientation [145] or an assigned number [146]. 
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Figure 1.3-3: Larval somatic muscles have a stereotypic pattern 
Internal (left) and external (right) muscle fibres in A2-A7 segments of stage 17 embryos.  The 
colour coding indicates position of the muscle (red- external, yellow and blue- internal).  
Nomenclature follows M. Bate [145] and AC. Crossley [146].  From bottom to top: VO, 
ventral oblique; VA, ventral acute; VL, ventral longitudinal; SBM, segment border muscle; 
LT, lateral transverse; LO, lateral oblique; LL, lateral longitudinal; DT, dorsal transverse; 
DO, dorsal oblique; DA, dorsal acute.  The images are from [128]. 
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1.4 Tramtrack is a transcriptional repressor with numerous 
developmental roles 
Tramtrack is a well-characterized transcriptional repressor and negative 
regulation of its target genes is essential for cell fate specification at several stages of 
the Drosophila life cycle.  In order to understand the contribution of Tramtrack to 
muscle development and to explain its loss-of-function and gain-of-function muscle 
phenotypes, it is important to introduce its diverse developmental roles, target genes, 
and regulators in other developmental systems. 
1.4.1 Molecular characteristics and embryonic expression of Ttk69 
and Ttk88 
1.4.1.1 Gene model of the ttk locus 
The two Tramtrack protein isoforms, Ttk69 and Ttk88, are encoded by genomic 
sequence spanning over 20 kb on the right arm of the third chromosome.  There are 
three different transcriptional start sites (TSSs), each of which contributes to two 
distinct mature mRNA transcripts encoding the two protein isoforms (Figure 1.4-1 A).  
The two mRNA transcripts are probably generated through alternative trans-splicing, 
a commonly observed phenomenon among TFs of the BTB (broad, tramtrack, bric-a-
brac) protein family to which Tramtrack belongs [147].   
As the precursor mRNA transcripts originating from the three TSSs differ only 
in their untranslated regions, there exist only two different protein coding sequences 
(Figure 1.4-1 B).  The encoded proteins were named after their molecular weight 
Ttk69 (69 kDa) and Ttk88 (88 kDa). Both proteins have a BTB protein-protein 
interaction domain [148] at their amino-termini, but they differ at their carboxy-
termini where one pair of C2H2 zinc finger domains resides [149].   
 
1.4.1.2 DNA binding properties of Ttk proteins 
Because of the different zinc fingers pairs, the two Ttk isoforms have different 
DNA binding preferences [150].  Ttk69 binding motifs were derived from DNAse I 
footprinting assays on the fushi tarazu (ftz) zebra element [151, 152], the even skipped 
(eve) promoter, the eve autoregulatory element [150], and on regulatory regions of 
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tailless (tll) [153].  Even though the identified sites slightly vary, they all share a 
TCCT (or AGGA) core motif that is essential for Ttk69 binding [153].   Ttk88, on the 
other hand, does not occupy the same sites and instead was found to protect a region 
upstream of the engrailed (en) locus which, in turn, is not recognized by Ttk69 [150].  
The in vitro binding studies have thus shown that the differences in the amino acid 
sequence of the zinc finger domains are reflected at the DNA sequence level of bound 
sites (Figure 1.4-1 B). 
 
 
Figure 1.4-1: Gene model of the ttk locus and basic features of Ttk proteins 
(A)  Genomic plot of the ttk locus (in blue) with the different mRNA transcripts generated by 
alternative splicing below.  Transcription from three TSSs gives rise to distinct 
transcripts that differ only in their non-coding regions (in grey) while the protein coding 
sequences are identical (in orange).  Generated with GBrowse genome viewer [154]. 
(B)  Schematic representation of ttk precursor mRNA (only exons are shown) and the two 
different encoded protein isoforms.  Coloured boxes represent the exons and the dashed 
lines symbolize splicing events.  The two different protein isoforms, Ttk69 and Ttk88, 
share the amino-terminus where a BTB domain is located but they differ in their zinc 
fingers at the carboxy-terminus.  As a result, the two protein isoforms have different 
DNA binding sites and their deletion has distinct effects on viability.  Modified from 
[155]. 
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1.4.1.3 Binding partners of Ttk69 protein 
One of the mechanisms of Ttk69 transcriptional repression has been elucidated 
in a yeast two-hybrid screen which uncovered a physical association between Ttk69 
protein and Mi-2, a subunit of the histone deacetyletion and chromatin remodelling 
complex NuRD [156].  The region mediating the interaction lies in proximity of the 
zinc fingers and is specific to the Ttk69 isoform.  Mi-2 and Ttk69 interact also 
genetically in the embryonic nervous system and co-localize on polytene 
chromosomes [156].  Recruitment of the chromatin remodelling machinery is 
therefore one way in which Ttk69 represses the transcription of its targets.   
Another binding partner of Ttk69 is the general co-repressor C-terminal Binding 
Protein (CtBP).  A well-characterized CtBP binding P-DLS motif [13, 157] is located 
in the carboxy-terminal portion of Ttk69 protein and its mutation interferes with the 
ability of Ttk69 to block neuronal development in eye precursors [158].  Physical 
interaction between Ttk69 and CtBP was confirmed in in vitro pulldown assays and 
the two genes are also linked genetically [158].   At least in the context of eye 
development, Ttk69 does not seem to interact with the co-repressor Sin3A or the 
histone deacetylase Rpd3, even though the BTB domain of the human B-cell 
lymphoma 6 (Bcl-6) protein interacts with their mammalian orthologues [159].    
 
1.4.1.4 Embryonic expression of Ttk69 and Ttk88 
The embryonic expression patterns of both Ttk isoforms at the mRNA and 
protein levels have been analysed in multiple previous studies [150, 152, 160] and are 
summarized in Table 1.4-1.  There are only minor differences in the expression of the 
two isoforms and their protein expression recapitulates mRNA distribution (with a 
few exceptions that are discussed in the Section 1.4.3) [150].  There are two main 
phases of Ttk embryonic expression: a maternal phase, when Ttk69 and Ttk88 are 
supplied maternally and diminish before the onset of cellularization, and a zygotic 
phase, starting at stage 5 with expression of Ttk69 in the endoderm primordia. The 
zygotic expression however starts to peak at stage 11 when both Ttk isoforms are 
strongly expressed in trachea, derivatives of endoderm, epidermis, and nervous 
system.  Ttk69 can also be detected in the mesoderm (Figure 4.2-1), but the strong 
signal from surrounding tissues obscures its mesodermal expression component, 
which has thus remained unidentified in most of the previous studies. 
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Tissue/cell type Stage (st.) Ttk69 Ttk88 Reference(s) 
follicle cells all stages of oogenesis ✔ ✖ [161] 
maternally deposited mRNA syncytial blastoderm 
 
✔ ✔ [152] 
yolk nuclei st. 5 - 10 ✔ ✖ [150] 
anterior endoderm st. 5 - 6 ✔ ✖ [150] 
midgut and its primordia st. 7 - 17 ✔ ✔ [150, 152] 
stomatodeum st. 11 - 17 ✔ ✔ [150, 152] 
trachea st. 11 – 17 ✔ ✔ [150, 162] 
glia in CNS st. 12 – 17 ✔ ✖ [155] 
support cells in PNS from st. 11 ✔ ✔ [163] 
epidermis st. 11 – 17 ✔ ✔ [160] 
 
ring gland unspecified ✔ ✔ [164] 
visceral mesoderm st. 11 – 17 ✔ ✔ [160], this study 
somatic mesoderm st. 11 ✔ ✔ this study 
Table 1.4-1: Overview of embryonic sites of Ttk69 and Ttk88 expression 
Green check marks indicate expression and red ‘x’ marks lack of expression.  Examples of 
references where the given expression was reported are indicated.  
 
 
1.4.2 Extensive developmental roles of Ttk69 and Ttk88 
As the complex expression of Tramtrack proteins suggests, they play multiple 
roles during embryonic as well as later stages of Drosophila development 
(summarized in Table 1.4-2).  Even though the expression patterns of the two protein 
isoforms are largely overlapping, their functions, as well as target genes, differ as a 
result of their different DNA binding preferences.  While an allele deleting Ttk88 only 
is homozygous viable [165], alleles that delete Ttk69 are lethal at embryonic stages.  
Based on the isoform specific and shared phenotypes, the roles of Ttk69 and Ttk88 
can be categorized into 4 different classes (Table 1.4-2) that are discussed in more 
detail below. 
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 Process Stage Targets Ttk69 Ttk88 
mitotic-to-endocycle 
transition of follicle cells 
stg, rap, dap, 
ci 
[166, 
167] no 
polar cell specification  [168] no I 
chorion synthesis, dorsal 
appendage morphogenesis 
oocyte 
 [161] no 
ftz, eve, tll, 
run, h, odd 
[160, 
169] no II 
maternal-zygotic 
transition; axis 
specification 
syncytial 
blastoderm 
en no [170] 
CNS glial cell 
development embryo 
ase, dpn, scrt, 
repo, CycE 
[155, 
171] no I 
trachea morphogenesis embryo mmy, esg, pyd, bnl [162] no 
embryo  [163, 172] [163] 
ac, sc, ase, 
CycE 
[163, 
173, 
174] 
NA III repression of neuronal fate in PNS 
larva 
ac, sc, ase * NA [163, 174] 
repression of 
photoreceptor fate larva lz 
[165, 
175] NA IV 
repression of R7 fate larva en NA [165, 176] 
mitosis regulation in eye 
development larva stg [177] no I 
maintenance of 
photoreceptor cell fate late pupa  [178] no 
Table 1.4-2: Ttk69 and Ttk88 have overlapping as well as distinct developmental roles 
and target genes 
A comprehensive summary of the described roles of Ttk69 and Ttk88 in developmental 
processes (column 1) during different stages (column 2).  Known downstream genes are in the 
third column, in green colour are genes that have been asserted to be positively regulated.  
Those genes whose regulatory regions were experimentally confirmed to be bound by Ttk are 
underlined.  Last two columns contain literature references as well as information on whether 
the role and/or targets are specific or common to the two Ttk isoforms (NA- not applicable).  
Class I, Ttk69-specific roles; class II, shared role but different target genes; class III, shared 
role and target genes; class IV, different role in the same developmental process. 
*repression of ac, sc, and ase by Ttk88 is weaker compared to Ttk69 
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1.4.2.1 Class I: Ttk69-specific roles in oogenesis, embryogenesis, and eye 
development 
There are multiple developmental roles that have been assessed as unique to the 
69 kDa isoform of Tramtrack. Some of these are linked to maternally supplied 
Tramtrack69 protein that is expressed in the follicle cells throughout oogenesis.  
There it contributes to the control of the transition between mitosis and endocycle 
[166, 167], the number of polar cells connecting the single egg chambers [168], and 
chorion synthesis and morphogenesis of dorsal appendages [161].  Differentiation and 
cell division of the follicle cells surrounding the oocyte are regulated by Notch 
signalling (reviewed in [126]).  The levels of Ttk69 protein in Notch mutant follicle 
cells are reduced and the cells also undergo prolonged mitosis similar to a ttk mutant 
[166].  Ttk69 is however not simply an effector of Notch signalling as the 
differentiation associated defects in Notch mutants are not phenocopied in ttk mutants 
[166].  Ttk88 is not required in oogenesis as it is, unlike Ttk69, absent from the 
follicle cells and the mutant phenotypes were observed in Ttk69-specific alleles ttk1e11 
and ttktwk [161, 166, 167].   
Ttk69, but not Ttk88, is also expressed in all glia cells of the embryonic central 
nervous system (CNS) and controls their number as well as proper differentiation by 
repression of the default neuronal program [155].  Its principal targets within the CNS 
are the pan-neural genes asense (ase), deadpan (dpn), and scratch (scrt) [171].  In 
addition, ectopically expressed Ttk69 downregulates the expression of the cell cycle 
regulator Cyclin E (CycE) and in ttk mutant embryos the number of glial cells is 
increased [171].  Therefore, similar to its role in oogenesis, Ttk69 is also involved in 
control of proliferation as it prevents supernumerary rounds of cell division in the 
CNS. 
 Another example of a role restricted to Ttk69 is the orchestration of multiple 
steps of late trachea development.  Unlike in the above-mentioned cases, Ttk88 also 
shows tracheal expression, yet mutants deleting or misexpressing Ttk88 isoform 
develop normal trachea [162]. ttkD2-50 homozygous embryos (affecting ttk69 and 
possibly ttk88) express reduced levels of branchless (bnl), the ligand of the Fibroblast 
growth factor (FGF) receptor breathless (btl), both of which together mediate tracheal 
migration and branching [179].  One of the sources of bnl is the visceral mesoderm, 
where it is co-expressed with Ttk69 and downregulated in ttk-deficient embryos, 
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suggesting a positive input of Ttk69 into bnl regulation [162].  Ttk69 is also involved 
in later steps of trachea development when subtle differences between its expression 
levels in presumptive fusion cells and adjacent cells are essential for their subsequent 
fusion [162].  In addition, Ttk69 is required for complex cell shape changes and 
rearrangements that are necessary for tubule and intracellular lumen formation.  In ttk 
mutants, intercalation of trachea cells is impaired due to downregulation of 
polychaetoid (pyd), an adherens junction associated protein necessary for this process 
[180].  Altogether Ttk69 acts at multiple stages of trachea differentiation both 
positively and negatively as a regulator of complex morphogenetic events.  Two 
targets, bnl and pyd, were suggested to be activated by Ttk69 [162]; however, it 
should be noted that this assertion is based only on their misexpression phenotypes in 
ttk loss- and gain-of-function scenarios, and no evidence for their direct activation by 
Ttk69 (e.g. binding of Ttk69 to their regulatory regions, reduced expression upon 
mutagenesis of Ttk69 sites) has been reported. 
One more case where Ttk69 (but not Ttk88) was suggested to play a positive 
regulatory role (presumably indirectly) are the late differentiation events of eye 
development.  Ttk69 is the only Tramtrack isoform expressed in all photoreceptor 
cells during pupal stages and it is required for their proper terminal differentiation 
[178].  Ttk69, however, represses the development of photoreceptor neurons earlier in 
development [165], hence it would be interesting to know what causes the switch in 
its function and what target genes Ttk69 regulates at these two stages. 
 
1.4.2.2 Class II:  Both Ttk69 and Ttk88 are involved in embryonic axis 
specification but they regulate different target genes 
The earliest studied role of Tramtrack that also led to its identification is the 
repression of pair rule genes in early Drosophila embryos.  A series of classic genetic 
experiments showed that ectopic expression of Ttk69 through heat shock inducible 
promoter represses, albeit to a variable extent, the expression of the pair rule genes ftz, 
eve [160, 181], run (runt), hairy (h) and odd skipped (odd) [160], but has no effect on 
the expression of the upstream gap genes hunchback (hb), Krüppel (Kr) [160, 181], or 
giant (gt) [181].  Binding of Ttk69 protein to the regulatory regions of ftz and eve has 
been extensively characterized in in vitro experiments [150-152].  Upon deletion of 
the Ttk69 binding sites in the enhancer of ftz, the expression of a linked reporter gene 
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initiated prematurely and was not resolved in the typical striped pattern along the 
anterior-posterior embryonic axis [151].   
On the other hand, the Ttk88 isoform does not cause misexpression of any of the 
above mentioned pair rule genes [181], but instead binds the promoter region of the 
segment polarity gene en [150] and, in cooperation with the pair rule protein Runt, 
establishes its stereotypic expression in 14 parasegmental stripes [170].  Therefore, 
even though both maternally supplied Ttk isoforms play a role in axis specification, 
they appear to do so by regulating distinct sets of downstream genes. 
The levels of maternally supplied Ttk proteins diminish before the onset of 
zygotic transcription and their gradual dilution is thought to be one mechanism by 
which the maternal-zygotic transition in Drosophila is orchestrated.  If the levels of 
maternal Ttk69 protein are increased, the onset of ftz expression is delayed, whereas 
in ttk mutants it initiates prematurely [169].  According to a suggested model, zygotic 
transcription does not initiate before the 8th nuclear cleavage as it is actively repressed 
by maternal Ttk69 protein [169]. With subsequent nuclear division cycles the 
nucleocytoplasmic ratio gradually increases and so the effective concentration of 
Ttk69 protein decreases, permitting transcription of its targets.  However, there must 
be more such maternally loaded repressors as, consistently with the previous results, 
altering the levels of Ttk69 does not influence initiation of Kr expression [169]. 
 
1.4.2.3 Class III:  Shared role and targets of both Ttk isoforms in the peripheral 
nervous system 
One of the most extensively characterized roles of Ttk is repression of the 
neuronal cell fate in the developing peripheral nervous system (PNS) during 
embryonic and larval stages.  Ttk proteins act as cell fate regulators in at least two 
types of Drosophila sensory organs, the chordotonal and the external sensory organs 
[163].  In wild type embryos and adults, these consist of one neuronal cell and three or 
four, respectively, support cells of distinct identities.  The different cell types 
originate via a series of asymmetric cell divisions from a single sensory organ 
precursor (SOP). For example, in the case of external sensory organs, the SOP divides 
into IIa and IIb progenitor cells that further divide to produce different types of 
support cells and a third progenitor, IIIb, which will give rise to the neuronal cell and 
yet another support cell (Figure 1.4-2 B).  The bristles visible on the notum of an 
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adult fly are therefore formed by one shaft and one socket cell (both support cells), 
while the neuron and two other support cells are positioned below the cuticle (Figure 
1.4-2 A).  
In ttk mutants, there are more neurons formed at the expense of support cells as 
a result of two IIb precursors being formed instead of one IIa and one IIb precursor 
cell [163].  At a phenotypic level, this change in cell identity is reflected in a so-called 
“bald“ phenotype where the external support cells on the notum are missing and thus 
no bristles are visible (Figure 1.4-2 C).  In contrast, when the levels of Ttk are 
increased, the SOP divides into two IIa precursor cells.  Twice as many shaft and 
socket cells are formed, giving rise to a double-bristle phenotype (Figure 1.4-2 D).  
These cell fate changes resemble those in Notch loss- or gain-of-function mutants, 
respectively [182], and it has been established that Ttk functions downstream of numb 
and executes the developmental program directed by Notch signalling only in the 
numb-negative daughter cell [163]. 
The repression of neuronal identity by Ttk in the PNS lineage was also 
confirmed by molecular studies in larval wing imaginal discs, where the specification 
of adult sensory organs is initiated [174].  These experiments also extended the 
potential of Ttk as a neuronal fate repressor as ectopic expression of Ttk69, and to a 
lesser extent Ttk88, prior the formation of SOPs leads to their ablation and almost 
complete absence of wing sensory organs [174].  The targets of Ttk69 and Ttk88 
responsible for this phenotype are the proneural genes achaete (ac), scute (sc), and 
asense (ase), albeit their repression by ectopic Ttk88 is milder compared to Ttk69.  In 
addition, ectopic expression of Ttk69, but not Ttk88, reduces the size of the wing due 
to a block in cell proliferation [174].  Given that many of the Ttk69-specific roles are 
linked to cell cycle regulation, it is likely that the repression of cell cycle progression 
is a general feature of Ttk69, but not Ttk88. 
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Figure 1.4-2: Cell fate changes in the PNS of ttk loss- and gain-of-function backgrounds 
(A) Schematic representation of cell composition of one external sensory organ on the adult’s 
notum. Sf, shaft cell; So, socket cell; Sh, sheath cell; N, neuron; G, glia.  Adapted from 
[183]. 
(B) Scheme of cell divisions in the lineage of an external sensory organ in wild type adults.  
Inset shows the notum of a wild type fly.  Modified from [183] and [163]. 
(C) In ttk or Notch mutants, the aberrant cell divisions produce more neurons, glia and sheath 
cells at the expense of socket and shaft cells.  As a result, the notum of a ttk mosaic fly 
(in the inset; the ttk-deficient area is outlined by a dashed line and red arrow) appears 
“bald“ as the outer shaft and socket cells are missing (red arrow).  Modified from [183] 
and [163]. 
(D) Ttk69 overexpression or constitutively active Notch signalling lead to lack of neurons, 
but twice as many socket and shaft cells formed, giving rise to a so-called double-bristle 
phenotype (in the inset; the red arrows point to doubled bristles on a notum of a Ttk69-
overexpressing fly).  Modified from [183] and [163].  
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1.4.2.4 Class IV:  Ttk69 and Ttk88 play divergent roles in eye development 
The compound eyes of Drosophila adults are composed of approximately 800 
ommatidia, each formed by six outer (R1-R6) and two centrally positioned (R7, R8) 
photoreceptor neuronal cells surrounded by non-neuronal support cells.  If the ttk88 
isoform is deleted, the average number of outer photoreceptor cells per ommatidium 
decreases, some ommatidia have more than one R7 cell, and the number of R8 cells 
remains unaffected [165].  It is however unlikely that the ectopic R7 cells were 
formed at the expense of R1-R6 cells as many ommatidia with increased number of 
R7 cells had wild type number of R1-R6 cells.  In ttk88 mutant larval eye discs, the 
levels of En protein are increased and in some cases its spatial expression pattern is 
affected as well [165].  The mechanism of Ttk88 action in R7 fate suppression seems 
to be novel as it acts independently of seven in absentia (sina), a major positive 
regulator of R7 determination [176].  As in the nervous system, Ttk88 acts as a 
repressor of neuronal cell fate in the developing eye and elaborate regulation is 
required to eliminate its function and enable the initiation of differentiation (see 
Section 1.4.3.3). 
Removal of Ttk69, on the other hand, interferes with specification of all cell 
types and leads to absence of ommatidial tissue as the ommatidia and sensory bristles 
are not formed [165]. The severe loss-of-function phenotype can be partially 
explained by Ttk69 regulating lozenge (lz) expression, encoding a transcriptional 
regulator of genes essential for the differentiation of R1/6/7 neurons and cone cells 
[184]. Combining ttk69 and lz mutant alleles attenuates the severity of the ttk 
phenotype and the formation of ectopic R7 neurons in ttk mutants is lz-dependent 
[175].  Expression levels of lz are responsive to changes in Ttk69 levels and as there 
are multiple putative Ttk69 binding motifs in its upstream regions [184], it is likely to 
be directly repressed by Ttk69. 
In the pool of precursor cells that will form the adult eye, Ttk69 directly 
represses transcription of string (stg) [177], a Cdc25 homologue that is essential for 
cell cycle progression from G2 to mitosis.  Ttk69 competes for binding with the 
activator Pointed and it was suggested that the ratio between the levels of the two 
proteins and/or changes in the affinity of their binding influences the regulatory 
trajectory [177].  According to a proposed model, Ttk69 keeps the precursor cells in 
the eye disc in an arrested state, but when Pointed is activated during the second 
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mitotic wave, it can compete Ttk69 away from stg regulatory regions and initiate 
mitosis.   
 Consequently, it appears that even though both Ttk isoforms are required for 
proper eye development, they exert different roles, possibly by regulating distinct sets 
of target genes.  These however remain to be identified, as the knowledge about genes 
downstream of Ttk69 and Ttk88 in the eye is currently very limited. 
 
1.4.3 Dynamic expression of Ttk69 and Ttk88 is achieved by diverse 
regulatory mechanisms  
The complex and dynamic expression pattern of Tramtrack is accomplished 
through extensive regulation at multiple tiers.  Currently, there is only limited 
information on transcriptional regulation of Ttk, but there is a wealth of data reporting 
regulation of Ttk at post-transcriptional and post-translational levels (summarized in 
Figure 1.4-3).  
 
1.4.3.1  Post-transcriptional regulation of ttk69 mRNA 
Ttk69 protein, but not ttk69 mRNA, is localized to only one of two daughter 
cells generated in Notch-mediated asymmetric cell division in the PNS (see Section 
1.4.2.3).  Only the numb-positive daughter cell expresses, through unknown means, 
an RNA binding protein Musashi (Msi) that directly binds a sequence within the 3' 
untranslated region (UTR) of ttk69 mRNA [183].  Via this sequence, Musashi directly 
represses translation of ttk69 mRNA in cell culture and also negatively regulates 
synthesis of Ttk69 protein in vivo [183].  As a result, Ttk69 protein is present only in 
the numb-negative daughter cells where it represses the neuronal cell fate.   
The 3' UTR of Ttk69 was also computationally predicted and then 
experimentally verified to be targeted by two microRNAs, miR-92b and miR-312 
[185].  Whether these microRNAs reduce the levels of Ttk69 protein also in vivo is 
unknown.  Another example of microRNA-mediated downregulation of Ttk69 protein 
levels was described to be active during early Drosophila embryogenesis.  miR-184 
mutant phenocopies overexpression of Ttk69 as expression of the pair rule genes, but 
not gap genes,  is delayed [186].  In a quantitative assay, the levels of Ttk69 protein 
were found to be reduced in the miR-184 mutant and both genes interact genetically as 
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well [186].  Repression of Ttk69 by maternally expressed miR-184 might therefore 
contribute to timely depletion of the Ttk69 protein to allow zygotic transcription to 
proceed. 
1.4.3.2 Covalent modifications of Ttk proteins in the developing eye 
During eye development, Ttk88 inhibits differentiation of R7 photoreceptor 
cells and activation of the differentiation program by the RAS/MAPK signalling 
cascade releases this block by decreasing the levels of Ttk88 protein.  The mechanism 
behind Ttk88 downregulation has been elucidated in genetic as well as biochemical 
studies, which linked the proteins Sina and Phyllopod (Phyl) to Ttk88 degradation.  
Sina via its E3 ubiquitin ligase activity, ubiquitinates Ttk88 and hence targets it for 
proteasome-mediated degradation [187].  Consistently, Ttk proteins contain stretches 
of PEST sequences [152] that are indicative of a short half-life and are often 
associated with proteasome-dependent proteolysis [188, 189].  However, the physical 
interaction between Ttk and Sina alone is unstable and Phyl, an adaptor protein whose 
expression is transcriptionally induced by RAS/MAPK signalling, is required to 
stimulate the ubiquitination activity of Sina [190].  The region of Ttk that interacts 
with Phyl resides in the BTB domain that is common to both Ttk isoforms and the 
interaction is highly specific as closely related BTB domains of other Drosophila 
proteins do not associate with Phyl [190].  Genetic evidence supports the findings 
from in vitro experiments as overexpression of Phyl can counteract the block in 
photoreceptor differentiation caused by ectopic Ttk88 only in the presence of Sina 
[191].  An additional layer of Ttk control is brought by Msi, a negative regulator of 
ttk69 mRNA translation in the PNS [183].  Msi genetically interacts with Sina in the 
eye imaginal disc in a redundant fashion as derepression of Ttk69 protein is more 
severe in msi sina double mutant compared to single mutants [192].   
A recently identified novel homologue of Sina, named SinaH, specifically 
recognizes a sequence unique to the Ttk69 isoform [193].  Similarly to Sina, it targets 
Ttk69 for proteolysis and it also requires an adaptor protein whose identity remains to 
be discovered.  In the presence of Phyl, SinaH can also interact with full-length Ttk88 
and Ttk69 through the BTB domain, yet the recognition of the Ttk69-specific motif 
seems to be more efficient [193].  The importance of regulating the protein levels of 
each Ttk isoform specifically is underscored by the finding that Ttk69 protein, unlike 
Ttk88, is a target of the enzyme Lesswright (formerly Ubc9) that covalently 
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conjugates an ubiquitin-like molecule Smt3 [194].  Ttk69 co-localizes with Smt3 in 
certain PNS precursor cells as well as on chromosomal sites in salivary-gland 
polytene chromosome spreads [194].  However, the effect of the conjugated moiety 
on Ttk69 levels or function is unknown. 
 
1.4.3.3 Additional mechanisms to regulate Ttk69 protein function 
 Another modification of Ttk69 that was detected in uncellularized Drosophila 
embryos is phosphorylation by MAP kinases [153].  The ability of MAP kinases to 
phosphorylate Ttk69 was confirmed only in vitro and so its existence and function in 
vivo remain to be investigated.  
The Ttk69 isoform has been linked to cell proliferation in multiple 
developmental contexts, where it blocks mitosis.  In the embryonic CNS it contributes 
to the regulation of glial cell number by repressing the S phase promoting factor CycE 
[171].  It is therefore not surprising that the expression of Ttk69 protein itself 
oscillates with cell cycle progression.  During S phase, when DNA is replicated, 
Ttk69 protein is expressed in lateral glia at undetectable levels but its expression 
increases once the cells exit S phase [171].  Expression of Ttk69 therefore seems to be 
incompatible with DNA replication, possibly also in other cell types as ectopic Ttk69 
was found to interfere with DNA replication in wing imaginal discs as well [174]. 
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Figure 1.4-3: Mechanisms of Ttk69 and Ttk88 mRNA and protein control 
Schematic summary of all known regulators of Ttk69 and Ttk88 mRNA and protein (not 
drawn to scale).   ttk69 mRNA is via its 3' UTR repressed by RNA-binding protein Musashi 
(Msi) and at least three different microRNAs.  Ttk69 protein is ubiquitinated (Ubi) by two 
different E3 ligases, Sina and SinaH, both requiring an adaptor protein for Ttk69 binding 
(Phyl for Sina, an unknown protein for SinaH).  Ubiquitination enhances degradation of the 
protein (red border).  Ttk69 is in addition modified by phosphorylation by MAPK (P- 
phosphate group), and SUMO-like moiety Smt3 mediated by Lwr.  The effect of both 
modifications on Ttk69 levels or function is unknown (blue border).  Ttk69 protein levels are 
also reduced during DNA replication.  Ttk88 is only known to be subjected to ubiquitination 
by Sina/Phyl and SinaH/Phyl complexes. 
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2 AIMS OF THE THESIS 
To date, approximately 50 of the 700 putative Drosophila transcription factors 
have been implicated in embryonic muscle development.  However, several 
experimental observations indicate that this number is greatly underestimated.  
Similarly, genome-wide studies have identified thousands of cis-regulatory modules 
(CRMs) occupied by the core myogenic transcription factors, yet our knowledge 
about the diverse regulatory inputs that they integrate remains limited. My thesis 
aimed to bridge this gap by systematically identifying novel myogenic regulators that 
would contribute to the underlying regulatory network. 
The vast majority of known mesodermal transcription factors regulate 
transcription positively.  However, studies in other developmental processes revealed 
that repression in developmental decision-making is at least as important as 
transcriptional activation.  A key aim of my thesis was therefore to understand the 
contribution of negative regulatory inputs to mesodermal gene expression.  One such 
transcription factor, Ttk69, was implicated in my screen to be a new potential 
negative regulator of mesoderm development. This was rather surprising, given the 
established role of Ttk69 as an essential regulator of neuronal development.  I used a 
combination of genetic and genomic approaches to characterise the role of Ttk69 in 
muscle development, and specifically addressed the following questions: At which 
particular step of myogenesis is Ttk69 involved?  What are the downstream targets of 
Ttk69?  What is the regulatory relationship between Ttk69 and other myogenic 
factors?  Where is Ttk69 positioned within the muscle regulatory network?  Is Ttk69 a 
dedicated repressor or could it potentially activate transcription as well?   
Many developmental regulators have the capacity to both activate and repress 
transcription.  Similar to Ttk69, Snail has been traditionally perceived as a dedicated 
repressor, yet several lines of evidence suggested that it could contribute to 
transcriptional activation.  Exploring the possibility that Snail is a bimodal 
transcription factor regulating mesoderm development was therefore another objective 
of my thesis. 
By seeking answers to these questions, I hope that my thesis will contribute to 
our understanding of the regulatory logic driving mesoderm development and the 
general complexity of metazoan gene expression.   
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3 MATERIALS AND METHODS 
3.1 MATERIALS 
3.1.1 Instruments 
Name Vendor 
10x ocular (35mm, 2.5x, 4”x5”) Zeiss 
10x/0.25 A-Plan Objective Zeiss 
20x/0.50 Plan-Neofluar Objective Zeiss 
63x/1.4 Plan-Apochromat Objective Zeiss 
ABI PRISM 7500 Sequence Detection System Applied Biosystems 
Analytical scales, AE50 Mettler 
Axiophot Light Microscope  Zeiss 
Bioruptor UCD-200TM ultrasonic cell disruptor water bath CosmoBio 
Centrifuges 5415D, 5417C, 5810 Eppendorf 
Dounce tissue grinder (homogeniser; 15ml) Wheaton 
Gel electrophoresis chamber Mini-Sub Cell GT BioRad 
Gel electrophoresis chamber Wide Mini-Sub Cell GT BioRad 
LSM 510 FCS Zeiss 
LSM 510 META  Zeiss 
Nanodrop Spectrophotometer ND-1000 Nanodrop 
Technologies 
Shaker table Gyrotory (Model G2) New Brunswick 
Scientific 
Shaker table Nutator (220V) Adams 
Sieves (0.125mm; 0.122mm; 0.335mm; 0.71mm) VWR or 
Buddeberg/Quadrolab 
Speed-Vac Concentrator 5301 Eppendorf 
Stereo Microscope Stemi SV6 Zeiss 
Stereo Microscope Lamps KL 1500 LCD Schott 
Thermal Cycler PTC-200 Multicycler DNA engine MJ Research Peltier 
Thermal Cycler PTC-225 DNA Engine Tetrad MJ Research Peltier 
VICTOR 1420 Luminescence Counter Perkin Elmer 
Water bath Thermomix 5BU B.Braun Biotech 
International 
Water bath GD100 Grant 
Water bath MP Julabo 
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3.1.2 Chemicals and reagents 
Name Catalogue 
number 
Vendor 
1 kB DNA ladder N3232L New England Biolabs 
100 bp DNA ladder N3231S New England Biolabs 
4-Nitro blue tetrazolium chloride (NBT) 11383213001 Roche 
5-Bromo-4-chloro-3-indolyl-phosphate 
(BCIP) 
1383221 Roche 
Agarose (LMP) 15517-022 Gibco 
Ampicillin A9518 Sigma 
AmpliTaq® DNA polymerase N8080171 Applied Biosystems 
Aprotinin A1153 Sigma 
Biorad protein assay 500-0001 Biorad 
Biotin (BIO) RNA Labeling mix 11685597910 Roche 
Boric acid (99.5%) B7660 Sigma 
Bovine Serum Albumine (BSA, fraction V) A-7906 Sigma 
Cellfectin 10362-010 Invitrogen 
Chloroform C2432 Sigma 
DAB substrate 1718096 Roche 
DEPC treated water 9920 Ambion 
DFS-Taq DNA polymerase 101100 Bioron 
Digoxigenin (DIG) RNA labeling mix 11277073910 Roche 
DNaseI 0 776785 Roche 
DMSO 8.02912.10 Merck 
Deoxynucleoside-5’-triphosphate (dNTPs) 
for PCR  
110002 Bioron 
Deoxyribonucleic acid, single stranded from 
salmon testes 
D9156 Sigma 
Dual-Luciferase® Reporter Assay System E1960 Promega 
EDTA E6758 Sigma 
EGTA E3889 Sigma 
Ethanol 1.00983.2500 Merck 
Ethidium bromide E-1385 Sigma 
Fluorescein (FITC) RNA labelling mix 11685619910 Roche 
Formamide F5786 Sigma 
Formaldehyde (16%, methanol) 18814 Polyscience Europe 
Glycogen 901393 Roche 
Glycerol 4043-00 J.T.Baker 
Hydrogen peroxide H1009 Sigma 
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Name Catalogue 
number 
Vendor 
Leupeptin L2884 Sigma 
Lithium chloride L9650 Sigma 
MEGAscript® T7 Kit AM1334 Ambion 
Methanol 1.06009.2500 Merck 
n-heptane H9629 Sigma 
N-Laurylsarcosine D-6750 Sigma 
Normal Goat Serum (NGS) S-1000 Vector Labs 
NP 40 13021 Sigma 
2-propanol 1.09634.2500 Merck 
Pepstatin P5318 Sigma 
Phenol:Chloroform:Iso-amyl-alcohol  9732 Ambion 
Phenyl methyl sulfonyl fluoride (PMSF) P7626 Sigma 
Protein-A Sepharose® 4B P9424 Sigma 
Proteinase K 745723 Roche 
QuickChange® site-directed mutagenesis 
kit 
200523 Stratagene 
RNase A 1006693 Qiagen 
Sodium acetate 9740 Ambion 
Sodium deoxycholate D6750 Sigma 
Sodium chloride 1.06404.5000 Merck 
Sodium dodecyl sulfate L6026 Sigma 
Sp6 RNA Polymerase M0207s New England Biolabs 
SybrGreen® PCR Master Mix 4309155 Applied Biosystems 
Pfu DNA polymerase  EMBL 
ProLong® Gold antifade reagent P36931 Invitrogen 
Restriction endonucleases  New England Biolabs 
Ribonuclease inhibitor 15518-012 Invitrogen 
T3 RNA polymerase 1 031 163 Roche 
T4 DNA ligase  799099 Roche 
T7 RNA polymerase 881 767 Roche 
Tris-base T6791 Sigma 
Triton-X-100 T8787 Sigma 
TSATM Plus Cyanine 3 & Cyanine 5 System NEL752001
KT 
Perkin Elmer 
TSATM Plus Cyanine 3 & Fluorescein 
System 
NEL753001
KT 
Perkin Elmer 
Yeast tRNA 15401-029 Invitrogen 
Vectastain Elite ABC Kit PK-611 Vector Laboratories 
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Name Catalogue 
number 
Vendor 
Western blocking reagent 11921673001 Roche 
 
 
3.1.3 Miscellaneous materials 
Name Catalogue 
number 
Vendor 
ABIprism 96-well optical reaction plates 4306737 Applied Biosystems 
AeroDuster 100  Servisol 
Brown microcentrifuge tubes (1.5 ml) 1-6180 NeoLab 
Brushes (various sizes) 9.172.050 Buddeberg 
GeneChip Drosophila Tiling 1.0R Array 900588 Affymetrix 
QIAprep Spin Miniprep kit  27106 Qiagen 
QIAquick PCR Purification kit 28106 Qiagen 
QIAquick Gel Purification kit 28706 Qiagen 
Parafilm  PM-996 Pechiney 
PCR tubes (0.5 ml, thin walled) 0030 124.502 Eppendorf 
PCR tubes (0.2 ml, thin walled) 0030 124.332 Eppendorf 
Phase-lock heavy gel tubes (2 ml) 0032-005-152 Eppendorf 
RNeasy Mini kit 74104 Qiagen 
Safe-Lock Tubes 1.5 ml 28004 Eppendorf 
Safe-Lock Tubes 2.0 ml 0030 120.094 Eppendorf 
SafeSeal Micro Tubes 1.5 ml 72.706.200 Sarstedt 
Siliconized microcentrifuge tubes (1.6 ml) 710176 Biozym 
 
 
3.1.4 Oligonucleotides 
Name 
Sequence 
Stock 
number 
Restrict. 
site 
Purpose 
WntD-F 1141 KpnI Cloning WntD-lacZ into pGL3 
GCGGTACCATAGCCTGCAAATCCCAAGCC 
WntD-R 1148 BglII Cloning WntD-lacZ into pGL3 
GCGAGATCTGCAACAATACTGGCAGTTCCC 
Tin-F 1149 KpnI Cloning Tin B-374 into pGL3 
GCGGTACCTCAAGCGTTGAGCGTTGAGC 
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Name 
Sequence 
Stock 
number 
Restrict. 
site 
Purpose 
Tin-R 1150 BglII Cloning Tin B-374 into pGL3 
CGAGATCTTGCGGGAAAGCAGGAAAATGG 
Mef2-F 1157 KpnI Cloning Mef2 I-D[L] into pGL3 
GCGGTACCCTGTAAAAATCACGCATAACCG 
Mef2-R 1164 BglII Cloning Mef2 I-D[L] into pGL3 
CGAGATCTCCTGAAGAAACCCCTGCCAAG 
Mdr49-F 1209 KpnI Cloning Mdr49 early mesoderm into pGL3 
GCGGTACCGCAACAAAGTCGATCGTATAAC 
Mdr49-R 1216 BglII Cloning Mdr49 early mesoderm into pGL3 
GCAGATCTCAGATTTCCTCTCGGTTAGTC 
sna-F 1372 NotI Cloning sna CDS into pAc5.1 A 
AGCGGCCGCGGCCGCCAACTACAAAAG 
sna-R 1373 XbaI Cloning sna CDS into pAc5.1 A 
CGCGTCTAGAGCACCAAAACCGAATCGACTTAG 
dl-F 1374 KpnI Cloning dl CDS into pAc5.1 A 
ATGGTACCCATGGATGTTTCCGAACCAG 
dl-R 1376 XbaI Cloning of dl CDS into pAc5.1 A 
CGTCTAGATGGTTCGTTGTGAAAAAGGTAT 
Mef2-23-F 1888 - Mutagenesis of Sna2 and Sna3 in Mef2 I-D[L] 
CTGCATGTTGCATGCACTCATCACATGTGCAATACTCGGCATCTGCGGCA
GTAGC 
Mef2-23-R 1889 - Mutagenesis of Sna2 and Sna3 in Mef2 I-D[L] 
GCTACTGCCGCAGATGCCGAGTATTGCACATGTGATGAGTGCATGCAACA
TGCAG 
Mef2-1-F 1890 - Mutagenesis of Sna1 in Mef2 I-D[L] 
GCGACGTACGGTTGATGCTGAGTATTGCATGCACTCATCACATG 
Mef2-1-R 1891 - Mutagenesis of Sna1 in Mef2 I-D[L] 
CATGTGATGAGTGCATGCAATACTCAGCATCAACCGTACGTCGC 
Tin-123-F 1892 - Mutagenesis of Sna1, 2 and 3 in Tin B-374 
GATCCCTTCTGGGCTGGTTGACATGTGAGATTCTCATGTGAGGACCG 
CCGCACAGGGGCG 
 Tin-123-R 1893 - Mutagenesis of Sna1, 2 and 3 in Tin B-374 
CGCCCCTGTGCGGCGGTCCTCACATGAGAATCTCACATGTCAACCAGCCC
AGAAGGGATC 
Tin-4-F 1902 - Mutagenesis of Sna4 in Tin B-374 
CTTTGTATTGCCTTGTTTCTAACTTCTCGCTTTTCCATTTTCCTGCTTTCC 
Tin-4-R 1903 - Mutagenesis of Sna4 in Tin B-374 
GGAAAGCAGGAAAATGGAAAAGCGAGAAGTTAGAAACAAGGCAATACA
AAG 
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Name 
Sequence 
Stock 
number 
Restrict. 
site 
Purpose 
lacZ-F 1842 - Mapping ∆MED24 by single-embryo PCR  
CGACTGATCCACCCAGTCCC 
lacZ-R 1843 - Mapping ∆MED24 by single-embryo PCR 
GCGATGTCGGTTTCCGCGAG 
pos-F 1844 - Mapping ∆MED24 by single-embryo PCR 
CGATGACACTATCGCAGTTACATCC 
pos-R 1845 - Mapping ∆MED24 by single-embryo PCR 
CTGGTTTTAAGTTGGAATTTAGAAAGAAC 
msk-F 1846 - Mapping ∆MED24 by single-embryo PCR 
CATCCACGATCGCAAACTTTG 
msk-R 1847 - Mapping ∆MED24 by single-embryo PCR 
ACCGATTGTCGCAGCATACAT 
Med24-F 1848 1848 Mapping ∆MED24 by single-embryo PCR 
GCTGTGCACCAACAAGGTCCAG 
Med24-R 1849 - Mapping ∆MED24 by single-embryo PCR 
GGCAGGTGACCAGCATCGACT 
CG7375-F 1948 - Mapping ∆MED24 by single-embryo PCR 
AGCACAGCCAAACGCGGAAG 
CG7375-R 1949 - Mapping ∆MED24 by single-embryo PCR 
CCACCACGCATCGCCTTCTT 
Atg18-F 1950 - Mapping ∆MED24 by single-embryo PCR 
CCAATGCAGTTGTTCCGCGTAAAT 
Atg18-R 1951 - Mapping ∆MED24 by single-embryo PCR 
AACGAGGAAGAATCATCGCTGACA 
CG8005-F 1952 - Mapping ∆MED24 by single-embryo PCR 
CGATTGGGCTCCCCTTGAGC 
CG8005-R 1953 - Mapping ∆MED24 by single-embryo PCR 
GAGCCTCCGCAGATCGGACA  
Med24-1-F 2291 - Genomic primer to validate ∆MED24 
CCTCGCGCATCTTCCCTTG 
RB-1-R 2286 - RB element primer to validate ∆MED24 
TCCAAGCGGCGACTGAGATG 
Med24-2-R 2291 - Genomic primer to validate ∆MED24 
CGACACCGGTTGCATGTC 
RB-2-F 2287 - RB element primer to validate ∆MED24 
CCTCGATATACAGACCGATAAAAC 
WH-F 2288 - WH element primer to validate ∆MED14 
GACGCATGATTATCTTTTACGTGAC 
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Name 
Sequence 
Stock 
number 
Restrict. 
site 
Purpose 
XP-R 2289 - XP element primer to validate ∆MED14 
AATGATTCGCAGTGGAAGGCT 
jumuB-F 2039 BglII Cloning jumuB into pDuo2n 
GCGCAGATCTAACCAACTAATTGCCCCAAA 
jumuB-R 2040 KpnI Cloning jumuB into pDuo2n 
ACTGGTACCCTGCCCCCCCAAAAAATTC 
jumuA-F 2041 BglII Cloning jumuB into pDuo2n 
GCGAGATCTGGTTGTGTTTATTTTGCTAGCCAC 
jumuA-R 2042 KpnI Cloning jumuA into pDuo2n 
ACTGGTACCGGAATCAAGTATTTGCCCGC 
rib-F 2057 BglII Cloning rib into pDuo2n 
GCGAGATCTAGACTGGGACACAGCTATGCC 
rib-R 2058 KpnI Cloning rib into pDuo2n 
ATAGGTACCCTTGAGTTTTCCGCTCGCC 
jumuB-1 2203 - Mutagenesis of Ttk2 and Ttk3 in jumuB 
CTCTCGGTTTAGCGGGTTTTAATTCGGTATATTCTCCGGGTTATTTCATTC
AT 
jumuB-2 2204 - Mutagenesis of Ttk4 in jumuB 
GTAACATCCTTAAACACACAGGATGAGTTAGGGTCGTAAATCG 
jumuB-3 2205 - Mutagenesis of Ttk7, 8, and 9 in jumuB 
CACTCAGGTAAAACCAACGATTGCTGTTGTTCGTTCTGGACGAATCTTCCC 
jumuB-4 2206 - Mutagenesis of Ttk12 in jumuB 
CTTTCTCGGCATTTTTCGTCACTGGCGATGGTTGTAAG 
jumuB-5 2207 - Mutagenesis of Ttk14 and Ttk15 in jumuB 
CCTTTTCAAGTTGTGCAACGAACCAATTTGTGACCGACGAGGGTATTTTC
GTC 
jumuA-1 2198 - Mutagenesis of Ttk2 in jumuA 
CGAAAATAACTCATGTTGCAACACTTTAACCAGTACAACAAAAAAAGTAT
CAGC 
jumuA-3 2200 - Mutagenesis of Ttk6 in jumuA 
GGGTCCGAATACGAATCCGATAGTTCTGTGCTGATGTTTGTGGG 
jumuA-5 2202 - Mutagenesis of Ttk10 in jumuA 
CAAGTATTTGCCCGCTATGCTTTAATATACTATTTCATTTTATCCGCTACG 
rib-1 2208 - Mutagenesis of Ttk1 in rib 
CGAATGCGAAGGGGAAACATTTAAACTGTGCTACGAATCCACCC 
rib-2 2209 - Mutagenesis of Ttk2 and Ttk3 in rib 
CGTGTGCAGCAAGTGTGTGAAGACCAAATTGTTCGAGCGCTGCCAGAGC 
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3.1.5 Antibodies 
Antigen/ 
Antibody 
Conjugated 
moiety Host species Dilution Vendor/Source 
GFP - chicken 1:300 Abcam 
β−Galactosidase - chicken 1:300 Abcam 
β−Galactosidase - mouse 1:100 Promega 
β3 tubulin - rabbit 1:300 R. Renkawitz-
Pohl 
Mef2 - rabbit 1:200 E. Furlong 
Ttk69 - rabbit 1:200 A. Travers 
Ttk69 - rabbit 1:200 A. Azorin 
Bin - rabbit 1:50 E. Furlong 
Kr - guinea pig 1:300 H. Jäckle 
Eve - guinea pig 1:200 H. Jäckle 
Asense - rabbit 1:600 Y. Jan 
Repo (8D12) - mouse 1:5 DSHB 
Achaete - mouse 1:15 DSHB 
PhosphoH3 - rabbit 1:200 Millipore 
Lmd - rabbit 1:100 E. Furlong 
Futch (22C10) - mouse 1:10 DSHB 
FasIII (7G10) - mouse 1:10 DSHB 
Digoxigenin Alkaline 
phosphatase 
sheep 1:1000 Roche 
Digoxigenin Peroxidase sheep 1:1000 Roche 
Fluorescein Peroxidase sheep 1:1000 Roche 
Biotin Peroxidase sheep 1:1000 Roche 
Rabbit IgG Biotin donkey 1:200 Jackson 
Immunoresearch 
Mouse IgG Biotin donkey 1:200 Jackson 
Immunoresearch 
Guinea pig IgG Biotin donkey 1:200 Jackson 
Immunoresearch 
Chicken IgG Alexa488 goat 1:300 Invitrogen 
Mouse IgG Alexa 488 donkey 1:300 Invitrogen 
Rabbit Cy5 donkey 1:200 Jackson 
Immunoresearch 
Streptavidin Cy2 - 1:200 Jackson 
Immunoresearch 
Streptavidin Cy3 - 1:300 Jackson 
Immunoresearch 
Streptavidin Cy5 - 1:200 Jackson 
Immunoresearch 
Streptavidin Horse reddish 
peroxidase 
- 1:200 Perkin Elmer 
3 MATERIALS AND METHODS 
 
 -72- 
3.1.6 Plasmids and vectors 
Name Purpose Source 
pH-pelican Generation of transgenic Drosophila melanogaster 
lacZ-reporter lines  
[195] 
pDuo2n Generation of transgenic Drosophila melanogaster 
lacZ-reporter lines 
[196] 
pAc5.1 A Constitutive protein expression in Drosophila Kc cells Invitrogen 
pGL3-Hsp70 Firefly luciferase reporter vector [108] 
pRL-Hsp70  Renilla luciferase control vector [108] 
pCRII-TOPO Template for in vitro transcription reactions Invitrogen 
 
3.1.7 Software 
Name Purpose Source 
Vector NTI Visualization and design of cloning 
projects, DNA sequence analysis 
Invitrogen 
ImageJ Export and processing of microscopy 
data files 
W. Rasband, NIH 
Integrated Genome 
Browser (IGB) 
Visualization of ChIP-on-chip data Affymetrix 
 
3.1.8 Media, solutions, and buffers 
LB+Amp –medium: 10 g Trypton Peptone 
5 g Bacto-yeast extract 
10 g NaCl 
ad 1 l with H2O 
after autoclaving: 
ad 1 ml 1000x Ampicillin 
 
LB+Amp –plates: 10 g Trypton Peptone 
5 g Bacto-yeast extract 
10 g NaCl 
15 g Agar-Agar 
ad 1 l with H2O 
after cooling off to 50°C: 
add 1 ml 1000x Ampicillin 
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SOC -medium: 5 g Bacto-yeast extract 
20 g Bacto-Peptone 
20 g Dextrose 
10 mM NaCl 
2,5 mM KCl 
10 mM MgSO4 
ad 1 l with H2O 
 
Standard fly medium: 1 l H2O 
12 g agar 
80g corn powder  
18 g dry yeast 
22 g sirup 
10 g soy powder 
6.2 g propionic acid 
80 g malt extract 
2.4 g nipagin 
 
1% Agarose: 1% Agarose (w/v) in 1x TAE 
buffer 
 
1kb DNA ladder: #N 3232 L (NEB)  
1000µl of 500 µg/µl 1kb-ladder  
diluted to 1 µg/10µl in 700 µl  
6x Loading Buffer (without 
xylene cyanol) and 3300 µl 1x 
TE-buffer 
used at 1 µg/10µl working stock 
 
100bp DNA-ladder: 
 
# N323L (NEB)  
500 µl of 500 µg/µl 100bp 
DNA-ladder diluted to 1 µg/10 
µl in 350 µl 6x Loading Buffer 
(without xylene cyanol) and 
1650 µl 1x TE-buffer 
use: 0.5 µg/10 µl working stock 
 
100x PMSF: 100 mM in 2-propanol 
 
1000x Ampicillin: 100 mg/ml, sterile  
 
1000x Aprotinin: 10 mg/ml in H2O 
 
1000x Leupeptin: 10 mg/ml in DMSO  
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20x PBS: 175.2 g NaCl 
44.8 g KCl 
46.6 g Na2HPO4 x 12 H2O 
4.2 g KH2PO4 
 
50x TAE: 2 M Tris/glacial acetic acid,  
pH 7.7  
5 mM EDTA in H2O 
 
6x Loading Dye: 30% glycerol  
0.25% bromophenol blue 
0.25% xylene cyanol 
 
Cell lysis buffer for Drosophila embryos: 
 
5 mM Hepes, pH 8.0 
85 mM KCl 
0.5% NP40 (IGEPAL) 
+ protease inhibitors 
 
Cross-linking solution: 
 
50 mM Hepes 
1 mM EDTA 
0.5 mM EGTA  
100 mM NaCl 
1.8% Formaldehyde, pH 8.0 
 
DAB Staining solution: 
 
3,3’ Diaminobenzidine (DAB) 
staining solution diluted 1:20 in 
3% H2O2 
 
DNA extraction buffer: 10 mM Tris-HCl 
25 mM NaCl 
1 mM EDTA 
0.02 mg/ml Proteinase K 
 
Fixing solution: 175 µl 16% formaldehyde  
(4% final)  
525 µl PBS 
 
Fix/Heptane: 
 
700 µl Fixing solution 
700 µl n-heptane 
 
LiCl – buffer: 
 
250 mM LiCl 
10 mM Tris-HCl, pH 8.0 
1 mM EDTA 
0.5% NP-40 
0.5% sodium deoxycholate 
 
Methanol/PBT: 50% methanol 
50% PBT 
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Nuclear lysis buffer: 
 
50 mM Hepes, pH 8.0 
10 mM EDTA•Na2 
0.5% N-Laurylsarkosin 
+ protease inhibitors  
 
PBS/Glycin/Triton: 125mM glycin 
0.1% Triton in PBS 
 
PBT: 1x PBS 
0.1% Triton-X-100 
 
PBT/BSA: PBT + 0.2% BSA 
 
PBT/BSA/NGS: 
 
PBT/BSA 
+ 0.2% Normal Goat Serum 
(NGS) 
 
PBTween: 1xPBS 
0.1% Tween 20 
 
1000x Pepstatin: 10 mg/ml in DMSO 
 
Protease inhibitors: 1x Aprotinin 
1x Leupeptin 
1x Pepstatin 
1x PMSF 
 
RIPA-buffer (140mM NaCl):  
 
140 mM NaCl 
10 mM Tris-HCl pH 8.0 
1 mM EDTA 
1% Triton-X-100 
0.1% SDS 
0.1% sodium deoxycholate 
1 mM PMSF (from 100 mM 
stock in 2-propanol) 
 
RIPA-buffer (500mM NaCl): 
 
500 mM NaCl 
10 mM Tris-HCl pH 8.0 
1 mM EDTA 
1% Triton-X-100 
0.1% SDS 
0.1% sodium deoxycholate 
1 mM PMSF (from 100 mM 
stock in 2-propanol) 
 
Streptavidin/HRP: 
 
A + B solutions  
(Vector Laboratories) 
1:100 in PBT/BSA each;  
incubated 1h at r/t prior to use 
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TE-buffer: 
 
10 mM Tris-HCl, pH 8.0 
1 mM EDTA 
 
HybA: 
 
 
25 ml Formamide 
12.5 ml 20X SSC pH 5.0 
0.515 ml salmon sperm   
                (9.7mg/ml) 
0.05 ml Tween 20  
ad 50 ml DEPC H2O 
 
HybB: 25 ml Formamide 
12.5 ml 20X SSC pH 5.0 
12.5 ml DEPC H2O 
 
 
3.1.9 Fly lines 
Genotype Source/Generated in the lab of 
€ 
wt
Y ;
wt
wt ;
ttkD2−50
TM3 ;
wt
wt  
C. Klämbt 
€ 
wt
Y ;
wt
wt ;
Df (3R)awd −KRB
TM3 ;
wt
wt  
Bloomington stock centre 
€ 
wt
Y ;
wt
wt ;
ttk1
ttk1 ;
wt
wt  
A. Travers 
€ 
rP298 − lacZ
Y ;
wt
wt ;
wt
wt ;
wt
wt  
M. Ruiz-Gomez 
€ 
rP298 − lacZ
Y ;
wt
wt ;
ttkD2−50
TM3 ;
wt
wt  
this study 
€ 
wt
Y ;
Adv
CyO ;
UAS −Ttk69
UAS −Ttk69 ;
wt
wt  
A. Travers 
€ 
UAS −Ttk88
Y ;
wt
wt ;
wt
wt ;
wt
wt  
A. Travers 
 
€ 
wt
Y ;
wt
wt ;
UAS −GFP
UAS −GFP ;
wt
wt  
Bloomington stock centre 
€ 
rP298 −Gal4
Y ;
wt
wt ;
wt
wt ;
wt
wt  
S. Abmayr 
 
€ 
wt
Y ;
sns−Gal4
sns−Gal4 ;
wt
wt ;
wt
wt  
R. Renkawitz-Pohl 
€ 
wt
Y ;
sns−Gal4
sns−Gal4 ;
wt
wt ;
wt
wt  
S. Abmayr 
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Genotype Source/Generated in the lab of 
€ 
wt
Y ;
ttk −VME
ttk −VME ;
wt
wt ;
wt
wt  
E. Furlong 
€ 
wt
Y ;
wt
wt ;
Dr
TM3,twi −Gal4,UAS −GFP ;
wt
wt  
Bloomington stock centre 
€ 
wt
Y ;
wt
wt ;
D
TM3,AbdA − lacZ ;
wt
wt  
E. Bier 
€ 
wt
Y ;
Sco
CyO,wg − lacZ ;
wt
wt ;
wt
wt  
Furlong lab stocks 
€ 
wt
Y ;
Sco
CyO, ftz − lacZ ;
wt
wt ;
wt
wt  
Furlong lab stocks 
€ 
wt
Y ;
sna10
CyO ;
wt
wt ;
wt
wt  
M. Leptin 
€ 
wt
Y ;
sna18
CyO ;
wt
wt ;
wt
wt  
Bloomington stock centre 
€ 
wt
Y ;
wt
wt ;
MHC − τGFP
MHC − τGFP ;
wt
wt  
E. Olson 
€ 
hs− FLP
Y ;
wt
wt ;
Dr
TM3;
wt
wt  
Bloomington stock centre 
€ 
wt
Y ;
wt
wt ;
PBac(RB)e03262
TM3 ;
wt
wt  
Exelixis (Harvard stock centre) 
€ 
wt
wt ;
wt
wt ;
PBac(RB)CG7375e02842
PBac(RB)CG7375e02842 ;
wt
wt  
Exelixis (Harvard stock centre) 
€ 
wt
Y ;
wt
wt ;
PBac(WH)CG17181f 06749
TM3 ;
wt
wt  
Exelixis (Harvard stock centre) 
€ 
wt
Y ;
wt
wt ;
PBac(XP)CG32345d 05325
PBac(XP)CG32345d 05325 ;
wt
wt  
Exelixis (Harvard stock centre) 
 
74 UAS-RNAi lines  
(listed in Appendix 7.1) 
Vienna Drosophila RNAi centre 
 
67 deficiency and loss-of-function lines 
(listed in Table 4.1-1) 
 
Bloomington stock centre 
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3.1.10  Web sites 
Name URL 
Flybase www.flybase.org 
BDGP in situ database www.fruitfly.org/cgi-bin/ex/insitu.pl 
FRT deletion hunter www.drosdel.org.uk/fdd/del_hunter.php 
FlyTF database www.flytf.org 
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3.2 METHODS 
3.2.1 Molecular biology and biochemistry 
3.2.1.1 Generation of transgenic reporter lines 
To investigate the regulatory potential of genomic DNA regions, transgenic 
Drosophila melanogaster reporter lines were generated.  
Regulatory regions identified in the Ttk69 ChIP-on-chip experiment were 
subcloned into the vector pH-pelican [195] and germ-line transformed into 
Drosophila melanogaster white- flies.  Following are the coordinates of the subcloned 
regions (dm3/BDGP release 5.0, April 2006): chr3R: 6182898-6183568 (jumuA), 
chr3R: 6178511-6179367 (jumuB), chr2R: 15162910-15163336 (rib). 
The elements assayed for Snail regulatory input were subcloned into the vector 
pDuo2n [196].   Germ-line transformation was then performed into Drosophila 
melanogaster flies with attP landing site mapped to the cytological band 51D on the 
second chromosome [197].  The coordinates of the subcloned regions are (dm3/BDGP 
release 5.0, April 2006): chr3R: 9118948-9119470 (WntD-lacZ), chr3R: 17205652-
17206054 (Tin B-374), chr2R: 5819019-5819498 (Mef2 I-D[L]), chr2R: 8833920-
8834301 (Mdr49 early mesoderm). 
For all constructs, at least two independent transgenic lines were obtained and 
assayed. 
  
3.2.1.2 Site-directed mutagenesis  
Mutagenesis of sequence motifs was performed using the QuikChange Multi 
site-directed mutagenesis or QuikChange II site-directed mutagenesis kits, following 
the supplier’s guidelines (Stratagene).  In all reactions, the enhancers were mutated in 
pGL3 vectors and then were transferred to pDuo2n or pH-pelican vectors.  All 
constructs were sequence-verified. 
 
3.2.1.3 Luciferase reporter assays 
Drosophila Kc cells were transiently transfected using Cellfectene (Invitrogen).  
Twist, Snail, and Dorsal were expressed from full-length ESTs (AT15089, RE58537, 
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and RE35237, respectively) in pAc5.1 vector.  Successful expression of the proteins 
was verified by a Western blot.  The enhancers (coordinates given above) were 
assayed in a pGL3 luciferase reporter vector with a Heat-shock-protein-70 (Hsp70) 
minimal promoter and the luciferase activity was normalized to Renilla standard.  The 
total amount of transfected DNA was kept constant by supplementing empty pAc5.1 
vector.  The measurements were performed according to the manufacturer’s 
recommendations (Dual-Luciferase Reporter Assay, Promega) with a PerkinElmer 
1420 Luminescence Counter. 
 
3.2.1.4 Chromatin immunoprecipitations from Drosophila embryos and analysis 
on genomic tiling microarrays 
ChIP-on-chip experiments were performed according to the previously 
described procedures [198].   
Briefly, tightly staged Drosophila wild type embryos were formaldehyde 
crosslinked and extracted chromatin was sonicated to approximately 500 bp 
fragments.  A chromatin aliquot was pre-incubated with the antibody or an equal 
volume of pre-immune serum and the complexes were then incubated with Protein A 
sepharose beads.  The immunocomplexes bound to the beads were then thoroughly 
washed, RNA and proteins were digested and the crosslinking was reversed by heat.  
Phenol-chloroform extracted and precipitated DNA fragments were assayed by 
quantitative PCR for enrichment of positive over negative control regions. 
 Next, a linker consisting of a 20mer and 5' phosphorylated 24mer was annealed 
to the DNA fragments.  Using the 20mer as a primer, the input material was amplified 
in two subsequent rounds of PCR.  After purification, quality of the sample was again 
verified by quantitative PCR.  Following DNAse I fragmentation the DNA was 
labelled using terminal deoxynucleotide transferase in the presence of biotinylated 
2',3'-Dideoxyadenosine-5'-Triphosphate. Samples were then hybridized to Affymetrix 
GeneChip® Drosophila Tiling array 1.0R at 43°C for 16 hours.  Washing and 
staining of arrays was performed according to the supplier’s guidelines. 
 Obtained raw data were normalized and evaluated by Bartek Wilczynski as 
described previously [196]. 
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3.2.2 Histological techniques 
3.2.2.1 In situ hybridization and immunohistochemistry 
In situ hybridizations were performed using standard protocols [199]. The 
following ESTs were used to generate digoxigenin, fluorescein, or biotin labelled 
probes: LD28689 (ttk69), RE35237 (sna), LD41072 (row), LD23630 (CG8478), 
GH01967 (gem), LD11946 (CG9650), HL07808 (luna), GH06338 (CG30431), 
SD10012 (Mdr49), LD47926 (lmd), AT15089 (twi), and SD06902 (zfh1). 
The full-length cDNA clones of Mef, tin, sns, and lacZ were a gift from M. 
Taylor, M. Frasch, S. Abmayr, and U. Elling, respectively.   
The probe against the Green Fluorescent Protein (GFP) transcript was made by 
amplifying the GFP sequence from the pH-Stinger vector.   
The probes for CG33936, dmrt11E, HmgZ, and htl were generated from their 
largest exons which were cloned into the pCRII-TOPO vector.   
 
3.2.3 Generation of Drosophila deletion lines by FRT-mediated 
recombination 
The custom-made deletion line ∆MED24 was generated according to the 
following crossing scheme [200]: 
Cross Progeny  
€ 
hs− FLP
hs− FLP ;;
Dr
TM3  
X 
€ 
wt
Y ;;
PBac(RB)e03262
TM3  
 
 
 
€ 
hs− FLP
Y ;;
PBac(RB)e03262
TM3  
€ 
hs− FLP
Y ;;
PBac(RB)e03262
TM3  
X 
€ 
wt
wt ;;
PBac(RB)CG7375e02842
PBac(RB)CG7375e02842  
 
€ 
hs− FLP
wt ;;
PBac(RB)e03262
PBac(RB)CG7375e02842  
 
During larval stages, subjected to a heat shock 
at 37ºC for 2 hours. 
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€ 
hs− FLP
wt ;;
PBac(RB)e03262
PBac(RB)CG7375e02842  
X 
€ 
wt
Y ;;
Dr
TM3   
 
All progeny screened by complementation test 
against a deficiency line and by two-sided 
PCR.  
Final stock 
€ 
wtorhs− FLP
Y ;;
PBac(RB)e03262 − PBac(RB)CG7375e02842
TM3  
 
 
The deletion line ∆MED14 was generated according to the following crossing 
scheme [200]: 
Cross Progeny  
€ 
hs− FLP
hs− FLP ;;
Dr
TM3  
X 
€ 
wt
Y ;;
PBac(WH)CG17181f 06749
TM3  
 
 
€ 
hs− FLP
Y ;;
PBac(WH)CG17181f 06749
TM3  
€ 
hs− FLP
Y ;;
PBac(WH)CG17181f 06749
TM3
X 
€ 
wt
wt ;;
PBac(XP)CG32345d 05325
PBac(XP)CG32345d 05325  
 
 
€ 
hs− FLP
wt ;;
PBac(WH)CG17181f 06749
PBac(XP)CG32345d 05325  
 
Subjected to a heat shock at 37ºC for 2 hours 
during larval stages. 
€ 
hs− FLP
wt ;;
PBac(WH)CG17181f 06749
PBac(XP)CG32345d 05325  
X 
€ 
wt
Y ;;
Dr
TM3  
  
White-eyed progeny was screened by 
complementation test against a deficiency line 
and by hybrid PCR. 
 
Final stock 
 
€ 
wtorhs− FLP
Y ;;
PBac(WH)CG17181f 06749 − PBac(XP)CG32345d 05325
TM3  
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4 RESULTS 
4.1 A molecular screen for novel transcription factors 
essential for Drosophila mesoderm development 
4.1.1 Experimental design of the screen 
 The main aim of the screen was to identify novel myogenic regulators that 
would fulfil two criteria: 
o Expression in mesoderm: in order to play a regulatory role in muscle development 
the TF must be present in mesodermal cells. 
o Essential role in mesoderm development: if the TF is involved in muscle 
development, in its absence the development of one or more muscle types should 
be perturbed. 
 The screen was therefore performed in two rounds; the first round focused on 
identifying novel mesodermally expressed TFs, and in the second round their 
requirement for myogenesis was systematically assessed. 
 
Figure 4.1-1: Experimental design of the molecular screen 
The number of unique TFs in each class (in boxes) is based on Release 1 of FlyTF [201] and 
Release 2 of BDGP expression patterns database [202]. 
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4.1.1.1 Selection of candidate mesodermal TFs 
 The screen was initiated by examining all putative Drosophila TFs which 
were manually curated based on their ability to bind DNA and/or regulate gene 
expression [201].  Altogether, there are 753 proteins which are annotated as being 
sequence-specific transcription factors.  To refine the number of TFs for further 
analysis, the Berkeley Drosophila Genome Project (BDGP) in situ hybridization 
database was used as a source of annotated embryonic gene expression patterns [202].  
Its Release 2 contained expression patterns of 370 TF-encoding genes, out of which 
88 were annotated as mesodermally expressed during at least one time point up to 
stage 11.  One half of these TFs have an already identified role in mesoderm 
development or are involved in the specification of embryonic axes.  I therefore 
focused on the other half of the mesodermally expressed TFs whose functional roles 
in the mesoderm have not yet been investigated. This group of TFs therefore 
represents candidate TFs whose requirement for myogenesis was further assayed 
(Figure 4.1-1). 
 In addition to the TFs with known expression patterns, there were 383 TFs 
without annotated expression in the Release 2 of BDGP database.  As many of these 
are likely to be present in mesoderm, available genome-wide data was used to 
prioritize them for further examination.  More specifically, putative regulation of 
these genes by mesodermal TFs (using ChIP-on-chip binding data) and expression 
profiling of mesodermal mutants were used as indicators of their likelihood to be 
involved in myogenesis.  Subsequently, colorimetric in situ hybridization of some 
candidates was performed and once their expression in mesoderm was confirmed, 
they were added to the group of candidate TFs (Figure 4.1-1). 
 
4.1.1.2 Identification of novel mesodermally expressed TFs 
Of the 383 TFs for which no information on their embryonic expression was 
available (Figure 4.1-1), in situ hybridization was performed based on their likelihood 
to be expressed in the mesoderm.  This likelihood was reflected by a score that was 
derived from two types of previously generated genome-wide data.  First, it was 
assumed that mesodermally expressed genes are activated by one or more key 
mesodermal transcriptional regulators.  CRMs identified in 8 different ChIP-on-chip 
experiments with Twi, Tin, and Mef2 [196] were therefore assigned to target genes.  
   4 RESULTS 
 
 -86- 
Each such target gene encoding a TF was allocated zero to eight points, depending on 
the number of experiments in which a CRM in its vicinity was detected.  Altogether, 
132 of the 753 TFs have at least one binding event in their proximity while about half 
of these TFs (53%) are regulated by at least two different mesodermal TFs. Second, if 
the potential mesodermal TFs are downstream of the known regulators, their 
expression levels should be reduced in their absence.  Gene expression changes in 
mutants for twi, tin, and Mef2 were previously quantified in genome-wide expression 
profiling experiments covering three to four different time windows [55, 62], 
contributing thereby 10 additional datasets.  Again, one point was assigned if the 
expression of a TF-coding gene was significantly reduced (log2<-0.77, q<0.05) in a 
given dataset.  The highest possible total score was therefore 18 as 8 ChIP-on-chip 
and 10 expression profiling datasets were included in the analysis (Figure 4.1-2 A). 
As expected, the TF-encoding genes that are annotated by the BDGP as 
mesodermal have on average higher scores than those expressed in other tissues and 
conversely, genes not expressed in mesoderm obtain very low scores  (Figure 4.1-2 
B).  The scores of genes without known expression pattern are distributed in between 
those of mesodermal and non-mesodermal genes.  39 of the 383 (10%) TFs that were 
not included in the BDGP database have a score of 4 or higher, compared to 3 of 282 
(0.01%) non-mesodermal TFs, and 61 of 88 (70%) mesodermal TFs (Figure 4.1-2 B 
inset).  As a consequence, this class of TFs without expression information is likely to 
contain mesodermal TFs and the assigned score should facilitate their systematic 
identification.  I therefore selected genes from this class for in situ hybridization 
analysis. 
By in situ hybridization I confirmed expression of three genes (row, CG8478, 
gem, Figure 4.1-2 C-E) that were annotated as mesodermal in BDGP database, yet 
their assigned score was low and the mesodermal aspect of their expression was not 
apparent from the images supplied by BDGP.  In addition, six TFs with unknown 
expression pattern were identified as mesodermal. Doublesex-Mab related 11E 
(dmrt11E) is the third highest scoring gene in the class of TFs with unknown 
expression pattern and is expressed in the trunk mesoderm of stage 9 and 10 embryos 
(Figure 4.1-2 F).  The only suggested role of dmrt11E is in sex differentiation [203].  
HMG protein Z (HmgZ) encodes a member of the high mobility group of proteins that 
are associated with chromatin remodelling [204].  So far no direct link between this 
type of DNA-binding proteins and Drosophila muscle development has been 
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established, yet HmgZ mRNA could be detected in the trunk mesoderm of stage 10 
embryos (Figure 4.1-2 H).  luna encodes a zinc finger TF and its loss- and gain-of-
function during embryogenesis interferes with viability [205].  The specific processes 
that are affected have however not been identified.  luna mRNA can be detected in the 
primordia of somatic and visceral muscle of stage 11 embryos (Figure 4.1-2 I), 
suggesting that it might play a role in the development of these mesodermal 
derivatives.  Finally, three TFs without any information on their developmental 
function have been identified as mesodermal.  CG9650 scores 8 points and shows 
panmesodermal expression at late stage 10 (Figure 4.1-2 G).  CG33936 can be 
detected in the somatic muscle primordium at stage 11 (Figure 4.1-2 J) and CG30431 
appears to be expressed in the mesoderm-derived fat body (Figure 4.1-2 K). 
In summary, ChIP-on-chip and expression profiling experiments are predictive 
of mesodermal expression and thereby facilitated the identification of novel 
mesodermally expressed TFs.  A number of low-scoring genes were also expressed in 
mesoderm (Figure 4.1-2 C-E), underscoring the fact that Twi, Tin, and Mef2 are not 
the only mesodermal regulators.  As the Release 3 of BDGP expression patterns 
database was anticipated to cover expression of most of Drosophila TFs, instead of 
analyzing embryonic expression of additional genes, I rather proceeded to the second 
round of the screen, focusing on the phenotypic analysis of the candidate mesodermal 
TFs. 
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Figure 4.1-2: Identifying transcription factors expressed in mesoderm 
(A)   Score assignment was used to reflect the likelihood of mesodermal expression.  Eight 
different ChIP-on-chip and 10 different expression profiling datasets were included 
for calculation of the score.  The numbers indicate all TFs (out of 753) identified in a 
given data set and the total number of TFs in the last column indicates unique TFs per 
a set of experiments (e.g. number of unique TFs regulated by Twi, Tin, or Tin across 
all considered time points). 
(B)   Distribution of the score among the three expression classes; TFs expressed in 
mesoderm (green), TFs with unknown expression (blue), and TFs not expressed in 
mesoderm (red).  The inset shows the number of TFs with a score equal to or higher 
than 4, the selected cut-off. 
(C-K)  Colorimetric in situ hybridization to confirm mesodermal expression of low-scoring 
TFs annotated as mesodermal (C-E) and to identify novel mesodermally expressed 
TFs (F-K).  In the brackets is a score assigned to each gene and the red arrows point 
to mesodermal expression. 
 
 
4.1.1.3 Phenotypic analysis of new mesodermal TFs 
 To assess the importance of candidate mesodermal TFs for muscle 
development, their mutant phenotypes were analysed.  First, available deficiency lines 
removing bigger parts of chromosomes, and thereby multiple genes, were used 
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individually or in combination.  Deficiencies were selected so that the smallest 
possible deletion around the candidate TF was achieved.  In most cases, two 
deficiency lines were combined so that the transheterozygous embryos were 
homozygous mutant only for their overlapping region. To enable unambiguous 
identification of the homozygous mutant embryos, all lines carried a wg-lacZ or abd-
A-lacZ marked balancer chromosome, depending on whether the deleted region was 
located on the second or third chromosome, respectively.   
 Ideally, the candidate TF was situated close to the centre of the deleted region, 
especially in the case of deficiency lines whose breakpoints were derived only from 
polytene chromosome squashes and not by recently developed Polymerase Chain 
Reaction (PCR)-based protocols [200, 206].  Finally, deficiency lines deleting already 
known myogenic factors and/or patterning genes were excluded as their phenotype 
would obscure the mutant phenotype of the candidate TF.  
When muscle-specific defects were observed in the deficiency lines, 
expression of the removed, mesodermally expressed genes was knocked down 
specifically in the mesoderm using RNAi lines (Appendix 7.1).  Altogether, 74 
different RNAi lines directed against 48 genes were used.  Out of these, 23 lines, 
corresponding to 18 genes, showed lethality at early larval to pupal stages when 
combined with a panmesodermal driver.  However, as the knockdown is effective 
only relatively late in embryogenesis, the RNAi lines do not provide definitive 
information regarding the requirement of the gene for mesoderm specification (see 
Section 5.1.2.1).  Therefore, smaller deletion lines removing the candidate TFs with 
the most interesting phenotypes were generated. 
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4.1.2 Classes of identified muscle phenotypes 
Altogether, 67 different deficiency and loss-of-function lines were used 
individually or in combination to delete 46 distinct genetic loci on the X, second, and 
third chromosomes.  In 25 cases, the phenotype was either wild type or obscured by 
pleiotropic, general embryonic defects, whereas in the 21 other cases muscle-specific 
defects were identified.  20 of these occurred within somatic musculature and they 
were further subdivided into three phenotypic classes (Figure 4.1-3).   
 
 
 
Figure 4.1-3: Distribution of identified phenotypes 
Phenotypes of 46 genetic loci deleted by deficiency and loss-of-function lines were 
subdivided into 4 major groups based on the overall phenotype.  The phenotypes in somatic 
musculature were further classified into three different subgroups reflecting the particular 
processes that were affected.  The number of unique loci in each group is indicated (the 
somatic muscle and visceral muscle phenotypes are non-exclusive). 
 
 
The genetic loci exhibiting abnormal somatic muscle development were divided 
into three loosely defined groups (classes III-V) based on the complexity of the 
observed somatic muscle phenotypes, while the wild type phenotype and pleiotropic 
defects represent classes I and II, respectively (Table 4.1-1). 
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Table 4.1-1: Analyzed genetic loci and the classification of their phenotypes  
Summary of all analyzed deficiency and loss-of-function lines and their phenotypes.  Each 
row represents a single genotype and each column a phenotype.  The genetic loci were 
grouped into 5 classes (I-V) based on their overall and somatic muscle phenotypes.  
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4.1.2.1 Class I: Embryos with no observable phenotype 
To assess the muscle phenotype of all analysed lines, an antibody directed 
against the cytoskeletal component β3 tubulin was used [207].  This antibody labels 
all mesodermally-derived cell types and tissues from stage 11 until the end of 
embryogenesis.  After stage 16, when the somatic musculature has fully 
differentiated, the staining is prominent in dorsal, dorso-lateral (Figure 4.1-4 A-B'), 
lateral, and ventral muscle fibres (Figure 4.1-4 B-D').  β3 tubulin is present in four of 
the six cardioblasts per hemisegment (Figure 4.1-4 A, A'), where its expression is 
controlled by the cardiac regulator Tinman [208].  The antibody also labels the trunk 
visceral mesoderm which constricts and loops after stage 15 (Figure 4.1-4 E-H). 
 
 
 
Figure 4.1-4: Somatic, cardiac, and visceral musculature in wild type embryos 
All three muscle types in Drosophila wild type embryos are visible using an anti-β3 tubulin 
antibody.  
(A-A')   Dorsal view of a stage 16 embryo showing dorsal somatic muscle and the heart (red 
arrow). 
(B-B')  Dorsolateral view of a stage 17 embryos. All four groups of somatic muscles (dorsal, 
dorsolateral, lateral, and ventral) are visible. 
(C-C')  Lateral view of a stage 16 embryos with lateral and ventral muscles displayed. 
(D-D')  Ventral view of a stage 17 embryos showing ventral musculature. 
(E-H) Development of visceral musculature in wild type embryos from stage 14 (E) to the 
end of embryogenesis (H). 
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Deficiency lines deleting 16 genetic loci exhibited no obvious defects in 
formation of the three muscle types  (Table 4.1-1, data not shown).  The absence of 
obvious phenotypes upon deletion of mesodermal TFs could have technical (mis-
mapping of deficiency breakpoints) as well as biological reasons (discussed in the 
Section 5.1.1). 
 
4.1.2.2 Class II: Pleiotropic defects 
In the second phenotypic class, encompassing nine genetic loci, specific muscle 
defects could not be assessed as the embryos suffered from pleiotropic defects (Figure 
4.1-5).  These include a failure in morphological events, such as gastrulation or germ-
band extension, that would lead to developmental arrest prior to muscle specification 
and differentiation.  As the subdivision of the presumptive mesoderm into the three 
muscle primordia requires an intact overlying ectoderm as a signal source (see Section 
1.3.1), any patterning or axis specification defects prevent analysis of muscle-specific 
phenotypes as well.  The pleiotropic defects could also be caused by deleted gene(s) 
other than the candidate TF and the inability to assess the phenotypes due to 
pleiotropic defects is one of the greatest limitations of deficiency lines. 
 
 
Figure 4.1-5: Phenotypic class II: Pleiotropic defects 
Example of three (out of nine, see Table 4.1-1, class II) genetic loci which upon deletion give 
rise to pleiotropic defects.  Embryos were subjected to an immunostain with the anti-β3 
tubulin antibody. 
 
 
 
 
 
 
   4 RESULTS 
 
 -94- 
4.1.2.3 Class III: Somatic muscle specification and myoblast fusion defects 
The largest class of identified somatic muscle phenotypes comprises twelve 
genetic loci.  Their deletion gives rise to complex defects in somatic muscle number, 
morphology, and overall organization, indicative of abnormal muscle specification 
and/or guidance and attachment to the ectodermal tendon cells.  In addition, the 
severe phenotypes were often accompanied by unfused myoblasts, a sign of myoblast 
fusion failure. 
The deficiency line Df(3L)XG10 deletes an approximately 300 kB genomic 
region and the homozygous mutant embryos exhibit a defect mainly in muscle 
morphology and attachment (Figure 4.1-6 A).  The most affected seem to be the 
lateral transverse muscles which do not extend but are rounded.  In some cases, they 
remain mononucleated, indicating impaired fusion.  The ventral muscles display 
dramatic muscle guidance defects and appear also randomly positioned. 
The exact physical limits of the deficiencies Df(3L)vin5 and Df(3L)BSC14 have 
not been mapped, but based on the cytological information from polytene 
chromosome squashes, we can estimate that about a 70 kB region covering 20 
predicted genes should be absent in transheterozygous embryos.  The embryonic 
somatic musculature of these embryos is affected mainly in the dorsal region where 
muscle fibres are either absent or have abnormal morphology (Figure 4.1-6 B). 
Transheterozygous embryos of Df(2L)A266 and Df(2L)A260 remove 34 genes 
spreading over about 500 kB.  The resulting embryos have defects in the development 
of distinct muscle fibres, such as the dorsal oblique 3 or ventral oblique 4 and 5 
muscles (Figure 4.1-6 C).  The candidate TF removed in this region, no ocelli (noc), is 
however not responsible for this phenotype as its amorphic allele nocTE35B [209] is 
viable when combined with the line Df(2L)A266. 
The left limit of the region shared by lines Df(2R)ED1552 and Df(2R)42 was 
approximated by polytene analysis, while the right limit was confirmed by a PCR-
based method.  The affected locus has a size of approximately 90 kB and it removes 
21 annotated genes.  In the dorsal somatic musculature of transheterozygous embryos, 
there are some muscle fibres missing and those that are present have aberrant 
arrangements (Figure 4.1-6 D).  
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 Deletion of 43 genes within a 450 kB region by the deficiency lines 
Df(2R)stan2 and Df(2R)X1 results in a mild phenotype affecting the dorsal somatic 
musculature with a few absent muscle fibres (Figure 4.1-6 E).   
 The overlap of deficiency lines Df(3L)B71 and Df(3L)ED201 removes about 
200 kB covering 42 genes.  The main feature of the transheterozygous muscle 
phenotype is the occurrence of a high number of unfused myoblasts, whereas some 
myofibers are absent or have abnormal shape and/or size, suggesting a defect in 
myoblast fusion (Figure 4.1-6 F). 
 The X-chromosome located deficiency Df(1)RR79 deletes 48 genes spanning 
490 kB.  Embryos deficient for this region lack some muscle fibres, for example the 
dorsal oblique muscles, and their ventral fibres cross the ventral midline, suggesting a 
defect in muscle guidance (Figure 4.1-6 G). 
 Deletion of 29 genes within the 211 kB region removed by the deficiency line 
Df(1)ED7067 gives rise to a very interesting phenotype in muscle identity 
determination.  The dorsolateral muscle fibres dorsal oblique 3 and 4, and dorsal acute 
3 are missing while some lateral transverse muscles are duplicated (Figure 4.1-6 H).  
As there are more muscle fibres of one type and fewer of another, it is likely that an 
identity transformation has occurred.  Alternatively, a defect in asymmetric cell 
division could also give rise to more instances of a particular muscle fibre at the 
expense of others.  
 The deficiency Df(1)m259-4 deletes approximately 280 kB containing 36 
genes.  The somatic musculature exhibits a few missing muscle fibres, while 
mononucleated, unfused myoblasts are present in their positions.  In addition, many 
myotubes fail to extend towards their attachment sites and instead form spheroid-like 
structures instead (Figure 4.1-6 I). 
Finally, the breakpoints of the deficiency Df(1)Exel6245 were precisely 
mapped; it deletes 15 genes within a 92 kB region.  In some of the mutant embryos, 
lateral transverse muscles are duplicated and their overall morphology is perturbed 
(Figure 4.1-6 J). 
Altogether, the ten described deficiencies give rise to a range of phenotypes in 
several groups of muscle fibres.  All show specification defects where either certain 
muscle fibres are missing or duplicated, accompanied by abnormal muscle 
morphology and arrangement. 
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Figure 4.1-6: Phenotypic class III: Aberrant somatic muscle number and/or 
organization 
Embryos of all genotypes were subjected to either fluorescent (A-F) or colorimetric (G-J) 
immunostaining with anti-β3 tubulin antibody. Red arrows indicate abnormal muscle 
morphology, red arrowheads point to unfused myoblasts, and red asterisks indicate absent or 
duplicated muscle fibres.  At least 3 different stage 16 or 17 embryos are shown per each 
genotype. 
 
 
4.1.2.4 Class IV: Somatic muscle morphology and organization 
The fourth class of identified phenotypes contains six unique genetic loci whose 
deletion results in abnormal muscle arrangement or morphology while the number of 
muscle fibres remains unaffected. 
The line Df(2R)Exel7135 deletes a 133 kB locus which removes 20 annotated 
protein coding genes.  Some of the somatic muscle fibres have an abnormal shape 
(Figure 4.1-7 A), suggesting that they fail to respond to attractant cues secreted by the 
ectoderm (or, alternatively, these cues are absent).  
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The breakpoints of the sequence deleted by Df(3R)by416 is not precisely known 
as it was derived from polytene chromosome squashes.  The largest possible region 
that it might delete encompasses 380 kB and 67 genes. Similar to Df(2R)Exel7135, 
lateral transverse muscles do not extend towards their attachment sites, but in 
addition, the ventral muscle fibres migrate over the ventral midline (Figure 4.1-7 B). 
In the case of the line Df(3L)ED4978, 380 kB of genomic sequence and 57 
genes are removed.  In the somatic musculature of homozygous embryos, many 
unfused myoblasts are present, predominantly in ventral regions (Figure 4.1-7 C).  
Moreover, some myofibres are thinner than normal and exhibit an unusual 
morphology. 
The endpoints of the deficiency Df(3L)BK10 were derived from polytene 
analysis. A region estimated of almost 600 kB, covering 67 genes, is deleted.  
Although the region partially overlaps with another analysed deficiency line, 
Df(3L)XG10 (Figure 4.1-6 A), the phenotype of Df(3L)BK10 is milder as only a few 
muscle fibres remain rounded and unextended (Figure 4.1-7 D). 
The overlap of the deficiencies Df(2L)Exel7042 and Df(2L)ED680 deletes 11 
genes spread over almost 60 kB.  The resultant somatic muscle phenotype is mild as 
only the lateral transverse muscles exhibit a thinner shape than normal (Figure 4.1-7 
E). 
The sixth member of class IV, Df(3R)Exel6202, removes approximately 220 kB 
encompassing 35 genes.  In the dorsolateral somatic musculature of mutant embryos a 
few mononucleated cells can be found and the muscle fibre ventral acute 3 is thinner 
than in the wild type embryos (Figure 4.1-7 F). 
 The shared feature of the phenotypes in class IV is a failure in muscle guidance 
and attachment to the tendon cells.  Whether this is due to muscle intrinsic or extrinsic 
defects would need to be determined by further experiments.  In addition, in many 
cases mononucleated myoblasts in combination with thinner muscle fibres were 
observed.  Even though these point to a defect in myoblast fusion, only very few 
myoblasts were usually affected, arguing against a general failure of the fusion 
process.  
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Figure 4.1-7: Phenotypic class IV: Abnormal somatic muscle guidance and attachment 
Anti-β3 tubulin antibody was used to reveal somatic musculature pattern in stage 16 to 17 
embryos with 6 different genetic loci individually deleted.  Red arrows indicate abnormal 
muscle morphology and arrowheads unfused myoblasts. 
 
 
4.1.2.5 Class V: Mononucleated somatic myoblasts 
In the last phenotypic class with two representatives, both the number and 
pattern of somatic musculature were normal, yet a high number of mononucleated, 
unincorporated cells recognized by the anti-β3 tubulin was revealed.  
The overlap of the deficiencies Df(3L)ED4475 and Df(3L)iro-2 delete a 116 kB 
large region containing only 8 genes.  Whereas the overall arrangement of the somatic 
muscle fibres was comparable to wild type embryos, numerous mononucleated 
myoblasts were present in the proximity of all muscle fibres and in all abdominal 
segments (Figure 4.1-8 A).   
The breakpoints of Df(3L)Exel6134 were precisely mapped to delete a 200 kB 
large region containing 19 genes.  In the mutant embryos, the muscle number and 
organization seemed unaffected, but there were a few unfused myoblasts present 
(Figure 4.1-8 B).  The phenotype is therefore similar to that of 
Df(3L)ED4475/Df(3L)iro-2, although it is substantially weaker.  
These phenotypes are rather unusual as the overall muscle organization appears 
wild type.  In contrast to more typical phenotypes seen when there is a block in 
myoblast fusion, the somatic muscle fibres are thick, multinucleated, and with normal 
morphology.  The excessive unfused myoblasts could result from a defect in cell 
proliferation or cell death, processes whose contribution to muscle development has 
not been studied in detail.  Alternatively, the cells might have undergone a cell fate 
transformation and originated from another tissue.   
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Figure 4.1-8: Phenotypic class V: Excessive mononucleated myoblasts in the somatic 
musculature 
Red arrowheads point to free, unfused myoblasts labelled by anti-β3 tubulin antibody.  The 
embryos are at the end of embryogenesis when the myoblast fusion has been completed and 
the muscle fibres should be fully differentiated. 
 
4.1.2.6 Defects in heart formation 
In the case of one deficiency line, a defect in heart development was also 
identified.  The line Df(2R)DII-MP deletes 34 genes in a 190 kB region and the 
homozygous mutant embryos form wild type somatic and visceral musculature.  
However, the heart tube is not properly assembled, although the cardioblasts are 
present (Figure 4.1-9).  The precise number of cardioblasts was not assessed and so 
the possibility that there are more or fewer cardiac cells than in wild type embryos 
cannot be excluded.  Consequently, the phenotype could arise from a defect in 
specification and/or morphogenesis.  
   4 RESULTS 
 
 -102- 
 
Figure 4.1-9: Defects in the heart development 
(A-A')  Whole-embryo views of two different stage 16 embryos showing wild type somatic 
musculature but absence of heart (red arrow). 
(B-C)  High magnification views of four hemisegments showing loose, disorganized 
cardioblasts in the position where heart tube should have been formed (red arrows). 
 
 
4.1.2.7 Abnormal visceral muscle morphology 
During the differentiation stages (15 to 17), the midgut is separated into four 
chambers by the formation of three constrictions.  Deletion of the genomic regions of 
10 deficiency lines led to abnormal gut morphology, in addition to somatic muscle 
defects (Table 4.1-1, data not shown), where the regular arrangement of the four 
chambers at stage 16 (Figure 4.1-4 G) was never observed.  The specification of 
visceral mesoderm however seemed unaffected as the cells were clearly recognized 
by the anti-β3 tubulin antibody and no gaps in the tissue were visible. Since the 
development of midgut, originating from endoderm, and visceral mesoderm are 
interdependent processes [210, 211], I currently cannot conclude which tissue 
contributes to the phenotype without the use of additional markers. 
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4.1.3 Role of the Mediator complex in muscle development 
The Mediator is a multi-subunit general transcriptional co-activator complex 
that is thought to link sequence specific transcription factors to RNA polymerase (see 
Section 1.1.3).  A number of experimental observations in Drosophila as well as 
vertebrates have associated the basal transcriptional machinery with different aspects 
of myogenesis (see Section 1.1.3.4).  However, the role of the Mediator complex in 
Drosophila muscle development has not been directly addressed.  I therefore 
investigated the requirement of the Mediator complex, concentrating on its two 
subunits MED24 and MED14, for myogenesis in more detail.  
 
4.1.3.1 Deletion of MED14 and MED24 by deficiency lines leads to severe somatic 
muscle phenotype 
From the set of analyzed deficiency lines, deletion of two genetic loci resulted 
in a remarkably similar, severe phenotype in somatic muscle development (Figure 
4.1-10).  A high number of gaps in the musculature suggested an absence of muscle 
fibres, and many mononucleated, unfused myoblasts were detected. Many muscles 
failed to extend and attach to ectoderm and remained rounded. As a result of the 
specification and myoblast fusion defects, the size and morphology of the individual 
muscle fibres as well as the whole muscle organization were abnormal.  
The overlap of the deficiencies Df(3L)ZP1/Df(3L)Exel6112 (Figure 4.1-10 A) 
deletes 48 genes, including MED24.  The specification and myoblast fusion defects 
are phenocopied, albeit to a slightly lesser extent, by Df(3L)7C/Df(3L)ED4177 
(Figure 4.1-10 B), which removes 45 annotated protein-coding genes.  One of the 
deleted genes is MED14, encoding another subunit of the Mediator complex.  
Mesoderm-specific knockdown of either MED24 or MED14 leads to lethality 
(Appendix 7.1).  In addition, embryonic injection of double-stranded (dsRNA) against 
MED24 was reported, but not demonstrated, to cause a muscle phenotype [52].  
Transcripts of both subunits can be detected in the mesoderm of stage 8 to 11 
embryos (Appendix 7.2).  Based on these observations, I generated smaller deletion 
lines for MED24 and MED14 that would enable an examination of their role in 
muscle development. 
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Figure 4.1-10: Deficiencies removing MED24 and MED14 show a similar somatic muscle 
phenotype 
(A)  The genetic locus removed by the deficiencies Df(3L)ZP1/Df(3L)Exel6112 includes 
MED24 and results in absent myofibres (asterisks), abnormal muscle fibre morphology, 
and presence of unfused myoblasts (arrows). 
(B)  The pair of deficiencies Df(3L)7C/Df(3L)ED4177 deletes, among other genes, MED14, 
and the homozygous mutant embryos suffer from absence of myofibres (asterisks), 
abnormal muscle fibre morphology, as well as unfused myoblasts (arrows). 
 
 
4.1.3.2 Generation of MED24 and MED14 deletion lines using FRT-mediated 
recombination 
The recently established collection of lines with Flippase Recognition Target 
(FRT) sites randomly transposed throughout the genome enables creation of custom-
made deletion lines without the need for transgenesis [200, 212].  When two lines 
with a FRT site are placed in trans and expression of the recombinase Flippase (FLP) 
is activated through a heat-shock inducible promoter, the region in between the FRT 
sites can be deleted with very high efficiency (see Section 3.2.3 for the crossing 
schemes).  As the exact position of the FRT sites is known, successful deletions can 
be identified by different PCR-based methods, depending on the types of transposable 
elements that were used to generate the original FRT lines. 
The MED24 locus is located on the left arm of the third chromosome and the 
nearest available FRT sites delete a 6.3 kB region that also includes two other genes, 
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CG7387 and CG7375 (Figure 4.1-11 A).  Generation of two independent deletion 
lines was confirmed by a two-sided PCR where bands corresponding to both 
transposon elements were detected (Figure 4.1-11 B).  Single-embryo based PCR 
mapping then confirmed deletion of MED24, CG7837, and CG7375, while the coding 
regions of Autophagy-specific gene 18 (Atg18) and CG8005, the closest genes outside 
of the removed segment, seem to be unaffected (Figure 4.1-11 C).   
The smallest possible deletion of the MED14 locus removes an approximately 
31 kB region that includes three other genes (Figure 4.1-11 D).  Since the original 
FRT lines were created using different transposon elements, the deletion resulted in 
the generation of a new hybrid element.  This can be then detected by PCR only in 
∆MED14 lines, whereas when either of the original lines is used as a template, no 
product is amplified (Figure 4.1-11 E). 
Finally, as the two newly generated lines are both located on the same 
chromosome arm, I recombined them onto the same chromosome to examine whether 
MED24 and MED14 are genetically linked.  The successfully recombined lines 
therefore carry all the transposon elements as the original deletion lines; two-sided 
PCR amplifies both regions from ∆MED24 and hybrid PCR detects the hybrid 
transposon element present in ∆MED14 (Figure 4.1-11 F).  
 
Figure 4.1-11: Generation of MED24, MED14, and MED14 MED24 deletion lines 
(A)  Genomic locus of MED24 (generated with GBrowse [154]).  The region in grey is 
deleted in ∆MED24. 
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(B)  Schematic representation of the final line, ∆MED24, and the two original lines, e02842 
and e03262.  Two pairs of primers, one of which aligns to the transposon backbone 
(orange, purple) and one to the genomic sequence (red), were used to confirm successful 
deletion within two lines.  While each original line gives rise to a single PCR product, 
only ∆MED24 results in both. 
(C) Single-embryo based PCR mapping of the sequences deleted in ∆MED24.  Primers 
directed against lacZ sequence were used to identify homozygous mutant embryos. 
Embryo with one or two copies of the original allele e02842 contains all the regions 
(with the exception of CG7375 in the fifth lane of homozygous e02842 embryo as it falls 
within the transposon insertion site).  A ∆MED24 homozygous embryo lacks only the 
regions that were predicted to be deleted (grey in A). 
(D) Genomic locus of MED14 (generated with GBrowse [154]) and the region (in grey) 
deleted in ∆MED14. 
(E) Hybrid PCR confirms successful recombination in two different ∆MED14 lines.  As the 
two original lines f06749 and d05235 carried different transposon backbone (unlike in 
∆MED24), deletion of the intermediate region gave rise to a hybrid element that is 
present only in the deletion line and in neither of the two original lines. 
(F) Confirmation of successful recombination of ∆MED24 and ∆MED14 onto the same 
chromosome.  Two candidate lines bear all the elements of the individual lines and could 
be therefore detected by the PCR methods used in (B) and (E). 
 
 
4.1.3.3 Deletion of MED24 results in the formation of excessive myoblasts 
While the deficiencies Df(3L)ZP1 and Df(3L)Exel6112 combined in trans led to 
severe muscle specification and myoblast fusion defects (Figure 4.1-10 A), embryos 
homozygous for the small deletion line of MED24 exhibit normal somatic 
musculature patterning (Figure 4.1-12 A).  However, presence of unfused myoblasts, 
a hallmark of Df(3L)ZP1/Df(3L)Exel6112, is partially phenocopied in ∆MED24 
embryos.  The number of mononucleated, β3 tubulin labelled cells within the somatic 
musculature was manually counted in 30 hemisegments of at least 10 different 
embryos.  While the wild type embryos occasionally contain free cells, in ∆MED24 
their number is significantly higher (Figure 4.1-12 D). 
Deletion of MED14 does not cause any apparent defects in the development of 
any muscle type (Figure 4.1-12 B), which is in contrast with the severe phenotype of 
the deficiency line (Figure 4.1-10 B).  It also does not seem to genetically interact 
with MED24 as a double mutant line removing both MED14 and MED24 shows a 
phenotype comparable to that of ∆MED24, although a weak genetic interaction 
especially in the dorsal muscles cannot be excluded (Figure 4.1-12 C, D).  
It therefore appears that the original phenotypes observed in the deficiency lines 
were caused by genes other then MED24 and MED14.  Nevertheless, MED24 seems 
to be involved in the control of cell number as in ∆MED24 embryos, the number of 
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myoblasts is significantly higher compared to wild type embryos (Figure 4.1-12 D) 
whereas the number and morphology of the muscle fibres remain intact (Figure 4.1-12 
A).  The suggested role for MED24 in controlling the cell number is further supported 
by its recently identified requirement for cell death in the salivary gland cells [213]. 
 
Figure 4.1-12: Muscle phenotypes in small deletion lines removing MED14, MED24, and 
both genes together 
(A)  The small deletion line ∆MED24 displays a high number of mononucleated myoblasts 
formed (arrows) while the number and organization of muscle fibres are intact. 
(B)  Deletion of MED14 by ∆MED14 does not seem to affect muscle development, with the 
exception of sporadically observed unfused myoblasts (arrows). 
(C) Embryos mutant for both MED24 and MED14 show many unfused myoblasts (arrows). 
(D)  Quantification of the free, mononucleated β3 tubulin-positive cells in wild type (grey), 
∆MED24 (orange), and ∆MED14 ∆MED24 (green) embryos.  The cells were manually 
counted in three different somatic muscle areas and in 30 hemisegments (within at least 
10 different embryos per genotype).  The significance values comparing ∆MED24 to 
wild type (orange) and ∆MED14∆MED24 to ∆MED24 (green) were calculated using 
exact Wilcoxon rank sum test. 
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4.2 The role of Tramtrack in Drosophila muscle 
development 
The transcriptional repressor Tramtrack was one of the novel mesodermal 
regulators identified within the molecular screen.  The contribution of Tramtrack to 
Drosophila muscle development was characterized in more detail due to the following 
reasons: 
o Multiple CRMs in the vicinity of ttk locus are bound by key mesodermal TFs (Twi, 
Mef2, Tin, Bin, Bap) and at least two of them have mesodermal in vivo activity 
[108, 214]. 
o Putative Ttk69 binding site is significantly enriched in early mesodermal CRMs. 
o Ttk69 (but not Ttk88) mutants are recessive lethal at embryonic stage and a 
neuronal marker was detected in the somatic musculature of amorphs [155]. 
o Ttk is a well-described TF that is potentially expressed in mesoderm. 
o Ttk is a dedicated transcriptional repressor and the current knowledge on 
repression within the myogenic network is very limited. 
 
4.2.1 Analysis of Tramtrack expression and its loss-of-function and 
gain-of-function phenotypes 
4.2.1.1 Expression of Tramtrack69 mRNA and protein in the mesoderm 
 As the reports on the expression of Ttk69 in the mesoderm were incoherent 
[150, 152], I analyzed the embryonic expression of both Ttk69 mRNA and protein 
(Figure 4.2-1).  The expression in mesoderm initiates at early stage 11 when ttk69 
mRNA has detectable expression in the visceral muscle primordium (Figure 4.2-1 A-
A'').  The expression of the Ttk69 protein lags behind as it is present in the visceral 
muscle only from late stage 11 (Figure 4.2-1 E-E'').  Both Ttk69 mRNA (Figure 4.2-1 
D-D'') and protein (Figure 4.2-1 F-F'') are maintained in the visceral musculature until 
the very end of embryogenesis.  In addition, the Ttk69-specific antibody identifies 
Ttk69 protein in the midgut endoderm primordia during multiple stages of 
development (Figure 4.2-1 D-F).  
 Expression of Ttk69 in the somatic muscle primordium is, on the other hand, 
very transient and therefore also very difficult to analyze.  ttk69 mRNA is present in a 
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subset of somatic muscle precursor cells at stage 11 (Figure 4.2-1 B-B''), 
corresponding to the time period of progenitor selection and founder cell 
specification.  However, already at stage 12 (Figure 4.2-1 C-C'') there is no ttk69 
mRNA detectable in the somatic mesoderm. 
 An additional tool to asses the expression of Ttk69 is a previously 
characterized enhancer ttk-VME [108], located upstream of the gene locus.  At stage 
11, the in vivo activity of this enhancer recapitulates the expression of endogenous 
Ttk69 protein in mesoderm and trachea (Figure 4.2-1 G-G'') and it co-localizes with 
Mef2 protein in both somatic and visceral mesoderm (Figure 4.2-1 H-H''). 
The very transient expression of Ttk69 in the somatic mesoderm primordium at 
the stages of specification suggests its involvement in this process and predicts, that 
misregulation of ttk69 in the mesoderm could be detrimental for its development. 
 
 
Figure 4.2-1: Expression of Ttk69 mRNA, protein and enhancer   
(A-D)   In situ hybridization against ttk69 (green) and Mef2 (red) mRNA in wild type 
embryos.  During stage 11, ttk69 co-localizes with Mef2 in the visceral mesoderm 
(arrows in A-A'') and subset of somatic mesoderm (arrows in B-B'').  At stage 12 (C-
C'') there is no overlap between ttk69 and Mef2 as ttk69 expression is maintained only 
in the trachea (arrowheads in A'' and C'').  At stage 15, ttk69 and Mef2 continue to be 
co-expressed in the visceral muscle (arrows in D-D'') lining the gut (arrowheads in D 
and D').  At all stages 4',6-diamidino-2-phenylindole (DAPI) was used to follow the 
nuclei.  Each image is an average intensity Z-projection of several focal planes. 
         4 RESULTS 
 
 -110- 
(E-F)  Ttk69 protein (green) co-localizes with the marker of visceral mesoderm, Bin (red), at 
stage 11 (arrows in E-E'') and 13 (arrows in F-F'').  Ttk69 protein is also expressed in 
the gut (arrowheads in E'' and F'').  
(G-H)  Previously characterized ttk enhancer line ttk-VME [108] was subjected to fluorescent 
double immunostain. GFP expression (green) recapitulates endogenous Ttk69 
expression (red) in mesoderm (arrows in G-G'') and tracheal placodes (arrowheads in 
G-G'') and co-localizes with Mef2 protein in the somatic and visceral muscle 
primordia (arrows in H-H'') of stage 11 embryos.  
 
4.2.1.2 ttk loss-of-function phenotype 
The amorphic allele ttkD2-50 was isolated in a genetic ethyl methanesulfonate 
(EMS) screen for mutants with defects in embryonic CNS development [215].  The 
precise lesion has not been mapped, but based on the severity of the CNS phenotype, 
ttkD2-50 was classified among the strongest ttk mutant alleles [155].  I confirmed that 
ttkD2-50 is a protein null allele by immunostaining the embryos with an antibody raised 
against the zinc fingers of the Ttk69 protein (data not shown).  As the CNS phenotype 
in ttkD2-50 is identical to Ttk69-specific allele ttk1e11 [155, 178], ttkD2-50 is a null allele 
of Ttk69, but potentially affecting expression of the Ttk88 isoform as well.  The 
Ttk88-specific allele ttk1 [165] is however homozygous viable and embryos develop 
wild type musculature (not shown).  ttkD2-50 allele is hence predominantly a loss-of-
function allele for Ttk69, although contribution of possible Ttk88 mutation to the 
observed phenotypes cannot be excluded.   
 Homozygous ttkD2-50 mutant embryos were unambiguously identified by the 
absence of lacZ or gfp, which was placed on the balancer chromosome, as well as the 
previously described defects in head involution and dorsal closure [163].  The muscle 
defects in ttkD2-50 homozygous embryos were indistinguishable from embryos carrying 
ttkD2-50 allele in trans to deficiency Df(3R)awd-KRB, removing the whole locus, in 
agreement with the amorphic nature of the allele.  Transheterozygous embryos were 
stained with an anti-β3 tubulin antibody that marks all three muscle types of the 
Drosophila embryo ([207], Figure 4.1-4). 
The most severely affected muscle tissue is the somatic musculature which 
shows abnormalities from stage 14 (Figure 4.2-2 A-B'').  While in wild type embryos 
myoblast fusion is underway at this stage, in ttkD2-50/Df(3R)awd-KRB 
transheterozygous embryos myoblast fusion is impaired and most myoblasts remain 
round and mononucleated.  At later stages the cells do undergo partial fusion, 
however rather than forming extended myotubes they are organized in large round 
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clusters (Figure 4.2-2 C-D'').  These clusters of myoblasts do not migrate or attach to 
ectodermal cells, making their identity unclear.  The observed defects are rather 
atypical as normally a failure in myoblast fusion is accompanied by unfused, round 
shaped fusion competent myoblasts (FCMs) that undergo apoptosis and thin 
myofibres with correct muscle attachments, generated from the founder cells (FCs).  
In the case of ttk mutants, however, the unfused FCMs do not seem to apoptose but 
rather aggregate around the FCs, which in turn fail to differentiate into correctly 
positioned and attached myofibres.  
Another perturbed tissue in ttk-deficient embryos is the gut which at stage 16 
has an abnormal morphology and fails to form the characteristic midgut constrictions 
(Figure 4.2-2 D').  As Ttk69 is expressed in both the visceral muscle and the gut 
primordia (Figure 4.2-1 D-F), this defect may be caused by its function in either, or 
both, tissues.  An immunostain with anti-Fasciclin III antibody revealed that the 
number as well as the morphology of visceral myoblasts are normal (not shown), 
suggesting that specification of the visceral mesoderm is not affected.  Specification 
of heart precursors also occurs normally (not shown), although a proper dorsal vessel 
is never formed in ttkD2-50 homozygous embryos as a secondary consequence of a 
dorsal closure failure.  
In multiple developmental contexts, Ttk69 negatively regulates cell cycle and 
in ttk69 mutants excessive rounds of mitosis occur (see Table 1.4-2).  Since both 
subpopulations of fusing cells, FCs and FCMs, undergo mitosis during stages 11 and 
12 [137],  the observed myoblast fusion defect in ttk69 mutants could be explained by 
an aberrant cell cycle.  To assess this, I used an antibody directed against the 
phosphorylation of Serine 10 residue on histone H3, a widely used marker of mitosis 
[216].  At stage 11 and 12, the number of muscle cells marked by anti-phosphorylated 
histone H3 antibody in wild type and ttk mutant embryos is comparable (Figure 4.2-2 
E-H), suggesting that the cell cycle is not perturbed in ttk69-deficient somatic 
myoblasts. 
Previous studies on the nervous system development reported that the 
neuronal marker 22C10 is aberrantly expressed in the somatic muscle in ttk69 loss-of-
function mutant alleles [155, 156].  To verify this finding, I repeated the experiment 
and double immunostained ttkD2-50 embryos with an anti-Mef2 antibody, labelling all 
three muscle types.  As expected, the microtubule-associated protein Futsch, the 
antigen of 22C10, and the nuclear Mef2 are co-expressed in a subset of somatic 
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muscle fibres and also in the visceral mesoderm  (Figure 4.2-2 I, I').  Futsch is also 
misexpressed in the heart, which is surprising considering that there is no detectable 
expression of Ttk69 in these cells (Figure 4.2-2 I'').  As 22C10 is a marker of 
differentiated neurons, its derepression in ttk mutants could be due to partial 
transformation of muscle to a neuronal identity.  To investigate this possibility, I 
analyzed the protein expression of key neuronal regulators (Asense, Achaete, Repo) 
in ttk mutants, but none of these proteins seem to be derepressed in the musculature 
(not shown).  Therefore, it cannot be concluded that myoblasts devoid of Ttk69 have a 
partial neuronal cell fate.  Nevertheless, the presence of Futsch alone might interfere 
with myogenesis as it is involved in axonal pathfinding [217, 218], a process that is at 
the molecular level parallel to myotube guidance (see Section 1.3.6). 
 
Figure 4.2-2: Ttk is essential for normal somatic muscle development   
(A-D)  Immunostain of wild type and ttkD2-50/Df(3R)awd-KRB embryos with anti-β3 tubulin 
antibody to visualize all three muscle tissues.  At stage 14 (A-B), ttk-deficient 
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myoblasts fail to fuse and instead remain mononucleated, form aggregates, and have 
aberrant shape (arrows in B and B'').  In stage 16 embryos (C-D), ttk mutants have 
abnormal gut morphology (arrow in D') and myofibres do not attach to tendon cells 
(increased distance between two hemisegments in D'').  Arrows in D and D'' point to 
fibres with abnormal morphology and asterisks mark areas normally filled with 
myofibres.   
(E-H) Immunostain against phosphorylated histone H3 (pH3, green), a mitosis marker, 
combined with in situ hybridization against Mef2 (magenta) in wild type (E, G) and 
ttkD2-50 homozygous embryos (F, H).  No apparent differences in the number of pH3 
and Mef2 double-stained cells could be observed at stage 11 (E-F) or 12 (G-H). 
(I) In stage 14, ttkD2-50 homozygous embryos, the cytoplasmic protein Futsch (22C10 
antibody, green) is co-expressed with nuclear Mef2 (magenta) in the cells of somatic 
(I), visceral (I'), as well as cardiac (I'') musculature. 
 
 
As ttk mutants exhibit impaired myoblast fusion (Figure 4.2-2 B''), I analyzed 
the expression of genes essential for this process by in situ hybridization.  The number 
of cells expressing FCM-specific genes lame duck (lmd) and sticks and stones (sns) is 
substantially reduced in ttkD2-50 homozygous embryos compared to their wild type 
counterparts (Figure 4.2-3).  
 
Figure 4.2-3: Reduced expression of two important FCM-specific genes in ttk mutants 
(A-B) In wild type stage 13 embryos, strong levels of sns (A) and lmd (B, B') mRNA can be 
detected by fluorescent in situ hybridization 
(C-D) In ttkD2-50 homozygous embryos (C-D'), sns (C) and lmd (D, D') are expressed in 
fewer cells compared to wild type embryos.   
High power images of 3 segments of stage 13 embryos show ventral and lateral 
somatic musculature (B', D'). 
 
This was surprising as there is no evidence that Ttk69 can directly activate 
transcription.  One possible explanation for the reduced expression of FCM-restricted 
genes is a decrease in the number of FCMs at the expense of FCs.  To assess this, I 
characterized the number of FCs by recombining the ttkD2-50 allele with rP298-lacZ, a 
transgenic Drosophila line isolated in a P-element enhancer trap screen [219, 220].  
The insertion point of the P-element has been mapped to the upstream region of the 
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gene dumbfounded (duf), encoding an FC-specific Ig-like transmembrane protein 
mediating recognition of FCMs [221].  The lacZ reporter expression is restricted to 
the FCs within somatic and visceral muscle from stage 11 [222] and rP298-lacZ is 
thus a widely used marker of FCs. 
Consistent with the decreased expression of FCM genes, the FC-specific 
marker rP298-lacZ is misexpressed in ttkD2-50 homozygous embryos, being detected in 
the majority of cells in both the somatic and visceral mesoderm (Figure 4.2-4 B-B'').  
Moreover, it is also misexpressed in additional cells outside the mesoderm (revealed 
by a lack of β3 tubulin staining), such as midgut (Figure 4.2-4 B') and ectoderm 
(Figure 4.2-4 B''), while in wild type embryos its expression is restricted to muscle 
founder cells (Figure 4.2-4 A-A'').  
The strong expression of the rP298-lacZ reporter outside the mesoderm 
impedes a direct visual evaluation of its expression in myoblasts.  To address this, I 
quantified the number of lacZ-positive cells only within the somatic mesoderm.  For 
this purpose, ttkD2-50 heterozygous and homozygous embryos were triple 
immunostained with antibodies against β-Galactosidase (the product of rP298-lacZ), 
β3 tubulin (a general muscle marker), and GFP (visualizing the balancer 
chromosome).  A series of images at multiple focal planes were then taken within the 
abdominal segments A3 to A6 in 13 different stage 12 to 13 embryos.   
In wild type embryos, the number of rP298-lacZ marked nuclei is highly 
dynamic [222].  Initially it increases as the progenitors divide to form the FCs and 
then its expression is acquired by FCMs upon fusion with FCs.  Before the onset of 
fusion, the number of rP298-expressing cells hence should not exceed 30 as there are 
30 distinct muscle fibres, each originating from a single FC.  Consistent with this, in 
ttkD2-50 heterozygous embryos, the number of counted FCs ranged from 15 to 30 and 
did not vary significantly across different segments (Figure 4.2-4 C).  In ttkD2-50 
homozygous embryos, the number of rP298-lacZ and β3 tubulin positive somatic 
myoblasts was also comparable between individual segments.  However, in contrast 
to the heterozygous embryos, the number of rP298-lacZ expressing somatic myoblasts 
in ttkD2-50 homozygous embryos was significantly higher, in the range from 31 to 52 
(Figure 4.2-4 C).  This result confirms that there are more rP298-lacZ positive 
somatic myoblasts in embryos devoid of Ttk69.  Even though they are marked by a 
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FC-specific reporter, their exact developmental identity is still not clear, hence they 
are referred to as FC-like cells. 
 
Figure 4.2-4: Ectopic founder cell-like cells in ttk mutants 
(A-B)  Compared to wild type embryos (A-A''), ttkD2-50 homozygous embryos (B-B'') display 
increased levels of founder cell marker, rP298, visualized by an antibody against β-
Galactosidase, both within (white arrows) and outside (red arrows) of mesoderm at 
stage 12 (A-A', B-B') and 13 (A'', B'').  Anti-β3 tubulin antibody (magenta) outlines 
all somatic (A, A'', B, B'') and visceral (A', B') mesodermal cells. 
(C) Quantification of rP298-lacZ positive myoblasts in 4 segments of stage 12 to 13   
ttkD2-50 heterozygous (WT) and homozygous (mut) embryos.  Significance p values 
were calculated using exact Wilcoxon rank sum test.  In total, 52 segments in 13 
different embryos per genotype were analysed (all). 
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4.2.1.3 Ectopic expression of Ttk69 in founder cells and fusion competent 
myoblasts 
 To further explore the role of Ttk69 in myogenesis, I utilized the yeast Gal4-
UAS system [223] to induce tissue-specific expression of Ttk69.  Expression of Ttk69 
in FCMs was achieved with two different FCM-specific sns-Gal4 driver lines [224, 
225].  Combination of the lines with UAS-GFP resulted in expression of GFP protein 
in the visceral and somatic mesoderm from stage 13 and 14, respectively, and had no 
effect on muscle development (Figure 4.2-5 A).  However, specific expression of 
Ttk69 in FCMs [155] with one of the sns-Gal4 driver lines [225] led to pupal lethality 
and a mild myoblast fusion phenotype in some, but not all, embryos (not shown).  
Embryos in which Ttk69 expression was induced with the other sns-Gal4 line [224] 
died at the end of embryogenesis and exhibited impaired myoblast fusion (Figure 4.2-
5 B, B').  The defect was relatively mild as only some unfused myoblasts were 
observed and the size of the myotubes did not appear substantially reduced compared 
to wild type embryos (Figure 4.2-5 A-B'). 
A FC-specific driver line (rP298-Gal4) was generated from the FC-specific 
reporter line rP298-lacZ (described above) by replacing the original P-element 
transposon with a P-element carrying Gal4 [226, 227].  rP298-Gal4 drives expression 
of GFP protein in the somatic and visceral mesoderm from stage 12 (Figure 4.2-5 C). 
Ectopic expression of Ttk69 in FCs gives rise to embryonic lethal phenotype with a 
severe myoblast fusion defect (Figure 4.2-5 D, D').  The FCs do not fuse with 
surrounding FCMs and so form very thin, but correctly attached, mini-muscles, while 
the FCMs remain mononucleated and later undergo apoptosis.   The thin muscle fibres 
maintain their correct shape, orientation, and ectodermal attachments, indicating that 
ectopic Ttk69 does not interfere with the expression of founder cell identity genes.  
However, due to the time delay introduced by the UAS-Gal4 system, ectopic Ttk69 
may only be functional after muscle identity has been specified.    
Consequently, it appears that Ttk69 is more detrimental when it is expressed 
in the FCs, while its forced expression in FCMs has a less dramatic effect.  Given the 
decreased number of FCMs and ectopic FC-like cells in ttk mutants (Figures 4.2-2 and 
4.2-3), the normal function of Ttk69 may be to repress FC-specific genes within 
FCMs.  This model would explain why ectopic expression of Ttk69 in FCMs would 
result in only minor defects, which are most likely caused by prolonged expression of 
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Ttk69 in somatic mesoderm after stage 11, compared to wild type embryos (Figure 
4.2-1 B).   
 
 
Figure 4.2-5: Ectopic expression of Ttk69 in founder cells and fusion competent 
myoblasts   
(A)  Expression of GFP was driven in the FCMs with an sns-Gal4 driver [224] and collected 
embryos were double immunostained with anti-β3 tubulin and anti-GFP antibodies.   As 
expected, somatic musculature develops normally without any apparent abnormalities. 
(B) Sns-Gal4 driver line [224] was used to induce expression of Ttk69 in FCMs.  All 
embryos developed normal heart and visceral muscle (not shown).  The somatic muscle 
fibres were correctly specified but myoblast fusion partially failed as there were some 
unfused myoblasts present (arrowheads). 
(C)  Embryos with GFP driven by the FC-specific Gal4 driver rP298 show normal somatic 
musculature pattern and strong GFP expression in the muscle fibres. 
(D)  When Ttk69 is ectopically expressed in FCs, only limited myoblast fusion occurs as 
most of the somatic muscle cells remain unfused (arrowheads).  The heart and the 
visceral muscle are unaffected (not shown).     
 
 
4.2.1.4 Ectopic expression of Ttk69 in presumptive mesoderm 
As the phenotype of ttkD2-50 embryos cannot be entirely explained by a 
myoblast fusion defect, Ttk69 was ectopically expressed in unspecified mesoderm 
from stage 9 with a combined twi, 24B-Gal4 driver [81, 223]  (Figure 4.2-6).   Such 
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embryos suffer from severe specification defects in all three muscle tissues.  In most 
embryos only very few, or even no, cardioblasts are present and there are also gaps in 
the visceral mesoderm, as revealed by anti-Fasciclin III antibody (Figure 4.2-6 B-D).  
As a result, there are no midgut constrictions formed and it remains a one-chambered 
organ (Figure 4.2-6 A).  Within the somatic musculature, there are hardly any 
correctly specified and differentiated myofibres.  Instead, there are many unfused, 
mononucleated cells and a few mini-muscles without a clear shape, size, or 
attachment (Figure 4.2-6 A', A'').  These observations suggest that premature Ttk69 
expression counteracts specification of all three muscle identities and hence very tight 
control of its wild type expression is essential.   
 
 
Figure 4.2-6: Panmesodermal Ttk69 interferes with specification of all three muscle 
types 
Ttk69 expression was driven with a panmesodermal driver twi, 24B - Gal4 [81, 223]. 
(A) Stage 16 embryos were immunostained with anti-β3 tubulin antibody. Almost all 
embryos with ectopic Ttk69 have abnormal visceral musculature with many gaps 
(arrow in A), lack heart (A'), and form only a few thin fibres without a clear identity 
(arrows in A'') while many myoblasts remain mononucleated (arrowheads in A'').   
(B-D)  Antibody against Fasciclin III was used to reveal gaps in visceral mesoderm in stage 
11 (B') and stage 13 (C', D') embryos with ectopic, panmesodermally induced Ttk69 
when compared to the wild type embryos (B, C, D).   
 
 
The severity and extent of the somatic musculature phenotype can be 
attributed to a reduction in twist (twi) levels compared to wild type embryos (Figure 
4.2-7).  In a wild type situation, twi is strongly expressed throughout the mesoderm at 
stage 9 (Figure 4.2-7 A) and during stage 10 its levels are modulated into high and 
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low expression domains (Figure 4.2-7 B) through the action of Notch signalling 
[120].  When Ttk69 is ectopically expressed from stage 8, the levels of twi mRNA at 
stage 9 decline dramatically (Figure 4.2-7 A').  Even though twi expression remains 
reduced, at stage 10 its modulation into the different domains is preserved (Figure 
4.2-7 B').   
High levels of Twist protein have been demonstrated to be fundamental for the 
development of somatic muscle [81].  However, it has been also reported that if Twist 
activity is genetically reduced after gastrulation using a temperature-sensitive allelic 
combination, visceral mesoderm and heart develop normally [81].  Therefore the 
defects in specification of these mesoderm derivatives upon expression of ectopic 
Ttk69 are probably due to the misexpression of other factors specific to the 
developmental programs of visceral and cardiac mesoderm.  
 
 
 
Figure 4.2-7:  Ectopically expressed Ttk69 represses twist expression 
Ttk69 expression was driven with a panmesodermal driver twi, 24B - Gal4 [81, 223].   
(A) In wild type embryos, twi is strongly expressed in all mesodermal cells at stage 9 (A).  If 
panmesodermal expression of Ttk69 is induced (arrow in A''), twi levels are reduced 
significantly (arrow in A'). 
(B) At late stage 10, expression of twist is segmented by Notch signalling into high and low 
Twist domains [120].  Ectopic expression of Ttk69 (arrow in B'') results in an overall 
decreased level of twi mRNA expression but its modulation seems to still occur (arrow in 
B').  Note that the microscope settings in (B') were changed compared to (A') to 
demonstrate the patterned expression. 
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4.2.2 Deciphering the molecular function of Ttk69 
4.2.2.1 ChIP-on-chip assay identifies direct targets of Tramtrack69  
To understand the dramatic muscle phenotypes of ttk69 loss-of-function and 
gain-of-function mutants, I performed a ChIP-on-chip experiment to identify its direct 
targets.  For this purpose, two different polyclonal antibodies specific against the 
Ttk69 isoform [194, 228] were used to immunoprecipitate chromatin extracted from 
6-8 hour old wild type embryos.  As a reference to account for non-specific binding, 
another aliquot of the same chromatin was immunoprecipitated with rabbit pre-
immune serum.  Purified, amplified, and labelled DNA fragments were hybridized to 
high-resolution Affymetrix GeneChip® Drosophila Tiling 1.0R Arrays covering the 
whole genome.  The resultant data were processed as described previously [196] and 
as significant binding were considered regions above the TileMap posterior score 
[229] of 5.5, corresponding to a false discovery rate (FDR) estimate of approximately 
2 %.  Cis-regulatory modules (CRMs) were defined within 100 bp from each direction 
of a detected peak.  By these criteria, there are 2,084 CRMs bound by Ttk69, the 
relatively high number of which possibly reflects its diverse developmental roles and 
widespread expression.  There is a significant overlap between Ttk69-bound and 
mesodermal CRMs [196], suggesting that a large portion of Ttk69 binding is in 
mesodermal cells and that this may contribute to the mesodermal regulatory circuitry.  
 
4.2.2.2 Validation of Ttk69 ChIP-on-chip data 
 In order to verify the acquired dataset of global Ttk69 occupancy, I utilized 
previously experimentally validated Ttk69-bound regions as well as genes known to 
be downstream of Ttk69 in the embryonic nervous system (see Appendix section 7.3).  
The identified CRMs cover the previously mapped binding sites of Ttk69 in the 
promoter regions of tailless [153], even-skipped [181], and string [177] (Appendix 7.3 
A-C).  Previous experiments demonstrated that two Ttk69 sites in the promoter region 
of eve are strongly bound when a nuclear extract from 5-10 hour old embryos is used 
as a source of Ttk69 protein [230].  Consistent with this, both sites are covered by a 
single CRM identified in the ChIP-on-chip experiment (Appendix 7.3 B). 
 A number of neuronal genes and cell-cycle regulator CycE are derepressed in 
ttk mutant embryos (see Table 1.4-2), but whether these genes are directly repressed 
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by Ttk69 was unknown.  Based on our ChIP-on-chip data, Ttk69 occupies multiple 
regions in the vicinity of dpn, sc, scrt, and CycE (Appendix 7.3 D-G), suggesting that 
it regulates these genes directly. 
 
4.2.2.3 ChIP-on-chip based validation of computationally predicted Ttk69 
binding 
Independent of my genetic analysis of ttk, a computational biologist in our 
group, B. Wilczynski, had also indicated a role for Ttk69 within the regulatory 
network driving mesoderm development.  The core mesodermal TFs Twi, Tin, and 
Mef2 co-bind to a ttk CRM [108] at 2-4 and 4-6 hours of embryogenesis.  Using a 
position weight matrix of Ttk69, Bartek discovered a significant enrichment of 
putative Ttk69 binding motifs in additional Twi-Tin-Mef2 co-bound CRMs, 
compared to general mesodermal CRMs [196].  Since Ttk69 itself is targeted by these 
TFs, its regulatory input into the Twi-Tin-Mef2 combinatorially bound CRMs would 
implicate its involvement in extensive feed-forward regulation  (Figure 4.2-8 A). 
To test the model, the ChIP-on-chip dataset was used as an accurate source of 
Ttk69 in vivo binding events.  The binding of Ttk69 within all mesodermal CRMs is 
significantly enriched compared to randomized regions, reflecting the high overlap 
between Ttk69-bound and mesodermal CRMs (Figure 4.2-8 B).    Even more striking, 
however, is the enrichment of Ttk69 binding within the Twi-Tin-Mef2 class of 
CRMs; over 36% of these CRMs are bound by Ttk69 as compared to 13% of all 
mesodermal CRMs  (Figure 4.2-8 B).  The Ttk69 occupancy data provides global 
validation for the predicted model and implicates an involvement of Ttk69, being a 
repressor, in incoherent type of feed-forward regulatory loops (reviewed in [57]).  As 
the Twi-Tin-Mef2 class of CRMs is bound by the mesodermal TFs earlier in 
development, one possible function of Ttk69 binding could be a need to terminate 
transcription of genes which are expressed in presumptive mesoderm and do not 
contribute to its later subdivision and differentiation. 
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Figure 4.2-8: Ttk69 binds to CRMs that are co-bound by Twi, Tin, and Mef2 during 
mesoderm development   
(A)  A predicted model in which Ttk69 occupies CRMs that are co-bound at earlier time point 
by Twi, Tin, and Mef2.  As Ttk69 is a repressor that is itself targeted by these TFs, it 
would imply incoherent feed-forward regulation.  Arrows pointing to CRMs indicate 
regulatory input rather than transcriptional activation. The question mark indicates the 
tested hypothesis. 
(B) Based on ChIP-on-chip data, Ttk69 binding is significantly enriched in CRMs co-bound 
by Twi, Tin, and Mef2 (blue) compared to all mesodermal CRMs  (orange) or random 
genomic sequences (green). *** p < 0.01.  Analysis was performed by B. Wilczynski. 
(C)  ChIP-on-chip profiles of Twi (red), Tin (blue), and Mef2 (orange) at 4-6 hours, and 
Ttk69 at 6-8 hours (purple).  In grey are highlighted regions that are bound at all 
conditions. 
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4.2.2.4 In vivo activity of Ttk69-bound CRMs 
 In order to assay the regulatory input of Ttk69 into the CRMs identified in the 
ChIP-on-chip experiment, I analyzed the in vivo activity of three selected CRMs. 
Transgenic reporter assays were performed to assess the activity of wild type CRMs 
as well as CRMs where several or all putative Ttk69 binding sites were mutated.  All 
three CRMs are co-bound by Twi, Tin, and Mef2 at 4-6 hours after egg laying (AEL) 
and therefore fall within the set of CRMs predicted to be targeted by the Ttk69 
incoherent feed-forward loop (see Section 4.2.2.3).  In addition, they are associated 
with genes encoding TFs with developmental functions related to Ttk69 [231, 232].   
 The tested CRMs were subcloned into a P-element vector upstream of a lacZ 
reporter with a Hsp70 minimal promoter [195].  For each CRM, at least three different 
transgenic lines were generated to account for spurious activity due to integration 
events as a result of P-element transposition.  
 Two selected Ttk69 CRMs fall into the intronic region of the gene jumeau 
(jumu) (Figure 4.2-9 A), coding for a TF implicated in asymmetric cell division in the 
nervous system [232].  Activity of the CRM jumuA initiates at early stage 11 when it 
is expressed strongly in tracheal placodes and weakly in the visceral mesoderm 
primordium (Figure 4.2-9 C').  At stage 11, strong lacZ signal comes from the cells of 
caudal visceral mesoderm that will eventually form the longitudinal visceral muscle 
(Figure 4.2-9 C'').  Expression in the trachea as well as visceral mesoderm persists 
until the very end of embryogenesis (not shown).  There are 10 putative Ttk69 
binding sites in the CRM, out of which 3 sites were mutated (see Appendix section 
7.4 for the sequences).  Interestingly, the mutated version of the enhancer exhibits 
lacZ derepression at stage 5 (Figure 4.2-9 D).  While the wild type enhancer is 
inactive at this stage (Figure 4.2-9 C), jumuA-Ttkmut shows expression in transverse 
ectodermal stripes (Figure 4.2-9 D).  In addition, the expression in tracheal placodes is 
reduced and in caudal visceral mesoderm it is completely lost (Figure 4.2-9 D'').  
However, the weak expression in the trunk visceral mesoderm is unaffected (Figure 
4.2-9 D').  
The second intronic jumu CRM, jumuB, shows ubiquitous activity during 
early stages (Figure 4.2-9 E).    At stage 11, it drives a complex lacZ expression in the 
tracheal primordia, discrete cells of the central nervous system, and caudal visceral 
mesoderm (Figure 4.2-9 E', E'').  When 9 out of the 15 Ttk69 motifs were mutated, the 
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early and tracheal placode CRM activities are unaffected (Figure 4.2-9 F, F'), but the 
number of lacZ-positive CNS cells is decreased and the signal from caudal visceral 
mesoderm is completely lost  (Figure 4.2-9 F''). 
Finally, the CRM upstream of the rib locus (Figure 4.2-9 B) drives weak 
expression in the mesodermal cells at stage 5 and 6 (Figure 4.2-9 G).  During stage 9 
and 10, the lacZ reporter shows metameric expression in dorsal ectoderm (Figure 4.2-
9 G') and at stage 11 it can be detected in the caudal visceral mesoderm (Figure 4.2-9 
G'') and a subset of neuroectodermal cells.  This CRM contains three putative Ttk69 
binding sites and mutations in all of them affect only the caudal visceral mesoderm 
activity (Figure 4.2-9 H-H''). 
 Overall, the activity of the wild type as well as mutant CRMs provides 
unexpected insights into the regulatory potential of Ttk69 (discussed in Section 
5.3.3.1).  First, the CRMs drive complex and dynamic expression in tissues that 
mirror the expression of ttk69 itself.  Second, mutagenesis of putative Ttk69 binding 
motifs results in a loss of expression in several different tissues.  Ttk69 binding seems 
to have a particular importance for activity in the caudal visceral mesoderm of all wild 
type CRMs as the expression is lost upon mutation of Ttk69 motifs.  Finally, one 
mutated CRM, jumuA-Ttkmut, shows derepression at blastoderm stage, which is most 
likely mediated by maternally provided Ttk69 protein.   
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Figure 4.2-9: In vivo activity of Ttk69-bound CRMs 
Activity of all CRMs was assayed by fluorescent in situ hybridization with a probe against 
lacZ (green) and Mef2 (red), labelling the mesoderm. 
(A-B)  Loci of jumu (A) and rib (B) with Ttk69 binding profile in purple and mesodermal 
CRMs [196] in black.  The sequences assayed in the transgenic reporter assays are 
highlighted in grey. 
(C-D) The wild type jumuA CRM is not active at stage 5 (C) but is weakly expressed in the 
trunk visceral mesoderm (C') and strongly in trachea and caudal visceral mesoderm 
(C'') at stage 11 (arrows).  When several Ttk69 sites are mutated, striped expression at 
stage 5 appears (arrow in D) while the activity in trachea is reduced (D'') and in the 
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caudal visceral mesoderm completely lost (D'').  In the trunk visceral mesoderm it 
remains unaffected (arrow in D'). 
(E-F) The CRM jumuB drives lacZ expression ubiquitously at stage 5 and in the tracheal 
placodes (E'), the CNS and caudal visceral mesoderm (E'') at stage 11.  Its mutated 
version shows lack of the caudal visceral mesoderm expression and reduction in the 
CNS expression (F'') while the other aspects seem unaffected (arrows in F, F'). 
(G-H) The CRM rib is expressed weakly in the mesoderm (arrows) and strongly in the 
anterior part of stage 5 embryos (G) and it shows a metameric distribution in dorsal 
ectoderm at stage 9 (arrows in G').  At stage 11 it is weakly expressed in the 
neuroectoderm and caudal visceral mesoderm (arrows in G'').  Mutagenesis of the 
three putative Ttk69 sites does not affect its activity in the presumptive mesoderm 
(arrow in H) or dorsal ectoderm (arrow in H'), but the activity in the caudal visceral 
mesoderm is lost (H''). 
 
 
 
 
 
 
 
 
 
4.2.3 An integrated network of Lame duck and Tramtrack69 
activity is required for FCM specification 
One explanation for the observed ttk69 loss- and gain-of-function phenotypes is 
its requirement for FCM specification, where it would repress FC-specific genes.  
There is currently only one other TF known to be essential for FCM specification; 
Lame duck (Lmd), a zinc finger TF that has been reported to act mainly as a 
transcriptional activator [133].  The only known direct target of Lmd is the 
differentiation factor Mef2 [131] and so the knowledge about the regulatory 
subnetwork downstream of Lmd is extremely limited. To understand if and how 
Ttk69 contributes to FCM specification, it is essential to discern if Ttk69 has an 
overlapping or distinct function to Lmd.  Consequently, to provide insights into the 
regulatory program driven by Lmd and its possible connection to Ttk69, I performed a 
ChIP-on-chip experiment against Lmd at the same stages that were used for Ttk69. 
 
4.2.3.1 Genome-wide occupancy of Lame duck and overlap with Tramtrack69 
ChIP-on-chip experiments with Lmd were performed under the same time 
points and conditions as Ttk69 (see Section 4.2.2.1).  Two independent Lmd 
antibodies generated in rabbit were used to immunoprecipitate Lmd-bound genomic 
regions.  The samples were hybridized to Affymetrix GeneChip® Drosophila Tiling 
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1.0R Arrays and data was processed as for Ttk69 and other mesodermal TFs [196].  A 
TileMap threshold score [229] was set to 5.5, equal to Ttk69, and corresponding to an 
FDR estimate of approximately 8%.  Above this threshold there are 1,024 
significantly enriched CRMs.  Expression of Lmd is restricted only to FCMs and is 
absent from non-mesodermal tissues.  Therefore the lower number of bound regions 
compared to Ttk69 (2,084) was expected.  
To date, there is only one known direct target of Lmd, Mef2.  The regulatory 
region bound by Lmd has been experimentally minimized to 20 base pairs [131].  The 
generated ChIP-on-chip dataset confirmed binding of Lmd to this sequence at the 
correct stages of development, demonstrating the sensitivity of the data (Figure 4.2-10 
A).  There is a substantial overlap between the Lmd-bound regions and mesodermal 
CRMs, as expected.   
Importantly, there is also a high overlap between Ttk69 and Lmd-bound 
regions, which is highly significant (p < 10-237) compared to randomly shuffled non-
coding regions (Figure 4.2-10 B).  There are altogether 191 CRMs that are co-
occupied by Ttk69 and Lmd, and almost all of them (166) are also bound by at least 
one other mesodermal TF [196].   In order to obtain insights into the functional role of 
this binding, the co-bound CRMs were assigned to the nearest gene and available 
databases and literature were surveyed for the embryonic expression patterns of these 
genes (Figure 4.2-10 C).  More than a half of the co-regulated genes lack information 
on their expression or are not expressed in spatially and temporally controlled 
manner.  However, 64 genes show specific expression patterns during embryogenesis, 
the majority of which (46 genes) are specifically expressed in mesoderm or its 
derivatives.   It therefore appears that Ttk69 and Lmd have a shared role in regulating 
a subset of mesodermal genes.  However, both TFs also provide important regulatory 
input independently of each other. 
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Figure 4.2-10: Overlap between Lmd and Ttk69 binding profiles 
(A) ChIP-on-chip data successfully recovered the only experimentally validated binding site 
of Lame duck (in black).  There are also additional Lmd-bound CRMs in the Mef2 locus 
identified in the experiment (green bars below the signal).  
(B) There is a significant overlap (p < 10-10) between CRMs bound by Ttk69 (purple), Lmd 
(green), and mesodermal CRMs (orange).  In brackets is a total number of CRMs in each 
class (black) and a number of CRMs that overlap with mesodermal CRMs (orange). 
(C)  Expression patterns (based on literature and BDGP in situ database [233]) of Ttk69 and 
Lmd co-regulated genes.  In brackets are the numbers of unique genes in each group. 
(D)  Example of a mesodermal gene (no ocelli, noc) with a CRM co-bound by Ttk69 (purple), 
Lmd (green), and at least one another mesodermal TF (orange) highlighted in grey. 
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4.2.3.2 Preference of Ttk69 binding to CRMs of founder cell-specific genes 
The genetic analyses suggested a model by which Ttk69 represses genes 
normally restricted to the FCs within FCMs.  To assess if this is true at a molecular 
level, I used the genome-wide occupancy data in combination with a collection of 
genes systematically classified as expressed only in FCs (FC-specific), FCMs (FCM-
specific), or both cell types [234].  Regions 1,500 bp upstream and downstream of the 
transcriptional start sites (TSSs) of these genes were scanned for Ttk69-bound CRMs.  
If such CRMs were identified, they would be further classified depending on whether 
they overlap with a mesodermal CRM or not.  Consequently, each myoblast fusion 
gene falls into one of three possible categories:  it either has no Ttk69 CRMs in the 3 
kb region around its TSS, or it has at least one such CRM overlapping a mesodermal 
CRM, or it has one or more Ttk69-bound CRMs that do not overlap mesodermal 
CRMs.  Classifying the CRMs based on their overlap with mesodermal CRMs was 
used to help restrict the analysis to binding events within mesodermal tissues. 
In agreement with the phenotypic results, there is indeed a significant 
preference of Ttk69 binding to CRMs associated with FC-specific genes compared to 
genes expressed only in FCMs or in both FCs and FCMs (Figure 4.2-11 A).  As most 
(90%) of these bound regions are in addition occupied by a mesodermal TF, it is 
likely that they have a potential to drive mesodermal expression.   
When the same analysis was performed using the Lmd ChIP-on-chip dataset, 
the opposite trend was apparent.  Binding of Lmd is clearly depleted at regulatory 
elements associated with FC-specific genes and enriched at the CRMs of genes 
expressed in the FCMs (Figure 4.2-11 B), consistent with its ability to activate 
transcription in FCMs.  Ttk69 and Lmd are thus both involved in the specification of 
FCMs, but while Lmd does so by activating a FCM-specific differentiation program, 
Ttk69 represses genes that could interfere with FCM fate.  In addition, both TFs co-
occupy a considerable number of mesodermal CRMs (see Section 4.2.3.1), however 
the biological role of this co-occupancy remains to be determined.  
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Figure 4.2-11: Occupancy of Ttk69 and Lame duck in the vicinity of genes essential for 
myoblast fusion 
(A-B)  Ttk69 binding is significantly enriched in the vicinity of genes expressed in FCs 
compared to genes expressed in FCMs or in both cell types (A). Lmd binding is, on 
the other hand, enriched in the vicinity of FCM-specific genes (B).  Dark colour 
indicates that at least one assigned CRM overlaps a mesodermal CRM [196].  CRMs 
within 1.5 kb distance upstream and downstream of the TSS were considered.  
Numbers refer to the number of genes in each class.  * p < 0.05, *** p < 0.01.  
(C-D)  Example of an FC-specific gene tribbles (trbl, C), an FCM-specific gene sugarbabe 
(sug, D), and corresponding ChIP-on-chip signal for Ttk69 (purple) and Lmd (green).  
In the track below the signal are the computed CRMs in the respective colour and in 
black are mesodermal CRMs bound by the five key myogenic TFs [196]. 
 Note that there is only background signal for Lmd in the trbl locus and similarly 
background signal for Ttk69 in the sug locus. 
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4.3 Snail as a transcriptional activator in the presumptive 
mesoderm  
Twist and Snail are two major regulators co-expressed in the presumptive 
mesoderm of blastoderm stage embryos.  While Twist is a master regulator of 
mesodermal gene expression, Snail has been traditionally viewed as a repressor of 
neuroectodermal genes (see Section 1.2.2).  It therefore came as a surprise to find that 
Snail binds to CRMs which are active in mesoderm at the stages of Snail occupancy 
(Figure 4.3-1). As multiple additional observations could be explained by Snail 
positively regulating gene expression (see Section 1.2.2.1), I directly addressed this 
possibility first in vitro and then in vivo using reporter assays. 
 
4.3.1 Snail binds to enhancer regions of early mesodermal genes 
As has been observed previously, there is a significant overlap in the binding 
profiles of the mesodermal activator Twist and the repressor Snail [56].  These 
observations were derived from ChIP-on-chip experiments in Toll10B embryos, in 
which, through a constitutively active Toll receptor, high nuclear levels of Dorsal 
protein activate the master mesoderm regulator Twist throughout the embryo [235].  
As a result, the entire embryo is composed of mesoderm at the expense of neurogenic 
and dorsal ectoderm.   
To confirm that these findings hold true in a wild type genetic background, 
Twist and Snail ChIP-on-chip experiments were performed in wild type 2-4 hours old 
embryos (by Robert Zinzen and Martina Rembold).  This wild type occupancy data 
confirmed Twist and Snail co-binding to previously identified enhancers of genes 
repressed by Snail, such as single-minded (sim), rhomboid (rho), or the wnt inhibitor 
of Dorsal (wntD) (Figure 4.3-1 A).  In addition, however, their binding was also 
detected near genes encoding key mesodermal regulators, such as Mef2 (Figure 4.3-1 
B) and Tin (Figure 4.3-1 C).  Enhancers responsible for early mesodermal expression 
of both genes, Mef2 I-D[L] [236] and Tin B-374 [60], respectively, are co-bound by 
Twist and Snail at 2-4 hours after egg laying (AEL) (Figure 4.3-1 B, C).  An example 
of yet another mesodermal enhancer bound by both TFs is the Mdr49 early mesoderm 
enhancer (Figure 4.3-1 D) which directs expression during cellularization and early 
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gastrulation stages [56].  Two mesodermal genes whose expression is reduced in sna 
mutant embryos are htl, which encodes an FGF-receptor required for mesoderm 
migration [237], and zfh1, a transcriptional repressor important for later development 
of particular mesoderm derivatives [238].   Both Snail and Twist bind to intronic as 
well as upstream regions within the loci of both genes (Figure 4.3-1 E, F).  
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Figure 4.3-1: Twist and Snail co-occupy multiple regions in the vicinity of mesodermal 
genes  
Results of a ChIP-on-chip experiment with 2-4 hours old wild type embryos and Twist or 
Snail antibodies.  Both TFs co-bind to numerous regions in the vicinity of wntD (A), Mef2 
(B), tin (C), Mdr49 (D), zfh1 (E), and htl (F) genes (in black).  Known enhancer regions that 
were selected for further analysis are shown in green.  In grey are other relevant enhancer 
regions.  Data kindly supplied by Robert Zinzen and Martina Rembold. 
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4.3.2 Endogenous expression of several mesodermal genes is 
dependent on Snail 
Earlier studies noted that the mRNA transcripts of some early mesodermal 
genes are significantly reduced or completely absent in sna-deficient embryos [86-88, 
90].  To confirm these findings, I performed in situ hybridizations in embryos 
carrying the sna loss-of-function null allele sna18 [239, 240] and compared 
mesodermal gene expression to wild type embryos.  Given the failure of gastrulation 
followed by additional morphological defects, expression of mesodermal genes in sna 
mutant embryos can only be judged during early embryonic stages. To facilitate the 
identification of mutant embryos, the balancer chromosome was marked with ftz-lacZ 
so that the absence of lacZ expression in ectodermal stripes indicated homozygous 
mutant embryos.    
The earliest time point when Mef2 mRNA is observed in wild type embryos is 
stage 6.  However, in homozygous sna18 embryos, no Mef2 expression can be detected 
at any developmental stage (Figure 4.3-2 A, A').  Similarly, the expression of tin in 
the trunk mesoderm of sna mutant embryos is completely absent at stage 7 (Figure 
4.3-2 B') and cannot be observed at any other time point.  An interesting aspect of tin 
expression in sna18 homozygous embryos is the normal expression of tin in the 
anterior head mesoderm (Figure 4.3-2 B, B').  Given that the complex expression 
pattern of tin is governed by independent modular CRMs [60] and that snail is not 
expressed in these cells, it is likely that Snail exerts its regulatory effect only on the 
CRM(s) responsible for tin expression in the trunk mesoderm. 
Based on the TF occupancy data, zfh1 and htl are additional mesodermal target 
genes that may be positively regulated by Snail.  While both genes are highly 
expressed at stage 7 in wild type embryos (Figure 4.3-2 C, D), in sna18 homozygous 
embryos their mRNA expression is absent (Figure 4.3-2 C', D'). 
Another candidate gene for activation by Snail is Mdr49 whose expression 
commences with the onset of cellularization.  However, neither the initiation nor the 
maintenance of Mdr49 mRNA expression seem to be Snail-dependent as no apparent 
changes in its pattern or levels could be observed at stage 5 (Figure 4.3-2 E-F') or at 
stage 7 (Figure 4.3-2 G-H') in sna18 homozygous embryos. 
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Figure 4.3-2: Expression of mesodermal genes in snail loss-of-function embryos 
Endogenous expression of genes expressed in the presumptive mesoderm was detected by 
colorimetric or fluorescent in situ hybridization in stage 5 or 7 wild type and sna18 
homozygous embryos. The sna mutant embryos also carry a ftz-lacZ marked balancer 
chromosome.  The absence of lacZ expression in the ectoderm was used to identify 
homozygous mutants. 
(A-A') Expression of Mef2 is completely lost in sna mutants compared to wild type. 
(B-B') tin is absent in the trunk mesoderm of sna18 homozygous embryos but it persists in the 
anterior tip of the head (arrow).    
(C-D') In sna mutant embryos, levels of zfh1 (C) and htl (D) mRNA are significantly 
reduced. 
(E-H') Fluorescent double in situ hybridization in embryos generated by sna18/CyO ftz-lacZ 
flies.  Probe against lacZ (red) facilitates discrimination between homozygous sna 
mutant embryos (F', H') and embryos carrying only one or none sna18 allele (E', G').  
There are no apparent changes in Mdr49 expression (green) at stage 5 (E-F') and 7 
(G-H') in sna18 homozygous embryos (F, H). 
 
 
 
In summary, there are several examples where Twist and Snail co-occupy active 
mesodermal enhancers and many of the co-bound enhancers are associated with genes 
whose expression is dependent on the presence of Snail.  This observation contradicts 
the traditionally assumed role of Snail as a dedicated repressor.  In an attempt to 
resolve this discrepancy, I tested the possibility that Snail could also positively 
regulate transcription.   
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4.3.3 Snail enhances the activation of mesodermal enhancers in vitro 
4.3.3.1 Luciferase reporter assays in Drosophila Kc cells 
As a first step in assessing whether the binding of Snail to mesodermal 
enhancers is functional, I performed luciferase reporter assays with three selected 
enhancers in Drosophila Kc cells.  This cell line is of late embryonic origin [241] and 
does not express detectable levels of endogenous Twist, Snail, and Dorsal mRNA or 
protein ([242, 243], data not shown).   In each experiment, the cells were transfected 
with a uniform amount of a firefly luciferase reporter vector with the luciferase gene 
linked to an upstream minimal Hsp70 promoter and the enhancer to be assayed.  In 
parallel, Renilla luciferase driven only by the Hsp70 minimal promoter was co-
transfected to account for variability in transfection efficiency.  In each assay, 
increasing amounts of one or two different protein expression vectors were co-
transfected and their quantity was equalized with an empty expression vector.  To 
eliminate background effects, the detected changes in firefly luciferase activity were 
adjusted to the levels in cells transfected with the empty expression vector alone.  
Each condition was measured in triplicate per experiment and the final values of 
mesodermal enhancers activity were derived from three independent experiments. 
I assayed the activity of the wntD-lacZ enhancer that is co-bound by Twist, 
Snail, and Dorsal at 2-4 hours AEL ([56], Figure 4.3-1 A) as a control for the 
experimental setup.  Expression of the endogenous wntD gene is regulated positively 
by Twist and Dorsal and negatively by Snail [244].  Kc cells were co-transfected with 
the wntD construct and with varying amounts of Dorsal and/or Snail expression 
vectors.  In agreement with in vivo observations, transfection of 100 ng of plasmid 
encoding Dorsal induces the activity of the enhancer approximately 80-fold when 
compared to the empty expression vector.  When an equal amount of Dorsal is co-
transfected with 100 ng of Snail, the relative expression levels of luciferase are 
reduced to approximately 50-fold (Figure 4.3-3 A).  The results obtained from the cell 
culture system are therefore consistent with the observations made in embryos, 
indicating that, at least to a certain extent, the cell-based luciferase assays reflect the 
in vivo situation. 
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4.3.3.2 Snail acts to synergistically enhance Mdr49 early mesoderm and Tin B-374 
enhancer activity 
The Mdr49 early mesoderm CRM recapitulates the early mesodermal 
expression of the endogenous Mdr49 gene [56].  Similar to the wntD-lacZ CRM, it is 
also co-bound by Twist, Snail, and Dorsal [56].  However, the strong expression of 
the Mdr49 early mesoderm CRM in the early mesoderm suggests a positive input 
from Snail.   Indeed, while Dorsal can activate the enhancer weakly, addition of Snail 
dramatically increases the average fold of luciferase activity (Figure 4.3-3 B).  100 ng 
of transfected Dorsal cDNA induces an average luciferase expression 4.6-fold, while 
addition of the same amount of Snail together with Dorsal raises the levels to 16-fold 
(Figure 4.3-3 B).  Co-transfection of Snail therefore induces almost a four fold 
increase in Dorsal-mediated enhancer activation. 
The expression of the endogenous tin mRNA is controlled by multiple 
modular enhancer elements with distinct spatio-temporal activities [60].  During early 
embryonic stages, tin expression is driven by two adjacent enhancers, Tin B-374 in 
the presumptive trunk mesoderm and Tin A in the anterior mesoderm of the head [60].  
While Twist and Snail co-bind to the Tin B-374 enhancer at 2-4 hours AEL, they do 
not seem to occupy the Tin A enhancer (Figure 4.3-1 C).  This is consistent with the 
normal head mesoderm expression of tin in snail loss-of-function mutant embryos 
(Figure 4.3-2 B'). The Tin B-374 CRM is also bound by Twist in vitro and this 
binding is dependent on at least three different E-box sequences, which are required 
for the activity of the CRM [60].   
As expected, the Tin B-374 CRM responds to Twist in Kc cells, where 50 ng 
of transfected Twist induces luciferase activity to approximately 4-fold (Figure 4.3-3 
C).  Transfection of Snail alone does not affect the CRM activity, but addition of 50 
ng of Twist in the presence of 100 ng of Snail increases the average luciferase activity 
to approximately 8-fold (Figure 4.3-3 C). There are four putative Snail binding sites 
in the Tin B-374 CRM identified using a Position Weight Matrix (PWM) of Snail that 
was generated by a Systematic Evolution of Ligands by Exponential Enrichment 
(SELEX) [196] (Figure 4.3-3 E).  However, as three Snail sites largely overlap with 
the Twist motifs, it was not possible to mutate these sites without also affecting Twist 
binding.  The fourth site, named Sna4, is non-overlapping (Figure 4.3-3 E), yet its 
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mutation does not have any effect on the activity of the CRM in vitro or in vivo (data 
not shown).   
 
4.3.3.3 The Mef2 I-D[L] enhancer is activated by Snail in vitro 
In a transgenic reporter assay, the Mef2 I-D[L] CRM drives reporter 
expression in the presumptive mesoderm, but not during later stages of muscle 
specification and differentiation [236].  The CRM is bound by Twist protein in vitro 
[59] and in vivo (Figure 4.3-1 A) and its activity can be induced in ectodermal cells by 
ectopically expressing Twist [236].  As expected, Twist can activate this CRM to 15-
fold in Kc cells (Figure 4.3-3 D).  Transfection of Snail alone has no effect on CRM 
activity, however co-transfection of both Snail and Twist almost doubles the average 
luciferase activity (Figure 4.3-3 D).  Similar to the Tin B-374 CRM, Snail therefore 
appears to stimulate the activity of the Mef2 I-D[L] CRM in the presence of Twist, 
but it does not seem to be able to activate its expression alone. 
There are three putative Snail binding motifs in the Mef2 I-D[L] CRM, one of 
which largely overlaps with a Twist site that is required for Twist binding in vitro 
[59].  Mutating this site in such a way as to preserve Twist binding, in combination 
with mutations in the other two sites (Figure 4.3-3 F), results in an enhancer (named 
Mef2 I-D[L] Sna123) that is still activated by Twist, albeit to a lower level (Figure 
4.3-3 D).  Importantly, the synergistic activation of Snail with Twist is now lost 
(Figure 4.3-3 D), demonstrating, that the positive effect of Snail is dependent on its 
ability to bind to DNA. 
In summary, Snail significantly contributes to the activation of three well-
characterized early mesodermal CRMs and in the case of Mef2 I-D[L] enhancer,  the 
Snail binding motifs are required for this positive regulatory input.  
 
 
 
 
 
 
 
4.3 Snail as a transcriptional activator in the presumptive mesoderm 
 
 -139- 
 
Figure 4.3-3: Snail acts to synergistically enhance CRM activity in combination with 
Dorsal or Twist 
(A) Activity of the Dorsal-activated CRM wntD-lacZ is gradually suppressed with increasing 
amounts of Snail transfected (n=2). 
(B) Mdr49 early mesoderm CRM is activated by Dorsal weakly, but co-transfection of Snail 
increases it activity almost four-fold (n=3).  
(C) Tin B-374 CRM is also activated by Twist alone, yet its activity is enhanced if Snail is 
co-transfected (n=3). 
(D) The wild type Mef2 I-D[L] CRM (full bars) is activated by Twist, but upon addition of 
Snail the average luciferase activity is approximately doubled (n=3).  If the putative Snail 
binding motifs are mutated (striped bars), addition of Snail does not increase the basal 
activity levels achieved with Twist (n=3). 
(E) Putative Snail and Twist binding motifs in Tin B-374 CRM. 
(F) Putative Snail and Twist binding motifs in Mef2 I-D[L] CRM.  Red asterisks and 
residues mark mutations in Mef2 I-D[L] Sna123. 
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4.3.4 In vivo activity of mesodermal enhancers further supports the 
ability of Snail to positively regulate transcription 
In order to test whether Snail can contribute to the activation of mesodermal 
CRMs in vivo, I generated transgenic reporter lines where each CRM was linked to a 
lacZ reporter gene.  To enable a direct comparison between the lacZ spatial 
expression and levels of expression in different lines, site-directed φC31-mediated 
transgenesis was used [197].  As all the discussed CRMs were targeted to the same 
landing site, their activity can be directly compared without the need to consider 
variation due to positional effects of different integration sites.  
4.3.4.1 Snail binding sites are required for Mef2 I-D[L] expression in vivo 
The expression of a lacZ reporter driven by the Mef2 I-D[L] CRM is initiated 
at early stage 6 in most, but not all, cells expressing the endogenous Mef2 transcripts 
(Figure 4.3-4 A, A').  At stage 7, during germ band elongation, there is robust lacZ 
expression in the entire trunk mesoderm (Figure 4.3-4 B, B').  Up to stage 8, both 
enhancer-driven lacZ and the endogenous Mef2 mRNA co-localize with endogenous 
sna expression (Figure 4.3-4 C-C'').  At the end of stage 8, the expression of sna in the 
mesoderm diminishes and instead appears in cells of the neurogenic ectoderm [245].  
lacZ-driven enhancer activity persists in the mesoderm until the end of stage 10 and 
ceases with the onset of segmentation and mesoderm subdivision at stage 11 (data not 
shown). 
Mutagenesis of the putative Snail binding motifs in the Mef2 I-D[L] CRM 
results in loss of its activation by Snail in Drosophila cells (Figure 4.3-3 D, F).  This 
enhancer can still be activated by Twist, although to a lesser extent.  One would 
therefore predict that the mutated CRM is still, at least partially, activated by Twist 
and therefore expressed in vivo.  When the activity of the Mef2 I-D[L] Sna123 CRM 
was assayed in transgenic flies with a probe directed against lacZ, it indeed showed 
lower, but not entirely absent, expression.  At stage 6, there are some lacZ positive 
cells (Figure 4.3-4 D), but their number is lower when compared to the original CRM 
(Figure 4.3-4 A).  At later stages, during which sna mRNA is still present in the 
mesoderm (Figure 4.3-4 E'', F''), the expression of lacZ is almost completely lost, with 
the exception of strong expression in a posterior patch of the trunk mesoderm, 
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corresponding to the precursors of the longitudinal visceral muscles (Figure 4.3-4 D, 
E).   
These observations are consistent with the in vitro results; the Mef2 I-D[L] 
Sna123 CRM shows only residual activity compared to the wild type CRM.  The 
Snail binding motifs are therefore also required for the activation of the Mef2 I-D[L] 
CRM in vivo. 
 
Figure 4.3-4: In vivo activity of wild type and mutated Mef2 I-D[L] CRM  
The levels of CRM activity (green) as well as Mef2 (red) and sna (blue) endogenous gene 
expression were detected by a fluorescent in situ hybridization. 
(A-C) The wild type Mef2 I-D[L] CRM drives lacZ expression (green) in an overlapping 
domain to the endogenous Mef2 gene (red).  sna (blue) is also expressed in the 
mesodermal cells at stage 6 (A''), 7 (B''), and 8 (C''). 
(D-F) When the putative Snail sites in the Mef2 I-D[L] CRM are mutated, the expression of 
lacZ (green) in the trunk mesoderm is almost completely absent (arrow).  However, 
expression of the endogenous Mef2 gene (red) or sna (blue) is not affected in stage 7 
(D, E) and 8 (F) embryos. Arrows indicate loss of mesodermal expression and 
arrowheads point to expression in the posterior-most mesodermal cells which will be 
contribute to longitudinal visceral muscles. 
 The lacZ expression in the anterior region is due to a non-specific transgenesis effect 
as it is also present in embryos transgenic for the empty vector (R. Zinzen, personal 
communication).   
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4.3.4.2 Expression of the Mef2 I-D[L] CRM is dependent on Snail activity in vivo 
The expression of the Mef2 gene is lost in embryos homozygous for a sna 
amorphic allele (Figure 4.3-2 A').  As Mef2 I-D[L] is the only CRM known to drive 
the early mesodermal expression of Mef2 [59], I tested whether Snail is necessary for 
its activity in vivo.  For this purpose, the CRM was placed into the genetic 
background of two different sna loss-of-function alleles.  sna18  is an amorphic allele 
identified in an EMS screen and has been classified as one of the strongest sna mutant 
alleles that have been isolated to date [239, 240].  The precise lesion has not been 
mapped, but both Snail mRNA and protein are not expressed in homozygous mutant 
embryos [90].  These embryos misexpress neuroectodermal genes such as sim and rho 
in the mesoderm [90], while the expression of several mesodermal genes is lost 
(Figure 4.3-2).  The mutation in the hypomorphic allele sna10 was characterized and 
mapped to a single base pair that leads to a conversion of a glycine to a glutamic acid 
[90].  The mutated residue is located between two of the four Snail zinc fingers [90] 
and it is currently not understood how this change in a single amino acid affects the 
DNA binding properties or the general activity of Snail.  However, the effect of the 
mutation on the expression of Snail downstream genes is rather peculiar.  
Derepression of sim is even more pronounced compared to sna18 homozygous 
embryos, while the expression of mesodermal genes zfh1 and srp, both absent in sna18 
embryos, is not affected [90].  The differential response of neuroectodermal and 
mesodermal genes to the mutated Snail protein in sna10 may therefore provide clues 
regarding the mechanism behind the distinction of inhibitory and activatory functions 
of the Snail protein. 
Embryos collected from either Mef2 I-D[L] sna18/CyO ftz-lacZ or Mef2 I-D[L] 
sna10/CyO ftz-lacZ adults were subjected to triple fluorescent in situ hybridization 
assays.  The genotype of the embryos was determined with a sim probe, using 
derepression of sim in the mesoderm as a hallmark of both alleles.  In addition, the 
probe directed against lacZ can distinguish the homozygous mutant embryos via an 
absence of ftz-lacZ expression on the balancer chromosome.  Finally, a probe against 
the endogenous Mef2 transcripts revealed whether the changes at the CRM and at the 
gene level are consistent. 
In sna18 mutant embryos, sim is misexpressed in some mesodermal cells and the 
endogenous expression of Mef2 is lost (Figure 4.3-5 A'-A'', B'-B'').  As expected, the 
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activity of the Mef2 I-D[L] CRM is also affected and no lacZ expression could be 
detected in mesodermal cells of stage 7 or 8 embryos (Figure 4.3-5 A, B).  However, 
the situation is different in embryos homozygous for the sna10 allele.  The 
derepression of sim in the mesoderm is substantially more robust than in sna18 
embryos, as it is widely expressed in the mesoderm (Figure 4.3-5 C'', D'', E'').  Both 
the distribution and the levels of Mef2 mRNA, as well as the CRM-driven lacZ, seem 
to be comparable to wild type in most embryos (Figure 4.3-5 C-C', E-E').  
Interestingly, in some sna10 homozygous mutant embryos the CRM is inactive in the 
mesoderm with the exception of a posterior patch (Figure 4.3-5 D), whereas 
expression of the Mef2 gene appears unaffected (Figure 4.3-5 D'). 
In summary, the expression of Mef2 in the two different alleles is in agreement 
with that of the previously observed mesodermal genes srp and zfh1 [90]; in sna18 
homozygous embryos it is completely absent while in sna10 embryos it seems 
unaffected.  In addition, these changes are recapitulated at the CRM level as Mef2 I-
D[L] activity is lost in sna18 but does not seem to be affected in most of the sna10 
homozygous embryos.  Snail is therefore required for the activation of the Mef2 I-
D[L] CRM in vivo. It is likely that the absence of endogenous Mef2 mRNA in sna18 
embryos is due to the inactivity of the Mef2 I-D[L] enhancer.  However, existence of 
an as yet unidentified early mesodermal Mef2 CRM that would also be responsive to 
Snail cannot be excluded. 
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Figure 4.3-5: The Mef2 I-D[L] CRM is dependent on Snail activity in vivo 
The Mef2 I-D[L] CRM was placed in the genetic background of two different sna alleles.  
Embryos were subjected to triple fluorescent in situ hybridization with anti-sense probes 
against lacZ (green), Mef2 (red), and sim (blue).  Absence of lacZ signal in the ftz expression 
domain and derepression of sim in the mesoderm (red arrows) are distinctive of sna 
homozygous mutant embryos. 
(A-B'')   In sna18 homozygous embryos of stage 7 (A-A'') and 8 (B-B''), no lacZ (green) or 
Mef2 (red) can be detected in the presumptive mesoderm (white arrows). 
(C-E'') In sna10 homozygous embryos of stage 6 (C-C''), 7 (D-D''), and 8 (E-E''), 
endogenous Mef2 (red) appears to be expressed at wild type levels.  lacZ driven by 
the Mef2 I-D[L] CRM is present in the mesoderm of most embryos (C, E) but is 
absent in some embryos (with the exception of patches of posterior-most cells, 
white arrowhead) (D). 
 
 
 
 
4.3.4.3 In vivo activity of the Mdr49 early mesoderm and the Tin B-374 CRMs 
The lacZ reporter driven by the Tin B-374 CRM recapitulates the pattern of the 
endogenous tin expression in the trunk mesoderm from stage 5 until stage 10.   At 
stage 7 it is strongly expressed in the trunk mesoderm, while the head mesoderm 
expression of the endogenous tin expression is not covered by the CRM (Figure 4.3-6 
A, A').  As reported previously, the CRM expression is patterned along the anterior-
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posterior axis by Eve, which directly binds the CRM and suppresses its activation by 
Twist [60].  As a result, both the CRM and tin gene show striped expression with 
lower levels in the Eve-expressing domains (Figure 4.3-6 A, A').   
In stage 6 embryos homozygous for the sna18 allele, the activity of Tin B-374 is 
almost completely absent, with the exception of a few mesodermal cells in the Eve-
negative stripes (Figure 4.3-6 B).  At stage 7, no lacZ signal can be observed in the 
mesoderm (Figure 4.3-6 C).  In agreement with the colorimetric in situ hybridization 
assay (Figure 4.3-2 B, B'), sna18 homozygous embryos express no endogenous tin in 
the presumptive mesoderm at stage 6 or 7 (Figure 4.3-6 B', C').  However, in the 
background of sna10 allele, both the Tin B-374 CRM and the tin gene show wild type 
expression (Figure 4.3-6 D-E'').  
The Mdr49 early mesoderm CRM drives expression of lacZ only transiently 
during stages 5 and 6 in the presumptive mesoderm (Figure 4.3-6 F, G).  Similar to 
the endogenous gene, the expression of the CRM does not seem to be affected in sna18 
homozygous embryos (data not shown), suggesting that the mode of its regulation by 
Snail might be different from Mef2 and tin. 
Taken together, tin and Mef2 show the same response to two different sna 
alleles at the gene, as well as at the CRM, level.  Their activity is almost completely 
abolished in sna18 homozygous mutant embryos in which the expression of other 
mesodermal genes such as htl, zfh1, or srp is also affected  ([90], Figure 4.3-2).  In 
contrast, the expression of these genes remains unchanged in sna10 embryos where the 
Snail protein bears a single amino acid mutation.  These experiments therefore reveal 
a new role for Snail as a transcriptional activator of mesodermal genes and in addition 
identify their Snail-responsive regulatory elements. 
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Figure 4.3-6: Expression of the Tin B-374 and Mdr49 early mesoderm CRMs 
In vivo activity of the CRMs was assayed by fluorescent in situ hybridization with a lacZ 
probe (green).  In addition, the endogenous gene expression of tin or Mdr49 is shown in red 
and the expression of sna in wild type or sim in mutant embryos is shown in blue. 
(A-A'') LacZ driven by Tin B-374 CRM (A) can be detected in the trunk mesoderm where it 
overlaps with tin (A') and sna (A''). 
(B-C'') In embryos homozygous for the amorphic sna18 allele, the activity of Tin B-374 is 
substantially reduced at stage 6 (B) and almost completely absent at stage 7 (C).  The 
endogenous tin transcripts are completely absent in the trunk mesoderm at both stages 
(B', C').  Expression of sim mRNA (blue) is derepressed in some mesodermal cells 
(red arrow) and was therefore used to recognize homozygous mutant embryos.  B-B'' 
is a lateral and C-C'' a ventral view. 
(D-E'') In the genetic background of a hypomorphic allele sna10, neither the Tin B-374 CRM 
activity (D, E) nor the endogenous tin expression (D', E') is affected while the 
neuroectodermal gene sim is expressed throughout the mesoderm (D'', E'') during 
stages 6 (D-D'') and 7 (D-E'').  D-D'' is a lateral and E-E'' a ventral view. 
(F-G'') At stage 5, the Mdr49 early mesoderm CRM (F, G) is detected in the presumptive 
mesoderm where its expression overlaps with the endogenous Mdr49 (F', G') and sna 
(F'', G'') mRNA.  F-F'' is a ventral and G-G'' a lateral view. 
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5 DISCUSSION 
5.1 Different approaches for forward genetic screening in 
Drosophila 
In the traditional, forward genetic screens pioneered in Drosophila [246], a 
collection of randomly mutagenized lines was generated and then evaluated for a 
phenotypic trait of interest.  Although these screens usually identified tens or even 
hundreds of new genes involved in a given process, they were exceptionally labour-
intensive, depending on the phenotypes being assayed.  Nowadays, there are diverse 
screening approaches and toolkits available and the selection of the most suitable one 
depends on the studied system and the objectives of the experiment. 
Here, I used a combination of multiple gene deletion or silencing methods to 
identify novel regulators of Drosophila embryonic myogenesis.  As my search for 
novel genes was restricted to transcription factors (TFs), I did not perform a random 
mutagenesis screen.  Instead, based on prior knowledge, I defined a set of candidate 
genes whose requirement for muscle development was systematically tested in a 
phenotypic assay. 
 
5.1.1 The advantages and limitations of deficiency lines 
In the second round of the screen, the functional requirement of mesodermally 
expressed candidate TFs for muscle development was analyzed using deficiency lines.  
As there are hundreds of different lines available, the deficiencies offered an efficient 
way of identifying genetic loci required for myogenesis and also to eliminate genes 
encoding TFs.  However, the lines delete large genomic segments that can cover up to 
hundreds of genes, therefore another round of analysis is required to define the genes 
responsible for the observed phenotypes.  
The fact that the deficiency lines remove multiple genes can at the same time be 
convenient as it allows a rapid screening and narrowing down of the regions of 
interest.  Another great advantage of the deficiency lines is that they are bona fide null 
alleles for the deleted genes.  In contrast, knockdown with RNA interference (RNAi) 
or random mutagenesis can give rise to a series of phenotypes (see Section 5.1.2.2) of 
variable strength that can complicate the analysis. 
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On the other hand, deficiency lines have many limitations that were also 
encountered in the course of the screening.  Some of them were circumvented by 
considerate selection of the lines, while others required additional experiments.  The 
most commonly experienced difficulties were the following: 
o As mentioned, the foremost limitation of deficiency lines is the deletion of a large 
number of genes.  The size of the deleted segments can be reduced by combining two 
partially overlapping lines in trans, yet tens of different gene loci are normally 
affected.  Subsequently, secondary phenotypic analysis at a single-gene level is 
necessary to identify the gene of interest.  Further dissection can however be elaborate 
as several of the deleted genes might contribute to the observed phenotype which is 
then the combination of multiple, more subtle defects.  
o Often, the candidate gene lies in the vicinity of a gene that is known to be 
involved in the assayed process.  For example, the loci of some candidate mesodermal 
TFs, such as CG12744 or CG13424, are near the locus of Mef2 and all available 
deletions that cover the candidate genes also delete Mef2.  As differentiation of all 
three muscle types fails in absence of Mef2 [247], the contribution of the candidate 
genes to muscle development can only be assessed by approaches specifically 
targeting the individual genes. 
o A similar problem occurs when the gene of interest is nearby a gene whose 
deletion impairs analysis of the given phenotypic trait.  Many times the presence of 
such a gene in the deleted region is not revealed before the actual analysis.  Then its 
deletion might result in cell death before the actual phenotype can be assayed or it 
might interfere with developmental processes that are a prerequisite for the studied 
trait.  Deficiency lines in this category form the phenotypic class II (Figure 4.1-5) as 
the muscle-specific defects in the embryos could not be evaluated.  This problem can 
be avoided by choosing other deficiency lines that would not delete the more general 
genes (if their identity is known) or again by using single-gene level analysis. 
o The recent ability to systematically generate deletiom lines enables precise 
mapping of their endpoints by PCR-based methods.   However, the breakpoints of 
older deficiency lines generated by X-ray mutagenesis were only estimated from the 
missing cytological bands in polytene chromosome squashes and by complementation 
analysis using other mapped lines.  The uncertainty if the genes at the breakpoints of 
the removed region are deleted can be circumvented by preferentially choosing 
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deficiency lines with the candidate gene in the centre of the predicted removed 
segment.  However, this was not always possible with the lines that were available. 
o Although there are hundreds of deficiency lines available, the genome is not yet 
fully saturated with deletions.  For example, the candidate mesodermal TF encoded by 
Misexpression suppressor of ras 4 (MESR4) was not covered by any deficiency line at 
the time of the screen.  This problem was partially solved by the advent of tools for 
generation of custom-made deletion lines [200, 206].  As these are however 
dependent on random integration of transposition elements, some genomic loci might 
still be underrepresented among the available deficiency lines. 
o  As deficiency lines remove only the zygotic component of a gene’s expression, 
maternally expressed factors important for mesoderm specification would be missed.  
In addition, phenotypes of some of the mesodermal TFs whose deletion does not lead 
to any apparent muscle defects (class I) could be attenuated by their maternally loaded 
transcripts.  
o Another explanation for situations when removal of a mesodermal TF does not 
cause any apparent muscle abnormalities is its redundancy with another factor.  
Redundancy among the core myogenic regulators is a well-studied phenomenon in 
vertebrates, and recently also uncovered in yeast (reviewed in [248]), yet its 
contribution to Drosophila muscle development remains unknown.  Although genetic 
interaction between two given genes can be readily tested, high-throughput screens 
for redundantly acting factors in vivo are currently not feasible.  
 
 
5.1.2 Alternative approaches to large-scale phenotypic screening 
The discovery that the introduction of double-stranded RNA (dsRNA) into cells 
leads to the silencing of gene expression [249] initiated a new era of screening 
techniques in numerous organisms, including Drosophila.  Two broad categories of 
RNA interference (RNAi) experiments, differing in the mode of dsRNA delivery, can 
be used to knockdown endogenous expression of specific genes in Drosophila 
embryos.   
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5.1.2.1 Inducible gene silencing using the Gal4-UAS system 
Libraries of transgenic fly lines, each carrying two inverted repeats of the target 
sequence placed downstream of the yeast UAS element, have been generated by both 
random, P-element mediated, as well as site-directed transgenesis ([250], 
unpublished).  When a source of the Gal4 activator is supplied, the inverted repeats 
are transcribed and the RNA molecule folds into a hairpin of effective dsRNA [251].  
The inducibility by the Gal4-UAS system [223] enables spatially and temporally 
controlled dsRNA expression, which in turn facilitates the assessment of the role of a 
gene specifically in the tissue and time of interest.  It became therefore possible to 
address the role of genes essential for embryogenesis during larval to adult stages.  
Since in the remaining, Gal4-negative cells the target gene is expressed normally, 
developmental processes can be studied in isolation without the need to consider 
extrinsic, secondary effects.   
At the same time, however, the indirect activation of the expression via Gal4 
introduces a time delay between the induction of Gal4 expression and the actual 
dsRNA transcription and folding.  Consequently, while the system works efficiently 
during later stages of the Drosophila life cycle, for the rapid process of 
embryogenesis the time delay is an impediment. 
Nevertheless, in the second round of the screen I used 74 different RNAi lines 
to narrow down the number of candidate genes contributing to the most interesting 
deficiency phenotypes.  With the earliest available mesodermal Gal4 driver, twi, 24B-
Gal4, 23 lines did not produce viable offspring (see Appendix section 7.1).  However, 
in all assayed cases, the lethality occurred after embryogenesis and the examined 
embryos developed wild type musculature (not shown).  As UAS-RNAi knockdown 
of the key myogenic factors also does not affect embryogenesis (not shown), RNAi 
lines with the set of currently available drivers are not a suitable method for screening 
of embryonic muscle phenotypes.   
An identical conclusion can be derived from a recent genome-wide screen 
which used a Mef2-Gal4 line as a driver for almost 18,000 RNAi lines corresponding 
to about 10,000 different genes [252].  While knockdown of 1,969 genes led to 
lethality, only 31 cases (1.5 %) of embryonic lethality were reported.  Gene ontology 
analysis in addition showed that most of the 31 genes encode structural muscle 
constituents rather than developmental regulators.  66 of the  RNAi lines that I 
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analyzed were also included in the genome-wide screen and the obtained results are 
well-correlated.  All the lines that were viable in our screen were viable in the large 
screen too, but 5 lines reported viable with the Mef2-Gal4 driver are lethal in 
combination with the twi, 24B-Gal4 line (see Appendix section 7.1).  The differences 
in lethality hence underscore the importance of the driver line for timing, and 
probably also levels, of dsRNA expression.   
5.1.2.2 Direct dsRNA injection into embryos 
The time delay limitation inherent to the Gal4-UAS system can be circumvented 
by injecting the double-stranded RNA directly into blastoderm embryos.  At the 
syncytium stage, when the nuclei are not yet separated by cell membranes, it can 
freely diffuse and spread across the embryo.  When highly concentrated, in vitro 
synthesized dsRNA is injected, it is thought to also silence maternally loaded 
transcripts [52].  An obvious disadvantage (similar to a genetic null allele) is the 
ubiquitous distribution of the dsRNA resulting in a gene knockdown in all, or most 
embryonic cells.  In addition, as it is supplied only in early embryogenesis, it may be 
used up or degraded before the actual process of interest occurs.  
By far the most important drawback of dsRNA injections is the high variability 
and low reproducibility of the detected phenotypes.  In a typical experiment, when 
about 100 embryos were injected with dsRNA against Mef2, a range of phenotypes 
was observed (Figure 5.1-1 A).  Many embryos were damaged by the injection itself 
and some embryos exhibited wild type musculature.  Only about one fifth of injected 
embryos displayed specific muscle defects.  However, the severity of these varied 
greatly and resembled the series of hypomorphic Mef2 alleles [253] (Figure 5.1-1B).  
This variability is likely the result of unequal volumes of dsRNA injected and its 
uneven distribution within the embryo.  In addition, knockdown of highly expressed 
genes might be less efficient and the overall efficiency can vary with differently 
designed dsRNA sequences.  To account for the variability, a high number of 
embryos need to be injected and evaluated to obtain a reliable result.  This is fairly 
simple if dsRNA injections are used to confirm a known phenotype.  However, if the 
expected phenotype is not known, as it would be in a screen, obtaining a definitive 
answer only from the dsRNA injections remains a major challenge. 
Nevertheless, with the fast development of new technologies, automatized 
dsRNA injection and phenotype evaluation methods might become available.  If the 
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variability as well as workload were reduced by robotics, high-throughput screens 
could be performed with the ease of the current cell culture screens.  Eventually, co-
injection of two or more different dsRNAs would be an efficient approach to study 
genetic redundancies. 
 
 
Figure 5.1-1: Injection of Mef2 dsRNA results in a hypomorphic phenotypic series 
(A)  Outcome of a typical experiment when 94 embryos were injected with dsRNA against 
Mef2.  The injected embryos carried a Myosin heavy chain (MHC)-τGFP transgene 
which labelled all muscle types with a microtubule-associated form of GFP, enabling 
live imaging of the specimen.  Injection of the dsRNA resulted in a range of phenotypes, 
from wild type (blue), through muscle defects of variable severity (green), to generally 
damaged embryos as a result of the injection (red).  
(B)  A series of embryos homozygous for different hypomorphic Mef2 alleles stained with an 
anti-Myosin antibody.  Images are from [253]. 
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5.2 The Mediator complex in Drosophila myogenesis 
While the Mediator complex and other members of the general transcriptional 
apparatus have been implicated in vertebrate myogenesis (see Section 1.1.3.4), their 
role in Drosophila embryonic muscle development has not been directly established.  
The molecular screen described here provides indications that distinct subunits of the 
Mediator complex are specifically required for Drosophila myogenesis as well 
(summarized in Table 5.2-1), similar to the situation in vertebrates. 
The observation that the injection of dsRNA against MED4, MED11, and 
MED24 led to embryonic muscle defects [52] prompted us to investigate the necessity 
of these and other subunits for muscle development.  Knockdown of each of the three 
and additional four Mediator subunits specifically in mesoderm leads to lethality 
(Table 5.2-1, Appendix 7.1).  As the lethality is at rather late stages (discussed in 
Section 5.1.2.1), no abnormalities in embryonic musculature could be observed (not 
shown).  However, mesoderm-specific knockdown of the key regulators Mef2, Tin, or 
Lmd similarly results in larval or pupal lethality, as opposed to the embryonic defects 
observed with null alleles ([252], unpublished).  Consequently, the RNAi lines do 
suggest, but do not definitively confirm, that the mesodermal cells require expression 
of at least 7 different Mediator subunits for their survival and/or development. 
Tissue-specific usage of Mediator subunits may require specific expression 
during mesoderm development.  I therefore examined the mRNA expression of 25 
subunits in an in situ hybridization assay.  Most genes show ubiquitous expression 
throughout embryogenesis, but mRNA levels of several genes seem to be higher in 
the presumptive mesoderm compared to other tissues (Appendix 7.2).  Nevertheless, 
the ubiquitously expressed subunits can contribute to spatio-temporal gene regulation 
by interacting with sequence-specific transcription factors. 
Finally, two subunits, MED24 and MED14, were analysed in more detail where 
new specific deletion lines were generated.  While deletion of MED14 did not lead to 
any observable defects in embryonic musculature, MED24 seems to be involved in 
the control of cell number as in its absence supernumerary myoblasts are present.  
Regulation of cell number might be a general role of MED24 as it was isolated in a 
screen for cell death regulators in salivary gland [47].  
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Table 5.2-1: Association between the Mediator complex and muscle development 
Overview of three types of experimental evidence (injection of dsRNA, knockdown with 
UAS-RNAi line, and mRNA expression in mesoderm) for 11 different Mediator subunits.  
Light green indicates a positive result (presence of phenotype or expression in mesoderm), 
dark green indicates ubiquitous expression, red stands for a negative result (no lethality or no 
mesodermal expression) and white for no information available. 
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5.3 Tramtrack is a novel regulator of Drosophila 
myogenesis 
Negative regulation of gene expression mediated by Ttk69 is essential for the 
proper specification of cell fates in diverse developmental contexts and an absence of 
Ttk69 is detrimental to several embryonic processes [155, 174, 176].  In contrast, the 
contribution of repression to the specification of muscle cell identity remains poorly 
understood and the current myogenic regulatory network is based primarily on 
positive regulatory inputs [54].  Using a combination of genetic as well as genomic 
approaches, I analysed the possibility that Tramtrack could be one of the missing links 
between transcriptional repression and Drosophila muscle development. 
 
5.3.1 Functional analysis links Ttk69 to myoblast fusion 
The ttk loss-of-function phenotype in the somatic muscle differs from 
previously described phenotypes.  Whereas at earlier stages it shows signs of a classic 
myoblast fusion defect, at later stages only very few myoblasts remain unfused.  
Instead, they aggregate into large cell clusters which fail to extend and attach to the 
ectodermal tendon cells.  This is in contrast to the typical myoblast fusion phenotype 
of mini-muscles where the unfused founder cells extend and form correct attachments 
to the epidermis. 
Analysis of the markers specific for the two fusing populations of cells, founder 
cells (FCs) and fusion competent myoblasts (FCMs), revealed a disproportion in their 
number.  While the number of FCMs decreases in ttk loss-of-function mutants, there 
are ectopic, FC-like cells formed.  Consequently, there are at least three populations 
of somatic myoblasts in ttk mutants: original, presumably unaffected FCs, FCMs, and 
a population of ectopic FC-like cells.  The number of cells undergoing mitosis is, 
however, comparable to wild type embryos, therefore it is unlikely that the imbalance 
between FCs and FCMs is caused by a cell cycle defect.  Instead, some FCMs seem to 
have acquired molecular properties characteristic of FCs and have lost some of their 
FCM-like characteristics. 
In wild type embryos, the differential expression of sns and duf (rP298-lacZ 
reporter) in FCMs and FCs, respectively, is essential for successful myoblast fusion.  
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When a source of duf is introduced outside of the mesoderm, it has the ability to 
attract FCMs which then aggregate around the site of its expression [221].  Similarly, 
the ectopic, duf-expressing FCs in ttk mutants seem to attract FCMs which then 
arrange in aggregates.  As these aggregates are rather large, it is possible that the 
ectopic FC-like cells have an ability to fuse with fibres generated from the original 
FCs (Figure 5.3-1).  Clustering between FC-like cells themselves may also occur as 
duf expressed in S2 cells can mediate their homotypic fusion [254].  In wild type 
embryos, a defined number of FCMs fuse with a single FC, and fusion between a FC 
and an FCM that is fusing with another FC has not been observed.  The exact 
mechanisms controlling the number and direction of fusion events are however not 
known.  It is possible that in ttk mutants these mechanisms are perturbed and the 
presence of ectopic FC-like cells interferes with proper fusion of the unaffected FCs 
as well. 
The possibility that ectopic FC-like cells affect the development of "normal" 
FCs is supported by their inability to migrate and attach to their ectodermal sites of 
attachment.  Expression of the founder identity factors Kr and Eve, which are 
assumed to dictate the specificity of guidance of particular muscles, does not seem to 
be affected in ttk mutants (not shown).  It is however possible that the large, compact 
aggregates physically block directed migration.  Alternatively, development of the 
tendon cells might be affected and the secreted guidance cues may be absent. 
 Based on the genetic analysis of ttk69 mutant embryos, Ttk69 seems to 
antagonize the FC specification program in FCMs.  Consistent with this, its ectopic 
expression in FCs results in embryonic lethality and their inability to fuse with the 
surrounding FCMs.  This proposed model predicts that expression of Ttk69 in FCMs 
should not interfere with their specification as FC-specific genes are already repressed 
in this context.  Compared to the ectopic expression in FCs, Ttk69 expression in 
FCMs indeed results in a milder phenotype, with some embryos surviving to pupal 
stages.  However, mild defects in myoblast fusion can still be observed, possibly due 
to prolonged expression of Ttk69 after stage 14 while in the wild type embryos its 
expression in somatic mesoderm ceases at stage 12.   
Finally, the premature expression of Ttk69 in the early mesoderm interferes 
with the specification of all three muscle types, implying that early Ttk69 expression 
is incompatible with myogenic cell fate acquisition.  The timing of the onset of its 
expression in mesoderm must therefore be subjected to very tight regulatory control.   
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Figure 5.3-1: Schematic summary of ttk phenotypes 
Overview of ttk loss- and gain-of-function phenotypes and gene misregulation based on in 
situ hybridization experiments (minus indicates downregulation, plus indicates upregulation). 
 
 
5.3.2 Regulation of Ttk69 expression in the somatic mesoderm 
According to the proposed model, Ttk69 represses FC-specific genes within the 
FCMs (Figure 5.3-3).  An important prerequisite for this model is the expression of 
Ttk69 specifically in FCMs, but not in FCs.  In spite of a large number of attempts, I 
failed to detect differential expression of ttk69 mRNA in the two populations of 
myoblasts.  However, there are several reasons why this might be challenging to 
capture.   
First, Ttk69 expression is very dynamic and occurs within the somatic 
mesoderm only very shortly when the mRNA, but not the protein, can be detected 
during stage 11.  The fact that the expression of the protein is even harder to detect is 
not surprising, considering the multiple mechanisms that suppress ttk69 mRNA 
translation and promote protein degradation (see Section 1.4.3).  In addition, small 
differences in the levels of Ttk69 protein in two types of tracheal cells are essential 
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for their subsequent fusion [162].  Similarly, the difference between ttk69 mRNA 
levels between the muscle FCs and FCMs may be too subtle to be uncovered.  
Additional mechanisms would then prevent accumulation of functional Ttk69 protein 
in FCs.  One such possible mechanism is proteasome-dependent degradation which 
reduces Ttk69 protein levels in the eye imaginal disc and requires the presence of 
Phyllopod, an adaptor protein linking E3 ubiquitin ligases to their targets [187, 193].  
Interestingly, Phyllopod is activated by RAS/MAPK signalling not only in the eye 
disc [255], but also in muscle founder cells where it is necessary for the specification 
of distinct muscle identities [256].  Proteolysis of Ttk69 exclusively in the FCs 
through Phyllopod might therefore be one mode of achieving its differential 
expression. 
 
5.3.2.1 Lame duck as a possible regulator of Ttk69 in FCMs 
Analysis of the occupancy of Ttk69 and Lmd suggests that they may both 
function in specification of FCM fate, separately and jointly.  However, the regulatory 
relationship between Ttk69 and Lmd themselves has not been explored.  In ttkD2-50 
homozygous embryos, the levels of lmd mRNA are decreased at stage 13, but this is 
probably a secondary effect due to decreased number of correctly specified FCMs 
rather than a direct regulatory input of Ttk69.   
Several observations however suggest that Lmd could contribute to Ttk69 
activation directly: 
o Lmd and Mef2 co-bind to multiple CRMs in the vicinity of ttk locus (Figure 5.3-
2).   
o One of the CRMs associated with ttk was previously tested by P. Cunha in our 
lab, using luciferase reporter assay [214], where Drosophila S2 cells were transiently 
transfected with Lmd and Mef2 expression vectors.  The assay revealed that either 
Lmd or Mef2 alone could weakly activate the CRM, while their combination led to a 
dramatic enhancement of its activity.  Lmd and Mef2 might therefore cooperatively 
activate ttk69 expression also in vivo. 
o Expression profiling of lmd mutant embryos revealed a slight decrease of ttk69 
mRNA levels when compared to their wild type counterparts [257]. 
 Twist may also activate ttk69 expression by binding to multiple regions within 
the ttk69 locus (Figure 5.3-2).   However, the input from Lame duck (possibly in co-
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operation with Mef2) may be another mechanism by which the presumed FCM-
specific expression of Ttk69 is reinforced.  
 
 
Figure 5.3-2: Twist, Mef2, and Lmd co-occupy CRMs within the ttk locus 
ChIP-on-chip binding profiles of Twi, Mef2 (from [196]), Lmd, and mesodermal CRMs 
bound by at least one core myogenic TF at one assayed time point (black, from [196]). An 
asterisk marks a gene annotated only with the Release 5 of Drosophila melanogaster genome 
whose existence is considered dubious [258]. 
 
 
5.3.2.2 Notch signalling may contribute to Ttk69 regulation in the mesoderm 
The Notch pathway is essential at multiple stages of somatic mesoderm 
development (see Section 1.3.4.1).  Ttk69, in turn, genetically interacts with Notch in 
several distinct cell types.  It is therefore tempting to speculate that Notch signalling 
and Ttk69 are associated in their function in muscle development. 
Selection of a single progenitor from the proneural and myogenic competence 
fields is controlled by a remarkably similar set of regulators and principles.   In the 
nervous system, Notch signalling suppresses neuronal fate and in the mesoderm it 
antagonizes myogenic fate.  Ttk69 acts downstream of Notch signalling and represses 
neuronal genes in non-neuronal cells [163, 182].  Similarly, Ttk69 may be activated 
by Notch signalling in the muscle non-progenitor, FCM cells, where it could repress 
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the myogenic, or FC-specific, genes.  Notch activity is necessary for the activation of 
lmd in the somatic mesoderm [132], hence it could in parallel contribute to ttk69 
activation.  The proposed model of the role of Ttk69 role in myogenesis would 
therefore be consistent with its activation by Notch signalling and it could be a novel 
Notch effector reinforcing FCM fate.  However, experimental evidence for a genetic 
interaction between Notch and Ttk69 would be required to confirm their association 
in the somatic mesoderm. 
 
 
 
Figure 5.3-3: Model of a Ttk69 expression and function in FCM specification 
A simplified model of experimentally confirmed and predicted regulatory connections 
upstream and downstream of Ttk69.  Dashed lines indicate indirect regulation, solid direct 
regulation, and the connections in grey are hypothetical and would require experimental 
evidence. Ubi- ubiquitinated. 
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5.3.3 In vivo activity of Ttk69 CRMs suggests that Ttk69 might 
contribute to transcriptional activation 
5.3.3.1 Ttk69 CRMs have diverse spatio-temporal activities  
Analysis of Ttk69 CRMs identified in the ChIP-on-chip experiment provided 
several unexpected insights into the regulatory potential of Ttk69: 
o All three tested CRMs drive a highly dynamic lacZ reporter expression in complex 
spatio-temporal patterns throughout embryogenesis.     
o The CRM activity peaks with the onset of segmentation, coinciding with the robust 
initiation of Ttk69 expression in the mesoderm, nervous system, and ectoderm (Table 
1.4-1).  The CRMs drive expression in the tissues where Ttk69 itself is expressed, 
such as visceral mesoderm, tracheal placodes or nervous system.  Ttk69 is however 
not present in all the cells within these tissues, for example in the nervous system it is 
only expressed in glia and not neurons [155].  Therefore a double in situ hybridization 
assay against ttk69 and lacZ would be necessary to reveal their overlapping or 
complementary expression. 
o In the case of one CRM, jumuA, mutagenesis of the Ttk69 binding sites resulted in 
ectopic lacZ expression in seven transverse stripes at stage 5.  Maternal Ttk69 has a 
well documented role in the repression of pair rule genes [160].  Interestingly, Ttk69 
itself is expressed ubiquitously so derepression of the CRM in vertical stripes cannot 
be simply explained by the inability of Ttk69 to repress the mutated CRM in these 
domains.  However, Ttk69 may act as a short-range repressor and counteract 
activation of the CRM by a transcriptional activator that is expressed in a pair rule-
like fashion.   This would suggest that in the wild type situation, the CRM is inactive 
not because of a lack of activation but rather because of active repression by Ttk69.  
A mechanism of active repression is used during maternal-zygotic transition when a 
progressive dilution of Ttk69 protein levels was hypothesized to establish the onset of 
zygotic transcription [169].  The wild type jumuA enhancer however remains inactive 
until the end of stage 10, which is several hours after depletion of maternal Ttk69 
protein, arguing against its control at the maternal-zygotic transition.  
o Most CRMs show decreased activity upon mutagenesis of Ttk69 binding sites.     
The reduction is not global, but rather specific as it differs between the CRMs and the 
sites of activity.  jumuA-Ttkmut not only shows derepression at stage 5, but also 
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reduced tracheal expression at stage 11.  The wild type CRM jumuB is expressed in 
trachea as well, but its tracheal activity is unaffected when Ttk69 sites are mutated.  
Instead, jumuB-Ttkmut is active in fewer cells of the nervous system compared to the 
wild type enhancer.  The loss of expression upon mutagenesis of Ttk69 sites implies 
that Ttk69 is needed for the activation of these CRMs rather than repression.   
o Finally, all three wild type CRMs drive strong expression in the caudal visceral 
mesoderm, the primordium of the longitudinal visceral muscle.  In mutant versions of 
all CRMs, this very specific and strong expression is completely lost.  This result is 
even more surprising considering that I could not detect Ttk69 expression in these 
cells.  A possible reason for the lost expression could be that the mutagenesis of 
Ttk69 sites interfered with the binding sites of another, positive regulator, which is 
not able to bind and hence activate the mutant CRMs in the cells of caudal visceral 
mesoderm.  
 Importantly, in the CRMs jumuA and jumuB only some of the predicted Ttk69 
binding sites were mutated (see Appendix section 4.4 for sequences).  Therefore it 
cannot be excluded that the complex changes in their CRM activity reflect residual 
binding of Ttk69.  The Ttk69 motifs might be used differentially across space and 
time so the generated mutations could affect expression only in some tissues or at 
some time points. Consequently, a complete mutagenesis of all putative Ttk69 might 
result in different cis-activities. 
5.3.3.2 Ttk69 as a potential transcriptional activator 
 As the analysis of the activity of Ttk69-bound CRMs in vivo activities suggests, 
Ttk69 may not be a dedicated repressor as it has been traditionally thought.  Instead, it 
could act as a bimodal transcriptional regulator that is acting in a context-dependent 
manner.  To validate that the loss of enhancer activity upon site mutagenesis is indeed 
due to absence of Ttk69 binding, the activity of the wild type CRMs should be 
investigated in ttk69 loss-of-function background.  Such an experiment would also 
clarify whether the activity of wild type CRMs in the caudal visceral mesoderm is 
indeed genetically dependent on Ttk69.   
Another piece of evidence supporting a positive regulatory role of Ttk69 comes 
from studies during tracheal development [162].  In ttk69 mutant embryos, expression 
of bnl and pyd is lost in the trunk visceral mesoderm and tracheal placodes, 
respectively [162].  Although this loss of expression was presumed to be an indirect 
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effect, our ChIP-on-chip data identified Ttk69 binding in the vicinity of these genes, 
suggesting that it may be direct.  Additional experimental evidence would therefore 
be required to confirm the direct positive regulatory input from Ttk69. 
5.3.4 The many aspects of Ttk69 regulatory roles 
Dissection of the myogenic role played by Ttk69 has revealed a remarkable 
variety of processes in which Ttk69 is likely to be involved: 
o Primarily, by repression of founder cell-specific genes, Ttk69 participates in the 
specification of fusion competent myoblasts and its presence is vital for the proper 
balance between the number of founder cells and fusion competent myoblasts. 
o Ttk69 and Lmd regulate distinct sets of target genes, yet they co-occupy a 
significant number of mesodermal CRMs.  As there are indications that both 
transcription factors might be able to activate as well as repress transcription [257], 
the cis-regulatory input to their combinatorial binding might be highly diverse (Figure 
5.3-3).  However, the possibility that the co-binding does not occur within a single 
cell cannot be excluded as the CRMs might be activated by Lmd in the FCMs but 
repressed by Ttk69 at other sites of its expression, such as visceral mesoderm, 
ectoderm, or endoderm. 
o In addition to the developmental cell fate choice between two closely related cell 
identities, Ttk69 might also act across tissues to reinforce tissue-specific gene 
expression.  The experimental evidence comes from the mesodermal expression of a 
neuronal marker and the ectodermal and endodermal expression of a founder cell 
marker in ttk69 mutant embryos. 
o Computational analysis, validated by genome-wide in vivo occupancy studies, 
implicates Ttk69 in incoherent feed-forward regulatory loops.  Through 
combinatorially bound mesodermal CRMs, Ttk69 may act to control temporal 
expression of early mesodermal genes. 
o Ttk69 may not act as a dedicated repressor but instead may contribute to 
transcriptional activation.  Mutations in a number of Ttk69 binding motifs result in 
specific loss or downregulation of CRM activity.  A number of genes are also 
genetically dependent on Ttk69 for their active expression [162], further supporting 
its possible function in positive gene regulation. 
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5.4 Snail is a bimodal factor that can both activate and 
repress transcription 
Based on multiple experimental observations in Drosophila as well as other 
species, the possibility that Snail plays a dual regulatory function as a transcriptional 
activator and repressor was investigated.   Luciferase reporter assays in Drosophila 
cells showed that Snail can indeed stimulate activity of three mesodermal CRMs.  
Interestingly, its positive function seems to be dependent on other factors, as Snail 
transfection alone does not affect reporter levels.  Snail enhanced Twist-mediated 
activation of two mesodermal enhancers approximately 2-fold, while in combination 
with the TF Dorsal it could stimulate the CRM activity to more than 4-fold.  
Mutagenesis of the putative Snail binding motifs in one enhancer, Mef2 I-D[L], 
showed that direct DNA binding is necessary for Snail to elicit this transcriptional 
activation both in vitro and in vivo.   
At these same stages of development and in the same cells, Snail acts to repress 
non-mesodermal genes.  How can Snail discriminate between its positive and negative 
targets to elicit two opposite transcriptional responses?  Two possible models, for 
which there is also precedence in other developmental contexts, may explain this. 
According to the first model, the DNA sequence recognized by the Snail protein 
plays an active role in dictating the direction of its regulatory input.  Several bimodal 
transcription factors undergo allosteric changes upon binding to DNA (reviewed in 
[259]) which in turn might lead to direct protein-protein interaction with specific 
protein factors.  In the simplest scenario, there would be two versions of Snail binding 
motifs, leading to different conformational changes of Snail upon DNA binding and 
therefore recruitment of distinct co-regulators.  For example, the repressive motif 
would expose the protein sequences mediating interaction with the co-repressors 
CtBP [13] and Ebi [9], whereas the activatory binding site would lead to interaction 
with transcriptional co-activators.  A similar mechanism was suggested for the DNA-
binding protein dTCF, the effector of Drosophila Wingless (Wg) signalling.  dTCF 
was traditionally viewed as a transcriptional activator induced by Wg signalling, but 
recently, genes repressed by dTCF were identified in several developmental processes 
[260, 261].  Analysis of the cis-regulatory region of one of these genes revealed a 
binding motif distinct from the typical dTCF binding site necessary for activation 
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[262].  In addition, the two different modes of activity depend on different domains of 
the TCF partner protein Armadillo, suggesting that they may be responsible for 
recruiting distinct co-factors [262].  If Snail functions in a similar manner, it should be 
possible to identify different Snail binding sites within the mesodermal enhancers 
compared to non-mesodermal enhancers.  
 In an alternative model, Snail would use one type of binding motif, but the 
response to Snail binding would be controlled by additional factors bound in its 
vicinity.  Interaction with such factors would influence, possibly again via 
conformational changes, whether a co-activator or a co-repressor would be recruited. 
The morphogen TF Dorsal functions in a context-dependent manner.  Although 
Dorsal is inherently a weak transcriptional activator, it can also repress specific genes.  
The Dorsal binding motifs that are necessary for the two modes of regulation are very 
similar.  When the Dorsal binding sites in an activated enhancer are replaced by the 
sites from a repressed enhancer, Dorsal can still activate the enhancer [263], 
suggesting that it is not the binding sites themselves, but rather the context of the 
enhancer that influences the direction of regulation.  If Snail requires an additional 
DNA-binding factor to determine the output of its regulation, the binding motifs of 
this factor should be found in the vicinity of the Snail-bound sequences. 
 To elucidate which mechanism is used by Snail, Snail-bound enhancers were 
classified as activated or repressed and scanned for differences in their sequence 
composition (A. Stark, unpublished data).  Unfortunately, up to now no alternative 
Snail binding motif or a binding site of another regulator was found to be enriched in 
either of the two enhancer classes. It cannot be excluded that Snail operates by 
another, novel mechanism.  An informative experiment would be to purify Snail 
protein complexes bound to mesodermal and non-mesodermal enhancers and 
subsequently compare the proteins interacting with Snail in each context.    
 The importance of Snail contribution to transcriptional activation is 
exemplified by the gastrulation defects and loss of mesodermal gene expression in 
snail mutants.  Being one of the earliest zygotically expressed genes [264], in wild 
type embryos Snail might be necessary to establish fast and robust activation of the 
mesodermal specification program in combination with Twist and Dorsal.  What is 
the exact mode of co-regulation between these three TFs and whether they interact 
physically remains to be addressed. 
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As we are only beginning to decode the regulatory events leading to muscle 
specification and differentiation, the currently known regulators cannot generate the 
diversity and complexity of observed cis-regulatory responses.  Other, as of yet 
unidentified, transcription factors clearly must play a role. I therefore initiated my 
PhD. research by conducting a molecular screen with the main objective to identify 
transcriptional regulators that are required for muscle development and hence are 
likely to contribute to the control of mesodermal gene expression.  The screen 
identified 20 genetic loci, deletion of which led to a spectrum of somatic muscle 
phenotypes.  Although the extent and strength of the mutant phenotypes varied, 
myoblast fusion, determination of distinct muscle fibre identity, and myotube 
guidance were the most frequently affected processes.  
Since the used deficiency lines typically deleted multiple gene loci, an 
additional dissection of the genomic region is required to identify the individual gene 
responsible for the observed muscle phenotype.  The regions whose deletion led to the 
most severe defects, could be systematically dissected using smaller deletion lines 
generated with available transposon-based recombination systems.  Alternatively, the 
deleted genes could be knocked down by RNA interference once its technical 
limitations are resolved.  When the identity of causative gene is known, its role in 
muscle development could be further characterized by genetic as well as genomic 
approaches.  I used a combination of these approaches to perform a detailed analysis 
of the role of members of the Mediator complex and the transcriptional repressor 
Tramtrack in muscle development.   
A more thorough analysis of two genes encoding subunits of the general co-
activator Mediator complex was conducted.  Although MED24 seems to play a role in 
mesodermal cell proliferation rather than specification, the results of RNA 
interference experiments point to a broader function of the Mediator complex in 
muscle development.  Given the accumulating evidence for specific developmental 
roles of distinct Mediator subunits in Drosophila as well as other species, it probably 
remains only a matter of time until a link between the general transcriptional 
apparatus and embryonic muscle development will be established.   
6 CONCLUSIONS AND FUTURE DIRECTIONS 
 
 -169- 
One of the more surprising outcomes of the molecular screen was the 
identification of Tramtrack (Ttk) as a potential new regulator of muscle development.  
The role of Ttk has been extensively studied in the context of neuronal and sensory 
organ precursor development.  As there are many genetic tools already available, I 
performed a detailed genetic and molecular characterisation of the role of this gene in 
mesoderm development.  Ttk is a transcriptional repressor, which may account for its 
rather unusual myoblast fusion phenotype in loss-of-function embryos. The myoblast 
fusion defect can be attributed to an imbalance between the number of the two types 
of fusing cells.  Similar to the nervous system, Ttk69 contributes to repression of the 
default, founder cell fate in the fusion competent myoblast (FCM) cells. 
Establishment of an FCM identity therefore requires active repression of the 
alternative, founder cell fate, concomitantly with activation of the FCM program.  
Importantly, the role of Ttk69 in repression of myogenic genes was confirmed by a 
global ChIP-on-chip analysis, which revealed an extensive overlap with the binding 
profiles of other mesodermal transcription factors.  One of them, Lame duck, the key 
regulator of FCM specification, co-occupies a substantial number of Ttk69-bound 
CRMs, which are associated with mesodermal genes.  The functional significance of 
this co-binding for mesodermal gene expression and myogenesis however needs to be 
further dissected. 
Analysis of Ttk69-bound CRMs in transgenic reporter assays revealed that the 
regulatory inputs of Ttk69 are highly complex and diverse.  Surprisingly, it also 
indicated that Ttk69 might act as a bimodal factor, regulating expression of its target 
genes both positively and negatively.  The ability of sequence-specific developmental 
regulators to influence transcription in both directions may be a more widespread 
phenomenon than generally anticipated. During my Ph.D. studies, I showed that 
Snail, another well-characterized repressor, can enhance activity of several 
mesodermal enhancers both in vitro and in vivo.  Elucidating the mechanisms by 
which Snail, and possibly Ttk69, discriminate between the positively and negatively 
regulated target genes and elicit their differential transcriptional response is of 
foremost interest, especially if the ability to stimulate transcription is a more general 
property of transcriptional repressors. 
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Appendix 7.1: Analysed RNAi lines and their phenotypes 
Expression of mesodermal genes whose deletion by deficiency lines shows muscle 
phenotype, or encode subunits of the Mediator complex, was knocked down specifically in 
mesoderm using the panmesodermal twi, 24B-Gal4 driver and one or more gene-specific 
UAS-RNAi lines.  Phenotype was scored as “viable“ (in light grey) or “lethal“ (in red) and 
the time point of lethality was recorded.  The results were compared with the genome-wide 
RNAi screen performed with Mef2-Gal4 driver [252].   
* the stage of lethality was not determined as the RNAi line was homozygous lethal and so 
adult, heterozygous offspring was always born (lethality was identified as absence of adult 
flies lacking the balancer chromosome) 
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Appendix 7.2: Embryonic expression of genes encoding the Mediator complex subunits 
Expression of 25 out of 33 Mediator genes was investigated by colorimetric in situ 
hybridization in wild type embryos and imaged during five different stages of embryogenesis.  
The genes were grouped by their overall expression and presence in mesoderm.  Probe against 
lacZ was used as a control for no expression. 
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Appendix 7.3: Overview of Ttk69 CRMs in the vicinity of its known downstream targets    
Normalized ChIP signal for Ttk69 is plotted in purple colour with significantly bound CRMs 
in the track below.  In black are mesodermal CRMs derived from ChIP-on-chip experiments 
with 5 key mesodermal TFs over 5 time points [196].  Ttk69 has been previously shown to 
directly regulate tll (A), eve (B), and stg (C) and either directly or indirectly dpn (D), sc (E), 
scrt (F), and CycE (G) in black.  Red lines indicate previously experimentally verified Ttk69 
binding sites in the promoter regions of tll (A), eve (B), and stg (C). 
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7.4 Sequences of cloned enhancers 
7.4.1 Sequences of Tramtrack69-bound enhancers 
Underlined are all predicted Ttk69 binding sites and in red are highlighted the 
base pairs that were mutated. 
 
JumuA (671 bp) 
GGTTGTGTTTATTTTGCTAGCCACCACTGTATGTACTCTCAGAAAATGTTT
ACATGTTGCTGATACTTTTTTTGTTGTACTGGTTCTGGTGTTGCAACATGA
GTTATTTTCGTTGTTTTGGTTGTTGTTGGGCGTGCTACAGGGAACTCAGAA
ATATCCAAACCCCCGACTTTTTCCCTTTTCCTATCCTTTGGCCGTCTGCTTC
GGTTTTGTTTATTTTTTTTCCTCTTACAGCCTGCCTGCCTTGGCGCGCAAAA
CTGGTTTTGAACTCGGCTCTGTTGCTCCTGTGGTCCCTCATTTGTTGTTGTT
GCTATTTTGTGTATTGTTGTTGTCCGTGCCTCATGTAGAAAATGAAAACTT
ATACGATCCCCACAAATATCAGCACAGGGATATCGGATTCGTATTCGGAC
CCAGATTCGAGCGACTTGTGTTACAGATTTAATCATTATAATATATGTACA
TATGTATGTTCTTATATACATACATATACTTGTATGTATGCGTGCCTATAT
GTGTGCAAAGGAATTGTAACCTATGGAATTCTTAGGAAAATAAATGCGCG
GGAAAACGATCAGTACGTGTTTCTGGATTTGTTTATGTTTTGATTGTGCTA
AGCGTAGCGGATAAAATGAAATAGTATATTCTTGCATAGCGGGCAAATAC
TTGATTCC  
 
 
JumuA-Ttkmut (671 bp) 
GGTTGTGTTTATTTTGCTAGCCACCACTGTATGTACTCTCAGAAAATGTTT
ACATGTTGCTGATACTTTTTTTGTTGTACTGGTTAAAGTGTTGCAACATGA
GTTATTTTCGTTGTTTTGGTTGTTGTTGGGCGTGCTACAGGGAACTCAGAA
ATATCCAAACCCCCGACTTTTTCCCTTTTCCTATCCTTTGGCCGTCTGCTTC
GGTTTTGTTTATTTTTTTTCCTCTTACAGCCTGCCTGCCTTGGCGCGCAAAA
CTGGTTTTGAACTCGGCTCTGTTGCTCCTGTGGTCCCTCATTTGTTGTTGTT
GCTATTTTGTGTATTGTTGTTGTCCGTGCCTCATGTAGAAAATGAAAACTT
ATACGATCCCCACAAATATCAGCACAGAACTATCGGATTCGTATTCGGAC
CCAGATTCGAGCGACTTGTGTTACAGATTTAATCATTATAATATATGTACA
TATGTATGTTCTTATATACATACATATACTTGTATGTATGCGTGCCTATAT
GTGTGCAAAGGAATTGTAACCTATGGAATTCTTAGGAAAATAAATGCGCG
GGAAAACGATCAGTACGTGTTTCTGGATTTGTTTATGTTTTGATTGTGCTA
AGCGTAGCGGATAAAATGAAATAGTATATTAAAGCATAGCGGGCAAATA
CTTGATTCC  
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JumuB (857 bp) 
AACCAACTAATTGCCCCAAAAAACCCTCACAGTCTCAGCAAATGGACTTC
CAGGCTAAAAATAAACATTTGGCAAATCTGATTTCTTGAAACACATGCAG
TTAATGAATGAAATAACCCGGAGAATCTGCCGATTTACTTCCCGCTAAAC 
CGAGAGATTTGAAAACGATTTACGACCCTGGATCATCCTGTGTGTTTAAG 
GATGTTACTTTGCGTTGGGAATCGGTCGGCAATTCAGGCAAGCGACTTTT 
ATTGCACCATAAAGTAATTTACAAATGGGCGCTCATGACCTCAGGGAAGA 
TTCGTCCAGAAAGGTCCACGGAAATCGTTGGTTTTACCTGAGTGAGGGAT 
TCCATTGCATTCCATTCCTTACCATCCTCCTCCCATCATTATTTACCATCTC
TTCTTGTGTTTTCTCTGTGTGTCAGCAGAGTGATTTCCTTCGGAGGTGAAA
GGCGGAGAAAGATGGAAAATATGTGCAACAAAAGAAACGAAGCAGATGC
AGGAAATGCAGGAGAACACTTACAACCATCGCCAGTGACGAATCCTGCCG
AGAAAGGACGAAAATACCCTCGTCGGCAGCTCCTTGGTTCGTTGCACAAC
TTGAAAAGGCCAACTGTAGGCAGCTGCAACAGAGCAGCAAAAACTTTTTA
TGGCCTACGGTGGGTTGTATGGGAGGGGGTGCTGAAATACGGGAGTGGTG
GCGGTGTCTGTAAGCCTCGTCGAAGTTTTACTGACAACTTTTGCATTTTCC
TTTAATCCCCCCGATAACCAAAAGCAGCTTGCTGTGAACTTTGCTCGCCTG
TTTGATGCATTTTTATTTCGGCACATTTTTTCGAGAATTTTTTGGGGGGGCA
G  
 
 
JumuB-Ttkmut (857 bp) 
AACCAACTAATTGCCCCAAAAAACCCTCACAGTCTCAGCAAATGGACTTC
CAGGCTAAAAATAAACATTTGGCAAATCTGATTTCTTGAAACACATGCAG
TTAATGAATGAAATAACCCGGAGAATCTACCGAATTAAAACCCGCTAAAC 
CGAGAGATTTGAAAACGATTTACGACCCTCAATCATCCTGTGTGTTTAAG 
GATGTTACTTTGCGTTGGGAATCGGTCGGCAATTCAGGCAAGCGACTTTT 
ATTGCACCATAAAGTAATTTACAAATGGGCGCTCATGACCTCAGGGAAGA 
TTCGTCCAGAACGAACAACAGCAATCGTTGGTTTTACCTGAGTGAGGGAT 
TCCATTGCATTCCATTCCTTACCATCCTCCTCCCATCATTATTTACCATCTC
TTCTTGTGTTTTCTCTGTGTGTCAGCAGAGTGATTTCCTTCGGAGGTGAAA
GGCGGAGAAAGATGGAAAATATGTGCAACAAAAGAAACGAAGCAGATGC
AGGAAATGCAGGAGAACACTTACAACCATCGCCAGTGACGAAAAATGCC
GAGAAAGGACGAAAATACCCTCGTCGGTCACAAATTGGTTCGTTGCACAA
CTTGAAAAGGCCAACTGTAGGCAGCTGCAACAGAGCAGCAAAAACTTTTT
ATGGCCTACGGTGGGTTGTATGGGAGGGGGTGCTGAAATACGGGAGTGGT
GGCGGTGTCTGTAAGCCTCGTCGAAGTTTTACTGACAACTTTTGCATTTTC
CTTTAATCCCCCCGATAACCAAAAGCAGCTTGCTGTGAACTTTGCTCGCCT
GTTTGATGCATTTTTATTTCGGCACATTTTTTCGAGAATTTTTTGGGGGGGC
AG  
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rib (426 bp) 
AGACTGGGACACAGCTATGCCCCTCTCCCTCGCACGCACTGCATCCAATG
GCAGCAACCATATATGCAGCTCGCACACACATGCACGCACGCACACGCAC
ACAAGCAGTCGCAATCGCAATCTCGCTCACGCACAAAACTGCAACTGCGC
GAAAGAGAGGGCGCGAGGGTGGATTCGTAGCACAGTTTTCCTGTTTCCCC
TTCGCATTCGAACAGTTTTCTCGCCGCTCTCTCGCTCTCACCCTCTGTGCAT
CGCTCCATCCCGCTCTGGCAGCGCTCGGGAAATTTGGTCTTCAATGACTTG
CTGCACACGAAAACCGTGGCAGTTTTATTCAAGTTTGAGCGCTCGAATCT
GCAACAACGTGCACGCAAAACTCTCAAAATTTTCTCAAAAACATCAAAAT
CACAAGGCGAGCGGAAAACTCAAG  
 
 
rib-Ttkmut (426 bp) 
AGACTGGGACACAGCTATGCCCCTCTCCCTCGCACGCACTGCATCCAATG
GCAGCAACCATATATGCAGCTCGCACACACATGCACGCACGCACACGCAC
ACAAGCAGTCGCAATCGCAATCTCGCTCACGCACAAAACTGCAACTGCGC
GAAAGAGAGGGCGCGAGGGTGGATTCGTAGCACAGTTTAAATGTTTCCCC
TTCGCATTCGAACAGTTTTCTCGCCGCTCTCTCGCTCTCACCCTCTGTGCAT
CGCTCCATCCCGCTCTGGCAGCGCTCGAACAATTTGGTCTTCACACACTTG
CTGCACACGAAAACCGTGGCAGTTTTATTCAAGTTTGAGCGCTCGAATCT
GCAACAACGTGCACGCAAAACTCTCAAAATTTTCTCAAAAACATCAAAAT
CACAAGGCGAGCGGAAAACTCAAG 
 
 
7.4.2 Sequences of Snail-bound enhancers 
Underlined are putative Snail binding sites and in red are highlighted the base 
pairs that were mutated (shown only for the enhancers that had a mutant version 
generated). 
 
Mdr49 early mesoderm (382 bp) [56] 
GCAACAAAGTCGATCGTATAACTAATCGGGATTCCCGCCTGGCAACCCGC
CTGTTCCTCGCACTCGTCCAGGCGGCGGGAAATACTGGTTCCTAGTCGCTG
GTCCTGTAACCAAAACAGAGCCATAAAGACGATGCAGATTAGATTGATTA
GACAGTTATGTTGTACGTACATACCATCGATTCGGCGTAAGTTTGTTATCA
GTCTCTCGTAACCGGTATTTGTTTACTGACCCAGCGTGTCCATAGATGCAG
TGGAGTCGGGTCTTTTTTGGCCAAAACAAAAACGGACTAAGCGTAATCCA
TTTGCGCGCATGGTTTTCCCCGCGCAAAAGATTTTAAGCTGAATTCG 
CCAGATCGGGGGACTAACCGAGAGGAAATCTG  
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WntD-lacZ (523 bp) [56] 
ATAGCCTGCAAATCCCAAGCCAGGGCGCCCTCCTGGGGCCGGCCCGTGGG
AATTTCGGGCCTGCTCAAAAAACCGGAAATTTGCCGTTTTCCACTTGGAA
ATTTTGCATGGGCAGGGGGTAGGAACTCCCGGCAATGGACGGGTACAAA
AACCCACTGGCAGCCCGAGACGCAATTGCGGAGCAGCCCAGTTTCCTGGT
TGACTACCTGCTCTCGTCCTGCGCCGGCGGAGGTGAAGGATCCGCCTTGCT
GCGAGCAAGTTTCCCACGCTTAGGCAGGTAGAGCCGTAAACGGCACCCGA
CGTGCTCATGAATGAAGCCCAGTCGAGTCCATTCAATACGGCCGGATTTT
CCCGGACTCACACTGCACAACATCAATGCCCGATACGGGGACGGGTTTGT
TTGGGTTTTGGACTGGTCAAGCCAATTATATAACAAAACATATGACCAAC
AGTATATACACGTATAATCTGGGAAATTAATTGTCCTTTGTGGTGAGCCGG
CGGGAACTGCCAGTATTGTTGC  
 
 
Mef2 I-D[L] (480 bp) [236] 
CTGTAAAAATCACGCATAACCGATACCAAGTGCAGCGCGACCAAGTTACC
CGTTTTATGGCCCTCGCCTCTCGGCGGCGCCACAATGTTGCATTTTGAGAA
CCGAACCCAGCAGCAAACGATCCATGTGTGTATATCCGAAGATCCCTTTC
TCACTTCCACTCCCATTACCATTCCCATTTCCATTTCCATTTCCATTCTGAT
TCCCGTTTGCAGTGTCCTTGTGACTTTTAACGCTTCCACTGGGTGCGACAA
CTGCCAACTGCAAACAGTCGTCGACAGTCTTAATTCAATAAACGCCGCCC
GGCGATTTGCGCATGACCATGTACCCCGATGCTGTGCGCCGTACGGTTGA
TGCTGCATGTTGCATGCACTCAACACATGTGCAACATGCGGCATCTGCGG
CAGTAGCAGCAGCAGCAGCATCGGCCTCAATGTGCGTTGAGTCCGA 
CTTTAACTGCTTGGCAGGGGTTTCTTCAGG  
 
 
Mef2 I-D[L] Sna123 (480 bp) 
CTGTAAAAATCACGCATAACCGATACCAAGTGCAGCGCGACCAAGTTACC
CGTTTTATGGCCCTCGCCTCTCGGCGGCGCCACAATGTTGCATTTTGAGAA
CCGAACCCAGCAGCAAACGATCCATGTGTGTATATCCGAAGATCCCTTTC
TCACTTCCACTCCCATTACCATTCCCATTTCCATTTCCATTTCCATTCTGAT
TCCCGTTTGCAGTGTCCTTGTGACTTTTAACGCTTCCACTGGGTGCGACAA
CTGCCAACTGCAAACAGTCGTCGACAGTCTTAATTCAATAAACGCCGCCC
GGCGATTTGCGCATGACCATGTACCCCGATGCTGTGCGCCGTACGGTTGA
TGCTGAGTATTGCATGCACTCATCACATGTGCAATACTCGGCATCTGCGGC
AGTAGCAGCAGCAGCAGCATCGGCCTCAATGTGCGTTGAGTCCGA 
CTTTAACTGCTTGGCAGGGGTTTCTTCAGG  
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Tin B-374 (403 bp) [60] 
TCAAGCGTTGAGCGTTGAGCTCGAGGCTTTGACAAATCATCGTTATTTGTA
CAAGAGGCCGAAGACAAAGACGAGGAGAGACAGTGTTAACAATAAGAAC
AACAATGTCCGAGGCAGGCAGTCGGGAGTCACGGCGATCGCTGGTCCGCC
CGATCCCTTCTGGGCTGGTCAACATGTGTGATTCGCATGTGTGGACCGCCG
CACAGGGGCGTCCTTAATTGCCTGATGAGCCATGAAATGATGTCACCATG
GATCCTGTCGCGCCAGCAGGAAGTGGGCAAAAAGTCCTCGTCCCAGCTCC
CCGGGCTGTGTCCTCCGTGATGCAACATATGGCGGCCATATACGAGACTT
TGTATTGCCTTGTTTCTAACCTTGCGCTTTTCCATTTTCCTGCTTTCCCGCA 
 
 
 
Tin B-374 Sna4 (403 bp) 
TCAAGCGTTGAGCGTTGAGCTCGAGGCTTTGACAAATCATCGTTATTTGTA
CAAGAGGCCGAAGACAAAGACGAGGAGAGACAGTGTTAACAATAAGAAC
AACAATGTCCGAGGCAGGCAGTCGGGAGTCACGGCGATCGCTGGTCCGCC
CGATCCCTTCTGGGCTGGTCAACATGTGTGATTCGCATGTGTGGACCGCCG
CACAGGGGCGTCCTTAATTGCCTGATGAGCCATGAAATGATGTCACCATG
GATCCTGTCGCGCCAGCAGGAAGTGGGCAAAAAGTCCTCGTCCCAGCTCC
CCGGGCTGTGTCCTCCGTGATGCAACATATGGCGGCCATATACGAGACTT
TGTATTGCCTTGTTTCTAACTTCTCGCTTTTCCATTTTCCTGCTTTCCCGCA  
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